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Abstract 
 
The technological developments seen in recent years have facilitated remarkable progress in the field 
of flexible gastrointestinal (GI) endoscopy. Smaller high-resolution charge-coupled devices (CCDs) 
have facilitated the manufacture of ultrathin (UT) (<6mm) endoscopes, while the introduction of 
device assisted enteroscopy (balloon-assisted and spiral enteroscopy) has allowed endoscopists to 
access the deep small bowel (SB) without the need for recourse to major surgery. Furthermore, the 
application of double-balloon colonoscopy (DBC) has shown promise to improve outcomes in 
patients with ‘technically difficult’ colons. Although these 3 types of innovative endoscopic 
technologies all share the potential capacity to enhance minimally invasive patient care, research into 
their optimal role and effectiveness (particularly within UK clinical practice) remains limited.  
This thesis has examined the potential role of this selection of advanced flexible GI endoscopic 
technologies for the enhancement of minimally invasive patient care. The first study evaluated 
transnasal upper GI endoscopy in the UK and confirmed that within this clinical paradigm, transnasal 
endoscopy using UT endoscopes, is a feasible, effective and more acceptable alternative to patients 
than conventional oral upper GI endoscopy. The next series of studies were dedicated to device 
assisted enteroscopy (DBE in particular) and showed that DBE is capable of providing a safe and 
effective, minimally invasive alternative to major surgery in selected cases. A comparison of spiral 
enteroscopy as an alternative to DBE, showed that spiral enteroscopy (in its current, manual form), 
appears to be inferior to DBE in its ability to facilitate deep enteroscopy. The final study evaluated 
technically difficult colonoscopy and included the development and validation of a score for 
technical difficulty which may in the future be applied to routine clinical practice. This study also 
highlighted the usefulness of DBC as a potentially more effective tool than conventional colonoscopy 
for technically difficult cases.  
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Introduction 
1.1 Minimally invasive aspects of gastrointestinal endoscopy: technological 
advancements in response to anatomical and physiological challenges  
 
1.1.1 Upper gastrointestinal (GI) endoscopy 
Although diagnostic oral upper GI endoscopy is one of the most common investigations 
performed in gastroenterology, it remains an uncomfortable procedure for patients [1-4]. This 
unpleasant experience is mainly the result of repeated triggering of the pharyngeal ‘gag’ reflex, 
caused by stimulation of afferent glossopharyngeal nerve fibres located in the tongue root, uvula 
and palatine arches (Figure 1), during insertion and withdrawal of the endoscope [1-4]. 
Upper GI endoscopy often remains unpleasant for patients despite the use of topical anaesthesia 
and/or intravenous conscious sedation. Furthermore, the use of sedation is associated with most 
of the serious adverse events relating to endoscopy, prolongs patient recovery time and 
introduces added costs (drugs, monitoring equipment, additional nursing, patient transportation 
and days-off-work) [1;3;5;6]. Improving patient tolerance of upper GI endoscopy such that 
sedation can be avoided has recognisable benefits.  
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Figure 1:  Anatomical dissection demonstrating the afferent pathway of the pharyngeal, ‘gag’ reflex 
conducted through glossopharyngeal nerve (CN IX) fibres, originating mainly at the root of the 
tongue, uvula and palatine arches. (Public domain image, modified by the author) 
 
The introduction of the charge-coupled device (CCD) in the 1980s, led to development of video 
endoscope technology [7], which apart from facilitating improved endoscopic imaging, also 
enabled the manufacture of minimally invasive instruments with the potential capacity to 
improve patient tolerance during endoscopic procedures. An example of this has been the 
development of ultrathin (<6mm diameter) endoscopes for transnasal upper GI endoscopy (T-
OGD) as an alternative to oral (conventional) upper GI endoscopy (C-OGD) (Figure 2) [4].  
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Figure 2:  Comparison of ultrathin (<6mm diameter) upper GI endoscope (A) with conventional (≥9.0mm 
diameter) upper GI endoscope, (B). (Image courtesy of Fujifilm, Saitama, Japan) 
 
In contrast to C-OGD, contact between the endoscope and the root of the tongue, uvula and 
palatine arches is minimized during T-OGD (Figure 3). This reduces stimulation of the gag 
reflex, and has been shown to enhance patient experience, obviating the need for sedation [2;8-
13]. Since the first report of unsedated T-OGD as an alternative to C-OGD by Shaker in 1994 
[4], several studies have confirmed its feasibility and improved patient tolerance [2;8-13]. 
However adoption of T-OGD into mainstream clinical practice has varied [14-17] and while its 
use in Japan is widespread, uptake in most Western countries has been slow [14-16]. Current 
endoscopy practice in the UK is typical of this and to date, there have been no studies to evaluate 
the potential benefits of T-OGD use in the UK. 
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Figure 3:  Route of insertion and withdrawal used for conventional (oral) (A) (thick black arrow) and 
transnasal (B) (thin black arrow), upper GI endoscopy. During conventional endoscopy (A), the 
endoscope is in constant contact with the tongue, whereas using the transnasal route (B), tongue 
contact is virtually eliminated. (Image courtesy of Fujifilm, Saitama, Japan) 
 
 
 
1.1.2 Small bowel endoscopy (enteroscopy) 
Comprising the longest part of the GI tract, the small bowel (SB) presents particular challenges 
to GI endoscopy. The anatomy of the SB consists of a coiled-up, loose tube, up to 8 metres long 
[18] (Figure 4), anchored only at the ligament of Treitz and the ileo-caecal valve [19], therefore 
predisposing to stretching and uncontrollable looping during endoscopic procedures [20].  
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Figure 4:  Computer generated 3D model (DigitalLab3D©, FallingPixel.com) antero-posterior view (A) and 
right postero-oblique view (B) of the small bowel (SB) (white arrow) in relation to the colon (red 
arrow). The 3D model demonstrates the anatomy of the SB as a long, coiled-up tube.  
 
 
 
 
 
 
 
Until recently, non-surgically assisted flexible endoscopy of the SB has been limited to push 
enteroscopy (PE) and ileo-colonoscopy (IC) [21;22], limiting visualisation to the most-proximal 
or most-distal parts of the SB respectively. Achieving complete SB evaluation therefore required 
recourse to major surgery and the significantly more invasive intra-operative enteroscopy (IOE) 
[21;22] (Figure 5).  
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Figure 5:  Invasive nature of intraoperative enteroscopy (IOE). The enteroscope (green arrow)      can be 
seen as it enters the exteriorised SB at the chosen site of enterotomy (blue arrow).  
 
The introduction of SB capsule endoscopy (SBCE) [23] and double-balloon enteroscopy (DBE) 
[20] in 2001 has revolutionised SB endoscopy, facilitating visualisation of the entire SB without 
the need for surgery. Although SBCE and DBE are complementary technologies, the role of 
SBCE is a diagnostic one and limited to the capture of endoscopic images while DBE offers 
tissue biopsy and the full range of therapeutic options of flexible endoscopy; DBE is frequently 
performed after SBCE when abnormalities have been identified [20;21;24-49] (Figure 6). Since 
SBCE is not classified as a flexible endoscopic technology, its role is beyond the scope of this 
thesis and shall therefore not be discussed further in this text. 
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Figure 6:   SB capsule endoscope (Given Imaging, Yoqneam, Israel) (A) and double-balloon enteroscope (B) 
(Fujifilm, Saitama, Japan). Although the SB capsule endoscopy (SBCE) is a less invasive 
procedure than double-balloon enteroscopy (DBE), SBCE is limited to image capture and is 
therefore frequently used to ‘scout’ for SB pathology which may biopsied or treated during a 
subsequent DBE procedure. (Image 6B courtesy of Fujifilm, Saitama, Japan) 
 
DBE overcomes the challenge of deep intubation related to SB anatomy by the employment of 2 
latex balloons and a stabilising plastic overtube [20;45;50-54] (Figure 6B). The 2 balloons allow 
for the application of gentle traction on the SB wall for plication of the SB onto the overtube 
during step-wise ‘push-and-pull’ manoeuvres in order to prevent SB stretching and minimise 
unfavourable looping (Figure 7) [20;45;50-54]. During the insertion phase, the endoscopist aims 
to enable deeper SB insertion by ‘encouraging’ the formation of favourable ‘wide’ spiral looping 
(Figure 8) while avoiding the formation of ‘tight’ and unfavourable ‘s-shaped’ deep looping, 
which may hinder depth of insertion and eventual success of the procedure. In certain cases 
(particularly in patients with a history of abdomino-pelvic surgery), SB tethering (relating to the 
presence of post-surgical adhesions), this may still be challenging to achieve and may result in 
limited SB insertion depths.  
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Nonetheless, with its ability to be performed via both the oral (anterograde) and rectal 
(retrograde) routes, DBE facilitates deep enteroscopy and may also allow for pan-enteroscopy 
(Figure 8), thus providing a minimally invasive alternative to IOE [20;45;50-54]. In selected 
cases endotherapy facilitated by DBE [20;21;24-49], has been shown to obviate the need for 
operative surgery. Several international registries have also reported on the effectiveness and 
safety of DBE, but as yet, there are no reports which describe the performance, limitations and 
complications of DBE within the UK.  
 
Figure 7:   Sequential steps involved during SB insertion at DBE performed via the anterograde route (A) 
and the retrograde route (B). Sequential inflation and deflation of the enteroscope (green circle) 
and overtube (blue circle) balloons coupled with advancement and withdrawal manoeuvres of the 
enteroscope (black line) and overtube (light-blue line) facilitates plication of the SB onto the 
overtube and allows enteroscope advancement into the SB in a ‘caterpillar’ like fashion. (Images 
courtesy of Sugano K, Yamamoto H & Kita H. Eds; Double-balloon Endoscopy (Nankodo Co 
Ltd.) (Tokyo) 2005) 
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Figure 8:  Fluoroscopy demonstrating insertion of the double-balloon enteroscope through the whole of the 
SB (pan-enteroscopy) during DBE performed via the anterograde route (A) and retrograde route 
(B). In these 2 cases favourable, wide spiral looping has facilitated pan-enteroscopy (Images 
courtesy of Sugano K, Yamamoto H & Kita H. Eds; Double-balloon Endoscopy (Nankodo Co 
Ltd.) (Tokyo) 2005) 
 
Since the introduction of DBE, two other types of device assisted enteroscopy (DAE), namely 
single-balloon enteroscopy (SBE) [55;56] and manual spiral enteroscopy (SE) [57] have been 
introduced into clinical use in 2007 and 2008, respectively. While all 3 currently available 
technologies make use of a stabilising overtube, SBE and DBE use 1 or 2 additional balloons 
respectively, whereas SE uses a raised soft-plastic spiral (Figure 9) in order to provide traction 
for plication of the SB onto the overtube [20;45;50-52;54;57]. SBE (Olympus, Tokyo, Japan) 
[55;56] is another form of balloon-assisted enteroscopy which uses a similar principle to DBE 
(albeit with a single, overtube balloon) to advance an enteroscope (and overtube) through the SB. 
In view of these similarities and the fact that our unit only uses the double-balloon system, SBE 
shall not be discussed further in this text.  
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However, SE uses rotational-traction as an alternative to balloon-assisted traction and appears to 
enable faster enteroscopy than the DBE technique [57-62]. Nonetheless, it remains uncertain as 
to whether SE in its currently available (manually-driven) form is able to regularly achieve 
similar SB insertion depths to those attained during DBE [59-61].  
 
Figure 9:   Spiral enteroscopy (SE) overtube, Endo-Ease Discovery
®
 SB (Spirus Medical, LLC, MA, USA) 
demonstrating its raised soft-plastic spiral (A). ‘Engagement’ of the SB mucosa, in order to 
provide traction for forward propulsion of the overtube and enteroscope into the SB (B); Insertion 
of the overtube and enteroscope by clockwise rotation of the overtube (green arrow) during SE 
(C). (Images 9A & 9B, courtesy of Spirus Medical, LLC, MA, USA) 
 
 
1.1.3 Colonoscopy 
Incomplete colonoscopy, defined as failure to achieve caecal intubation at colonoscopy is 
reported to occur in up to 10% of attempted cases [63-65]. If complete colorectal examination is 
needed after failed colonoscopy, patients may require alternative investigations which in turn, 
carry their own intrinsic risks (for example, radiation exposure from computed tomographic 
colonography (CTC)) [66]. These additional investigations may then detect proximal colonic 
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pathology, necessitating even further attempts at colonoscopy [66]; measures to improve caecal 
intubation therefore merit serious consideration. 
Several studies have identified certain patient-related characteristics associated with technically 
difficult (TD) colonoscopy, higher risk of failure, increased patient discomfort and longer 
procedure duration [67-79]. These factors include: female gender [63;65;67;68;70-74;76;77;80-
85], increasing age (>60 years) [68-72;74;83], chronic constipation [71;77] (often associated 
with a ‘long redundant colon’ (dolichocolon) [65;66;75;76;84;86-91]); small body habitus, as 
indicated by a low body mass index (BMI) or low waist-to-hip (W/H) ratio [67-70;72;73], a past 
history of abdominal/pelvic surgery [63;65;69;72;73;77;80;83;84] and a history of failed 
colonoscopy [65;66;84;92-100]. To date however, these factors have not been incorporated into 
an evidenced-based combined scoring-system. The development of such a scoring-system may 
enable endoscopists to predictively risk-stratify patients for TD colonoscopy and may allow 
strategic planning (e.g. allocation of extended time-slots and dedicated equipment) before such 
procedures are attempted. 
Approaches which have been reported to facilitate successful intubation of the TD colon include: 
fastidious attention to the application of good basic technique, enhanced loop management aided 
by use of a magnetic endoscopic imager (MEI) (ScopeGuide
®
 UPD, Olympus, Tokyo, Japan), 
switching to a paediatric colonoscope or an upper GI endoscope (slimmer instruments with 
shorter bending sections, which may allow negotiation of tight sigmoid angulations); the use of a 
colonoscope which incorporates a variable-stiffness shaft (designed to minimise re-looping), 
longer colonoscopes or enteroscopes and the attachment of a plastic hood to the tip of the chosen 
instrument (also designed to facilitate passage through an angulated sigmoid colon) 
[66;84;98;99;101-116]. Despite the use of these strategies and techniques, TD colonoscopy may 
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still result in failure to achieve caecal intubation, even in the hands of expert colonoscopists [66] 
and alternative technologies such as the recently developed balloon assisted colonoscopy, 
double-balloon colonoscopy (DBC) in particular, are being explored for this indication 
[66;113;117-123]. 
DBC, being directly derived from DBE, applies the use of gentle bowel wall traction by two 
latex balloons and a stabilising overtube, to advance a dedicated, slim colonoscope around the 
colon. The technique of DBC insertion and withdrawal is identical to that used for retrograde-
route DBE [20;54;117;122;124] (Figure 7B).  
DBC may have several potential advantages over conventional colonoscopy (CC):  
 
i) The endoscope itself is narrower and more flexible than a standard colonoscope; this 
characteristic may allow it to ‘slalom’ past a sharply angulated and ‘fixed-down’ sigmoid colon 
while the overtube and its balloon stabilise the rest of the colon (Figure 10) 
ii) The overtube provides additional stiffness when this is needed to negotiate lengths of 
redundant colon 
iii) The sequential inflation and deflation of the latex balloons on the colonoscope and overtube 
provide additional stability, while also providing the capacity to plicate (and effectively 
‘shorten’) the colon 
Although these potential advantages of DBC have been suggested by 4 non-comparative studies 
[92;117;121;122], only one prospective randomised study comparing DBC and CC in TD cases 
has been published to date [113]. This study from Kanagawa, Japan showed that DBC allowed 
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significantly faster caecal intubation, a higher caecal intubation rate and improved patient 
comfort as compared to CC (with supplementary use of MEI and a plastic cap at the colonoscope 
tip). However, parameters relating to patient selection with regards to TD were based solely on 
the experience of a previous colonoscopy. Studies which incorporate an objective, evidence-
based ‘predictive’ scoring-system for TD may add value to further DBC vs. CC comparisons.  
 
Figure 10:   Cartoon (A) and corresponding fluoroscopic image (B) demonstrating complete colonoscopy 
achieved by the use of a double-balloon colonoscope. The red circles seen in (A) represent post-
surgical adhesive disease affecting the sigmoid colon and caecum (white arrow) and the 
transverse and ascending colon (red arrow). (Images courtesy of Sugano K, Yamamoto H & Kita 
H. Eds; Double-balloon Endoscopy (Nankodo Co Ltd.) (Tokyo) 2005) 
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1.2 Research rationale and hypothesis 
 
1.2.1 Rationale 
Research into the optimal role and effectiveness of these flexible endoscopic technologies in 
clinical practice remains limited.  
 
 Although several investigators from other countries have studied the use of T-OGD vis-à-
vis C-OGD, no studies on its potential role in a UK clinical paradigm have been 
performed.  
 
 An evaluation of the performance, limitations and safety of DBE practice in the UK is 
also lacking. Furthermore, data on the impact of DBE endotherapy on Crohn’s disease 
(CD) SB strictures, Peutz-Jeghers (PJS) SB polyposis and enteral feeding access are still 
required. Data evaluating for any potential benefits of the newer SE technology as 
compared with DBE are still sparse and to date only 2 prospective studies have attempted 
this comparison.  
 
 Although several factors have been shown to be associated with TD colonoscopy, these 
have never been incorporated into a scoring-system which may allow colonoscopists to 
predict a TD procedure. The development of an evidence based scoring-system may 
allow pre-planning for TD cases e.g. with the allocation of longer time-slots and choice 
of ancillary equipment. Such a scoring-system may also facilitate more objective case-
selection for research studies evaluating the use of new technologies (such as DBC) for 
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TD colonoscopy.  No comparisons of DBC vs. CC for TD colonoscopy as defined by 
evidence-based criteria have been performed to date. 
 
This research attempts to address some of these issues by investigating the performance, 
limitations and safety of advanced flexible endoscopic technologies, focusing particularly on the 
evaluation of patient comfort, diagnostic ability and new therapeutic indications in the provision 
of minimally invasive care. 
 
1.2.2 Hypothesis 
 
‘Technological advancements in flexible GI endoscopy, in the form of ultrathin endoscopes and 
device assisted enteroscopy and colonoscopy systems will provide an alternative, minimally 
invasive option of care which is both safe and effective’ 
 
Specifically, the aims of this research were to: 
i) Perform the first evaluation of performance of ultrathin T-OGD as an alternative to C-
OGD in a UK setting (Chapter 2) 
ii) Perform the first evaluation of  performance, limitations and complications of DBE in 
clinical practice within the UK (Chapter 3) 
iii) Describe original DBE techniques (developed by the author and the author’s co-
supervisor, during the conduct of this research), designed to surmount technical 
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challenges which may impede DBE in the setting of a retroverted ileo-caecal valve or 
unfavourable looping, relating to adhesive disease or a short SB mesentery (Chapter 4) 
iv) Examine the effectiveness and safety of DBE facilitated dilatation of CD SB strictures 
(Chapter 5) 
v) Examine the effectiveness and safety of DBE facilitated polypectomy of clinically 
significant SB polyps in patients with Peutz-Jeghers syndrome (PJS) (Chapter 6) 
vi) Examine the feasibility and safety of DBE facilitated direct percutaneous endoscopic 
jejunostomy (DPEJ) tube placement (Chapter 7)  
vii) Compare the performance of DBE and SE in the same cohort of patients (Chapter 8) 
viii) Compare the performance of DBC and CC in TD colonoscopy (incorporating the use of a 
newly proposed, original, evidenced-based scoring-system for selection of TD cases) 
(Chapter 9) 
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2 Evaluating the role of transnasal upper 
gastrointestinal (GI) endoscopy as compared with 
conventional (oral) GI endoscopy in a UK clinical 
setting 
 
2.1 Background 
 
Patient discomfort during oesophagogastroduodenoscopy (OGD) via the conventional, oral route 
(C-OGD) is due mainly to repeated triggering of the gag reflex. Although C-OGD is employed in 
daily practice, patients often find it to be an unpleasant experience, which frequently warrants the 
use of intravenous sedation
 
[1-3]. However, sedation use is associated with additional risks, 
prolonged patient recovery duration and added costs [1;3;5;6;125-128].  
 
Since unsedated transnasal OGD (T-OGD) was introduced as alternative to C-OGD by Shaker 
[4], several studies done in other countries have demonstrated its feasibility and association with 
improved patient tolerance [2;8-13;16]. Despite these findings, adoption of T-OGD into 
mainstream clinical practice, possibly due to cultural or other perceptions has varied widely, with 
rapid adoption in Japan and less wide acceptance in parts of Europe [14-17]. In the UK for 
example, the potential role for T-EGD in clinical practice has not been formally evaluated to 
date. In order to address this and to explore the potential benefits of 2 different sized ultrathin 
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(UT) endoscopes for both T-OGD and C-OGD, we performed the St Mark's Conventional 
Endoscopy versus trans-Nasal endoscopy sTudy (SCENT).  
 
2.2 Aims 
 
The primary objective was to compare T-OGD using UT (5.9mm, 4-way angulation endoscopes, 
T-OGD1 or 4.9mm, 2-way angulation endoscopes, T-OGD2) with C-OGD using standard 
9.0mm endoscopes, C-OGD1 or UT (5.9mm, 4-way angulation, or 4.9mm, 2-way angulation) 
endoscopes, C-OGD2 (Table 1) in a UK clinical setting. Parameters of patient tolerance, 
endoscopic quality, patient safety and feasibility of the OGD (patient preparation, procedure and 
recovery duration and technical ease of the procedure) were assessed. The secondary objective 
was to compare all groups (i.e. T-OGD1 vs. T-OGD2, C-OGD1 vs. C-OGD2 and C-OGD2 vs. 
T-OGD) in addition to T-OGD with C-OGD with or without sedation.  A quick-reference guide 
to the type of procedure performed in each group is shown (Table 2). 
 
Table 1: Technical specifications of UT endoscopes used in SCENT 
Table 1: Technical specifications of UT endoscopes used in SCENT 
Model /Make Angulation Field of 
view 
Depth of 
field (mm) 
Shaft 
diameter 
(mm) 
Accessory channel 
diameter (mm) 
Working 
length (mm) 
EG-530N/    
(Fujifilm, 
Saitama, 
Japan) 
210˚up/90˚down 
100˚ left/100˚ right 
120˚ 3-100 5.9 2.0 1100 
EG-530NP/  
(Fujifilm, 
Saitama, 
Japan) 
210˚up/120˚down                No 
left/right angulation 
120˚ 3-100 4.9 2.0 1100 
GIF-N60/   
(Olympus, 
Tokyo, Japan) 
210˚up/120˚down                No 
left/right angulation 
120˚ 3-100 4.9 2.0 1100 
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Table 2: Quick reference guide to type of procedure performed in each group 
Table 2: Type of procedure performed in each group 
Group name Route of OGD Shaft diameter of endoscope 
used (mm) 
C-OGD1 Oral 9.0 
C-OGD2 Oral  4.9 or 5.9 
T-OGD1 Transnasal  5.9 
T-OGD2 Transnasal 4.9 
 
 
2.3 Methods 
 
2.3.1 Patients 
The study was performed between September 2008 and November 2009; patients (both genders, 
over 18 years-of-age and able to give informed consent) referred to our institution for routine 
diagnostic OGD were invited to participate. Exclusion criteria were the following: patient 
reluctance to undergo a T-OGD or to participate in the study, history of major nasal trauma or 
nasal/sinus surgery, recurrent epistaxis, haemorrhagic tendency, use of anticoagulation, severe 
cardio-respiratory co-morbidity (American Society of Anesthesiologists physical status ≥4) 
and/or allergy to drugs used (lidocaine, phenylephrine and midazolam) during OGD.  All 
patients fulfilling the entry criteria gave their written informed consent to participate. The 
research protocol and conduct of the study was approved by the regional research ethics 
committee and by the institution’s research and development review board (Harrow REC (North 
London REC 3) Ref. 08/H0719/24; RD 8/038) and is registered with the International Standard 
Randomised Controlled Trial Number Register (ISRCTN77474635). The study was carried out 
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in accordance with the World Medical Association Declaration of Helsinki, 1964 (incorporating 
all later amendments) [129]. 
2.3.2 Study design 
This was a prospective, randomized, comparative study (of parallel design). Participating 
patients were randomized 1:1 with a computer-generated random number sequence, to 1 of 4 
groups: T-OGD1, T-OGD2, C-OGD1 or C-OGD2. Patients were allocated their designated 
procedure by an endoscopy research fellow or a research nurse. 
 
2.3.3 Endoscopic procedures 
Prior to OGD procedures, patients were instructed to withhold oral intake for 6 hours. All 
procedures were performed by 1 of 4 experienced endoscopists (1 consultant, 2 advanced 
endoscopy fellows and 1 senior nurse endoscopist) proficient in both oral and transnasal upper 
gastrointestinal endoscopy.  Patients in the T-OGD group received local anaesthesia to the nasal 
passages in the form of fine-mist sterile nasal spray consisting of 5% lidocaine and 0.5% 
phenylephrine (co-phenylcaine nasal spray, Aurum Pharmaceuticals, Romford, UK), 
standardized to 4 sprays into each nostril (Figure 11A, Co-phenylcaine spray, with fine-mist 
spray nozzle attached). The phenylephrine component of the nasal spray served the purpose of a 
topical vasoconstrictor, to decongest the nasal passages and reduce the risk of peri-procedure 
epistaxis. Approximately 3 minutes after the application of the local anaesthetic, patients in the 
T-OGD group had a soft-silicone 6mm diameter dilatation catheter (N 18F-SS, Fujifilm, 
Saitama, Japan) (Figure 11B),  (lubricated with non-proprietary 2%, aqueous lidocaine gel)  
inserted 80mm deep into either nasal passage (Figure 11C). This ensured the nasal passage 
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chosen for the T-OGD was wide enough and well lubricated to allow insertion and withdrawal of 
the endoscope.  
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Figure 11:   Co-phenylcaine spray (with fine-mist spray nozzle attached) (A); Soft-silicone, (6mm diameter) 
transnasal preparation catheter before transnasal insertion (B) and on transnasal insertion 
through patient’s right nostril (C).  
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Figure 12:   Right nostril being prepared with co-phenylcaine spray (A); insertion of soft-silicone transnasal 
preparation catheter into right nostril (B) and transnasal endoscopy being performed through the 
right nostril (with the patient in the left lateral decubitus position) (C). 
 
 
 
 
 
 
 
If neither of the nasal passages allowed catheter insertion, the T-OGD was converted to a C-
OGD2 procedure. Patients who underwent C-OGD received local anaesthesia to their oro-
pharynx in the form of 10 sprays of 10% lidocaine (Xylocaine
®
, Astra Zeneca, London, UK) and 
intravenous conscious sedation (using low dose intravenous non-proprietary midazolam), given 
only on demand. Supplemental oxygen was only given to patients who required intravenous 
conscious sedation. 
OGD procedures were carried out using a standardized method according to the study protocol 
with patients in the left lateral decubitus position. Upper gastrointestinal (GI) anatomical 
‘landmarks’ (i.e. oesophageal, gastro-oesophageal junction, forward and  retroflexed views of the 
stomach, views of the 1st (D1) and 2nd parts (D2) of the duodenum) were photo documented. 
Anti-foaming agent (bubble-breaker) in the form of 1% simethicone suspension (Infacol
®
, Forest 
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Laboratories, Dartford, UK) was sprayed down the endoscope working channel to improve 
endoscopic view quality as required. 
All UT endoscopes were equipped with charge-coupled device (CCD) technology, giving optical 
characteristics comparable to the GIF-XQ260 (9.0mm diameter) endoscope (Olympus, Tokyo, 
Japan) used for C-OGD1 procedures. Technical specifications of the UT endoscopes are 
described (Table 1). 
 
2.3.4 Questionnaires 
Separate questionnaires incorporating 10cm visual analogue scales (VAS) [130] were used to 
evaluate i) patient tolerance, ii) endoscopic view quality, iii) patient safety and iv) technical ease 
of the procedure. Patient preparation, procedure and recovery duration were recorded. Patient 
satisfaction with the procedure undertaken was recorded on a 5-point Likert scale [131] (very 
satisfied, satisfied, neutral, dissatisfied or very dissatisfied). 
i) Evaluation of patient tolerance 
On recovery, the patients were assessed on their tolerance to the OGD procedure by marking a 
10cm VAS (0, non-existent; 10, unbearable) to quantify 5 separate sensations: overall 
discomfort, pain, gagging sensation, nausea and anxiety. Similar VAS’s for perceived patient 
overall discomfort and anxiety were completed by the endoscopist and the attending nurse.  
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ii) Evaluation of view quality 
The following views of the upper GI tract were scored by the endoscopist, using a 10 cm VAS 
(0, very poor views; 10 very good views): oesophagus, forward (F) view and retroflexed (R) 
views of the stomach, D1 and D2 in addition to overall impression of quality of endoscopic view. 
iii) Evaluation of patient safety 
Measurements of patient vital parameters (lowest and highest systolic blood pressure, lowest and 
highest heart rates and lowest oxygen saturations) taken by nurses during the endoscopy were 
used as surrogate markers of patient safety.  
iv) Evaluation of feasibility 
Technical handling and ease of procedure performance were evaluated by the endoscopist using 
a 10cm VAS (0, very difficult; 10 very easy) to quantify 5 separate parameters relating to: 
technical difficulty or ease of endoscope insertion, general handling of the instrument, intubation 
of the 2
nd
 part of duodenum and taking of random or targeted biopsies. In addition, the 
endoscopist’s overall impression of practical feasibility of the procedure was evaluated. Duration 
of pre-procedure patient preparation (from the start of application of local anaesthetic spray to 
the start of insertion of the endoscope), actual OGD procedure duration (from start of insertion to 
end of withdrawal of the endoscope) and the post procedure recovery period (from end of OGD 
to when nurses were satisfied the patient was able to drink water without spluttering and to leave 
the endoscopy unit safely) were recorded as markers of overall practical feasibility. 
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2.3.5 Statistical analysis 
Power calculation and statistical analyses were performed with the assistance of a nominated 
consultant medical statistician. By recruiting 50 patients into each group (C-OGD1, COGD2, T-
OGD1 or T-OGD2) it was calculated that the study had 90% power to detect a difference of at 
least 2 units on the VAS between groups for the primary objective parameters (considering a 
standard deviation of 2.5). A P value of <0.05 was regarded to be statistically significant. Patient 
demographics (age and gender) in the different groups were analysed using the Kruskal-Wallis 
test and the χ2 test respectively. Specific comparisons of the various recorded parameters 
between types of OGD were pre-determined before commencing the analysis of the data. The 
majority of the outcomes were measured on a continuous scale and the appropriate analysis 
method was dependent on the distribution of the outcome measure. For outcomes found to be 
normally distributed, analysis of variance (ANOVA) followed by linear contrasts were used to 
compare between the different OGD types. For outcomes that were not found to be normally 
distributed, the Mann-Whitney U test was used to compare between OGD groups. Categorical 
outcomes such as success of T-OGD procedures, diagnostic yield and biopsy quality were 
assessed using Fisher’s exact test.  
 
2.4 Results 
 
2.4.1 Study population 
Of a total number of 286 patients assessed for eligibility to participate in the study, 86 were 
excluded, due to a history of nasal trauma/surgery, recurrent epistaxis or on-going use of 
anticoagulation (n=12) or because of refusal to participate (n=74).  The remaining 200 patients 
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(106 women and 94 men; median age, 54 years; range 19-95 years) were prospectively recruited 
over a period of 18 months as shown in the CONSORT [132] study flowchart (Figure 13).  
Patient demographics and indications for OGD are shown (Table 3). There were no significant 
demographic differences among the patients in the 4 study groups. Passage of UT endoscopes 
via the transnasal route was possible in 48/50 (96%) T-OGD1 procedures and 46/50 (92%) T-
OGD2 procedures (P=0.69). Failure of passage of catheter or UT endoscope was due to narrow 
(bilateral) nasal passages in all 6 patients. The failed procedures were converted to C-OGD2 
procedures and analysed as such for the purposes of the study.  
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 Figure 13:  SCENT flow diagram (CONSORT [132])  
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Table 3:    Patient demographics and indications for OGD *Kruskal-Wallis test; **χ2 test; P values compare 
the differences in demographic variables among the four study groups and show that there are no 
significant differences among the groups 
Table 3: Patient demographics and indications for esophagogastroduodenoscopy (OGD) 
 
 C-OGD1 C-OGD2 T-OGD1 T-OGD2  
Patients (n) 50 56 48 46  
Age (median; range)( years) 54 (23-87) 53 (22-95) 54 (19-89) 55 (26-84) P=0.98* 
Gender (women/men) 22/28 34/22 25/23 25/21   P=0.29** 
 
Indications (n)      
Dyspepsia 22 27 25 22  
Iron deficiency anaemia 6 10 2 6  
Weight loss 7 4 7 5  
Reflux symptoms 5 6 6 3  
Dysphagia 4 1 5 4  
Barrett’s surveillance 1 0 0 0  
Melaena 2 2 1 0  
Gastric ulcer follow-up 0 2 1 2  
Malabsorption 1 0 0 1  
Coeliac disease follow-up 0 2 0 1  
Nausea/vomiting 2 2 1 2  
 
 
2.4.2 Comparison of C-OGD1 and T-OGD 
Outcomes between patients undergoing C-OGD1 (n=50) and T-OGD (n=94) were examined first 
(Figure 14, Table 4A). Median preparation and procedure times increased by 16% and 30% 
respectively for T-OGD compared with C-OGD1 (5.5 vs. 4.6 minutes, P <0.001 and 10.0 vs. 7.0 
minutes, P=0.004). However, T-OGD was associated with a 50% reduction in recovery time (5 
vs. 10 minutes, P <0.001). Mean systolic blood pressure (SBP) during procedures was lower in 
the C-OGD1 group compared with the T-OGD group (122 vs. 132 mm Hg, P <0.02). Median 
VAS scores reflecting patient tolerance were all lower (i.e. better tolerance) for T-OGD with a 
60% reduction in overall discomfort score for T-OGD compared with C-OGD1 (1.6 vs. 4.0, P 
<0.001). Median pain, gagging, nausea and anxiety scores were reduced by 71% (0.7 vs. 2.4, P 
53 
  
<0.02), 73% (1.0 vs. 3.7, P <0.001), 83% (0.4 vs. 2.4, P <0.001) and 70% (1.0 vs. 3.3, P <0.001) 
respectively when compared with C-OGD1. Nurse and endoscopist VAS scores for perceived 
patient anxiety and discomfort mirrored the reduction in patient VAS scores for T-OGD (Table 
4A). No differences were detected in quality of endoscopic views obtained (supplemental 
images, Appendix 2.5) and in technical handling of instruments between T-OGD and C-OGD1. 
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Figure 14:   Box plots comparing preparation duration, procedure duration and recovery duration (14A) and 
patient tolerance VAS tolerance scores, (14B) for C-OGD1 and T-OGD procedures. Values are 
expressed as medians (horizontal lines) and 25
th
 and 75
th
 percentiles (boxes) of the interquartile 
range (IQR). The whiskers of the box plots are set at 1.5x the 25
th
 and 75
th
 percentile respectively; 
*Mann-Whitney test. 
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Table 4:  Overall comparative study of variables between C-OGD1 and T-OGD (T-OGD1 + T-OGD2), (4A) and between C-OGD2 and T-OGD, (4B); 
(Patient=patient’s VAS score; Nurse=Nurses VAS score; Endosc. =Endoscopist’s VAS score); IQR, interquartile range; †ANOVA, linear 
contrasts; ‡ Mann-Whitney test 
 4A 
 
 3B 
 
 
             4B 
Variable C-OGD1 
Mean (SD) 
T-OGD 
Mean (SD) 
P-value†  C-OGD2 
Mean (SD) 
T-OGD Mean 
(SD) 
P-
value† 
Lowest Systolic BP (mmHg) 122 (23) 132 (24) 0.02 128 (23) 132 (24) 0.34 
Highest Systolic BP (mmHg) 140 (26) 145 (27) 0.22 143 (19) 145 (27) 0.87 
Lowest Pulse Rate (beats per 
minute) 
79.4 (11.7) 76.6 (12.4) 0.21 78.1 (13.0) 76.6 (12.4) 0.97 
Highest Pulse Rate (beats per 
minute) 
91.0 (13.9) 86.0 (13.5) 0.05 87.6 (15.9) 86.0 (13.5) 0.13 
Lowest O2 Saturation (%) 98 (97, 99) 97 (96, 99) 0.11 98 (95, 99) 97 (96, 99) 0.19 
 C-OGD1 
Median (IQR) 
T-OGD 
Median 
(IQR) 
P-value‡ C-OGD2 
Median (IQR) 
T-OGD 
Median (IQR) 
P-
value‡ 
Nurse - Discomfort 
 
3.5 (1.3, 4.5) 1.3 (0.5, 2.2) <0.001 2.2 (1.3, 4.5) 1.3 (0.5, 2.2)   0.003 
Nurse - Anxiety 3.1 (1.2, 4.5) 1.2 (0.5, 2.5) <0.001 2.0 (0.7, 4.3) 1.2 (0.5, 2.5)   0.009 
Endosc. - Discomfort 4.2 (2.5, 7.3) 0.7 (0.4, 1.5) <0.001 3.0 (0.5, 5.0) 0.7 (0.4, 1.5) <0.001 
Endosc.  - Anxiety 4.4 (2.7, 7.5) 0.8 (0.4, 2.0) <0.001 3.5 (1.2, 6.5) 0.8 (0.4, 2.0) <0.001 
Endosc. - Ease of insertion 9.0 (8.6, 9.3) 9.2 (8.7, 9.4) 0.25 9.2 (9.1, 9.5) 9.2 (8.7, 9.4) 0.97 
Endosc. - Overall handling 9.2 (8.7, 9.4) 9.0 (8.6, 9.4) 0.75  9.3 (9.0, 9.5) 9.0 (8.6, 9.4) 0.41 
Endosc.  - D2 intubation 9.2 (8.6, 9.4) 9.0 (8.5, 9.4) 0.28  9.2 (9.0, 9.5) 9.0 (8.5, 9.4) 0.10 
Endosc. - Random biopsies 9.2 (8.9, 9.4) 9.0 (8.6, 9.4) 0.06  9.2 (9.0, 9.5) 9.1 (8.6, 9.4) 0.08 
Endosc. - Targeted biopsies 9.2 (8.8, 9.4) 9.0 (8.5, 9.3) 0.06  9.2 (9.0, 9.5) 9.0 (8.5, 9.3) 0.07 
Endosc - Feasibility 9.1 (8.6, 9.3) 9.0 (8.7, 9.3) 0.99  9.2 (9.0, 9.5) 9.0 (8.7, 9.3) 0.39 
Endosc. - View oesophagus 9.1 (8.6, 9.3) 9.0 (8.4, 9.3) 0.21  9.0 (8.8, 9.4) 9.0 (8.4, 9.3) 0.32 
Endosc. - View stomach (F) 9.2 (8.7, 9.3) 9.0 (8.2, 9.2) 0.08  9.0 (8.8, 9.4) 9.0 (8.2, 9.2) 0.07 
Endosc. - View stomach (R) 9.0 (9.0, 9.0) 9.0 (8.0, 9.0) 0.18  9.0 (9.0, 9.0) 9.0 (8.0, 9.0) 0.21 
Endosc. - View D1 9.1 (8.7, 9.2) 9.0 (8.5, 9.2) 0.22  9.0 (8.7, 9.3) 9.0 (8.5, 9.2) 0.24 
Endosc. - View D2 9.2 (8.9, 9.3) 9.1 (8.4, 9.3) 0.06  9.0 (8.8, 9.3) 9.0 (8.4, 9.3) 0.08 
Endosc. - Overall view 
quality 
9.1 (8.5, 9.2) 8.9 (8.4, 9.2) 0.47  9.0 (8.8, 9.4) 8.9 (8.4, 9.2) 0.50 
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2.4.3 Comparison of C-OGD2 (UT endoscopes) and T-OGD 
Outcomes between C-OGD2 using ultrathin endoscopes (n=56) and T-OGD (n=94) were 
examined (Figure 15, Table 4B). No differences were found in vital parameters or 
preparation duration. There was a 30% increase in median procedure time for T-OGD 
(10.0 vs. 7.0 minutes, P=0.005) offset by a 38% reduction in median recovery time (8.0 
vs. 5.0 minutes, P <0.001). Although there was no difference in median VAS score for 
pain, there was a trend in reduction of median overall discomfort for T-OGD (P=0.09).  
A 67% reduction in patient gagging median VAS score (1.0 vs. 3.0, P <0.001) for T-
OGD compared with C-OGD2 (Figure 15) was noted. Nausea and anxiety median VAS 
scores were reduced by 75% and 50% (0.4 vs. 1.6, P <0.001and 1.0 vs. 2.0, P=0.02) 
respectively for T-OGD. Nurse and endoscopist VAS scores for perception of patient 
discomfort and anxiety were also significantly lower for T-OGD (Table 4B).  
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Figure 15:   Box plots comparing preparation duration, procedure duration and recovery duration, 
(15A) and patient tolerance VAS tolerance scores, (15B) for C-OGD2 and T-OGD 
procedures. Values are expressed as medians (horizontal lines) and 25
th
 and 75
th
 
percentiles (boxes) of the interquartile range (IQR). The whiskers of the box plots are set  
 
 
 
 
 
 
 
at 1.5x the 25
th
 and 75
th
 percentile respectively; *Mann-Whitney test. 
 
 
 
 
 
 
 
2.4.4 Comparison of C-OGD without sedation (sub-group) and T-OGD 
Outcomes between unsedated C-OGD (C-OGD1 and C-OGD2 unsedated, n=77) and T-
OGD (T-OGD1 and T-OGD2, n=94) were examined (Figure 16A, Table 5A). Median 
T-OGD preparation and procedure times increased by 9% and 20% respectively (5.5 vs. 
5 minutes, P=0.001 and 10.0 vs. 7.0 minutes, P=0.005) compared with unsedated C-
OGD. Recovery time for T-OGD was 38% less than for unsedated C-OGD (5 vs. 8 
minutes, P <0.001). Median patient VAS tolerance scores were generally lower (i.e. 
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better tolerance) for T-OGD with a 43% reduction in overall discomfort (1.6 vs. 2.8, 
P=0.001). Patient VAS scores for gagging, nausea and anxiety reduced by 71% (1.0 vs. 
3.4, P <0.001), 78% (0.4 vs. 1.8, P <0.001) and 60% (1.0 vs. 2.5, P <0.001) respectively. 
Nurse and endoscopist VAS scores for patient anxiety and discomfort were also 
significantly lower for the T-OGD (Table 5A). 
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Figure 16:   Box plots comparing preparation duration, procedure duration and recovery duration, 
(16A) and patient tolerance VAS tolerance scores, (16B) for unsedated C-OGD and T-
OGD procedures. Values are expressed as medians (horizontal lines) and 25
th
 and 75
th
 
percentiles (boxes) of the interquartile range (IQR). The whiskers of the box plots are set 
at 1.5x the 25
th
 and 75
th
 percentile respectively; *Mann-Whitney test. 
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Table 5: Overall comparative study of variables between unsedated C-OGD (unsedated C-OGD1+ unsedated C-OGD2) and T-OGD (T-OGD1 + T-OGD2), (5A) and between sedated C-OGD 
(sedated C-OGD1+ sedated C-OGD2) and T-OGD (T-OGD1 + T-OGD2), (5B); (Patient=patient’s VAS score; Nurse=Nurses VAS score; Endosc. =Endoscopist’s VAS score); IQR, 
interquartile range; †ANOVA, linear contrasts; ‡ Mann-Whitney test 
 5A        5B 
Variable Unsedated C-OGD 
Mean (SD) 
T-OGD 
Mean (SD) 
P-value†  Sedated C-OGD 
Mean (SD) 
T-OGD 
Mean (SD) 
P-value† 
Lowest Systolic BP (mmHg) 125 (25) 132 (24) 0.14 115 (17) 132 (24) 0.01 
Highest Systolic BP (mmHg) 139 (27) 145 (27) 0.23 141 (25) 145 (27) 0.58 
Lowest Pulse Rate (beats per minute) 79.3 (11.5) 76.6 (12.4) 0.29 79.6 (12.7) 76.6 (12.4) 0.40 
Highest Pulse Rate (beats per minute) 91.5 (13.3) 86.0 (13.5) 0.05 89.9 (15.9) 86.0 (13.5) 0.35 
Lowest O2 Saturation (%) 98 (97, 99) 97 (96, 99) 0.20 98 (97, 99) 97 (96, 99) 0.20 
 Unsedated C-OGD 
Median (IQR) 
T-OGD 
Median (IQR) 
P-value‡ Sedated C-OGD 
Median (IQR) 
T-OGD 
Median (IQR) 
P-value‡ 
Nurse - Discomfort 
 
2.2 (1.0, 3.5) 1.3 (0.5, 2.2)   0.003 4.5 (3.7, 6.6) 1.3 (0.5, 2.2) <0.001 
Nurse – Anxiety 2.0 (1.0, 4.0) 1.2 (0.5, 2.5)   0.002 4.0 (2.4, 5.7) 1.2 (0.5, 2.5) <0.001 
Endosc. – Discomfort 2.9 (1.2, 5.2) 0.7 (0.4, 1.5) <0.001 5.1 (2.7, 8.0) 0.7 (0.4, 1.5) <0.001 
Endosc.  – Anxiety 3.3 (1.5, 5.4) 0.8 (0.4, 2.0) <0.001 5.9 (4.2, 8.1) 0.8 (0.4, 2.0) <0.001 
Endosc. - Ease of insertion 9.2 (9.0, 9.4) 9.2 (8.7, 9.4) 0.47 9.1 (7.7, 9.3) 9.2 (8.7, 9.4) 0.08 
Endosc. - Overall handling 9.2 (9.0, 9.5) 9.0 (8.6, 9.4) 0.15 9.0 (8.6, 9.3) 9.0 (8.6, 9.4) 0.43 
Endosc.  - D2 intubation 9.2 (9.0, 9.5) 9.0 (8.5, 9.4) 0.09 9.0 (8.7, 9.2) 9.0 (8.5, 9.4) 0.28 
Endosc. - Random biopsies 9.2 (9.0, 9.5) 9.0 (8.6, 9.4) 0.07 9.1 (8.7, 9.3) 9.0 (8.6, 9.4) 0.89 
Endosc. - Targeted biopsies 9.2 (8.8, 9.4) 9.0 (8.5, 9.3) 0.06 9.0 (8.9, 9.3) 9.0 (8.5, 9.3) 0.27 
Endosc – Feasibility 9.1 (8.9, 9.4) 9.0 (8.7, 9.3) 0.11 8.9 (8.6, 9.3) 9.0 (8.7, 9.3) 0.31 
Endosc. - View oesophagus 9.1 (8.7, 9.3) 9.0 (8.4, 9.3) 0.19 9.0 (8.7, 9.3) 9.0 (8.4, 9.3) 0.73 
Endosc. - View stomach (F) 9.1 (8.9, 9.4) 9.0 (8.2, 9.2) 0.10 8.9 (8.6, 9.2) 9.0 (8.2, 9.2) 0.78 
Endosc. - View stomach (R) 9.0 (9.0, 9.0) 9.0 (8.5, 9.0) 0.10 9.0 (9.0, 9.0) 9.0 (8.0, 9.0) 0.82 
Endosc. - View D1 9.1 (8.7, 9.3) 9.0 (8.5, 9.2) 0.11  8.8 (8.6, 9.2) 9.0 (8.5, 9.2) 0.68 
Endosc. - View D2 9.2 (8.9, 9.3) 9.0 (8.4, 9.3) 0.16  9.1 (8.7, 9.3) 9.0 (8.4, 9.3) 0.98 
Endosc. - Overall view quality 9.1 (8.6, 9.2) 8.9 (8.4, 9.2) 0.13  8.9 (8.6, 9.3) 8.9 (8.4, 9.2) 0.67 
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2.4.5 Comparison of C-OGD with sedation (sub-group) and T-OGD 
Outcomes between C-OGD with sedation (C-OGD1, n=14 and C-OGD2, n=15; total 
n=29) and T-OGD (T-OGD1 and T-OGD2, n=94) (Figure 17, Table 5B) were 
examined. The midazolam dose for sedation during C-OGD1 and C-OGD2 was the same 
(mean of 2.5 ±1mg). This was associated with a 13% reduction in mean SBP during 
procedures compared with T-OGD (115 vs. 132 mm Hg, P =0.01). While no differences 
in pre-procedure preparation time or procedure duration were noted, there was a 
reduction in median recovery time of 80% for T-OGD (5.0 vs. 25.5 minutes, P < 0.001) 
compared with C-OGD with sedation. Median VAS scores for patient tolerance were 
significantly lower (indicating better tolerance) for T-OGD across all parameters (Figure 
6), with the greatest reduction in VAS score being 84% for gagging (1.0 vs. 6.4, P < 
0.001). Nurse and endoscopist VAS scores for patient anxiety and discomfort were 
significantly lower for T-OGD (Table 5B). 
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Figure 17:  Box plots comparing preparation duration, procedure duration and recovery duration, 
(17A) and patient tolerance VAS tolerance scores, (17B) for sedated C-OGD and T-
OGD procedures. Values are expressed as medians (horizontal lines) and 25
th
 and 75
th
 
percentiles (boxes) of the interquartile range (IQR). The whiskers of the box plots are set 
at 1.5x the 25
th
 and 75
th
 percentile respectively; *Mann-Whitney test. 
 
 
2.4.6 Comparison of C-OGD1 and C-OGD2 (UT endoscopes) 
Outcomes between the two C-OGD groups (C-OGD1, n=50 and C-OGD2 using 
ultrathin endoscopes, n=56) were examined (Figure 18, Table 6A). No differences were 
found in vital parameter observations, preparation duration or procedure duration. 
However there was a 38% reduction in median patient VAS score for overall patient 
discomfort for C-OGD2 using ultrathin endoscopes compared with C-OGD1 (2.5 vs. 4.0, 
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P=0.03). There was a trend towards reduced patient anxiety in the C-OGD2 group (2.1 
vs. 3.6, P=0.09). C-OGD2 was associated with reductions in endoscopist and nurse 
median VAS scores for overall perceived patient discomfort of 29% and 37% 
respectively (3.0 vs. 4.2, P=0.03 and 2.2 vs. 3.5, P=0.03). Technical ease of insertion of 
the endoscope was rated marginally easier for C-OGD2 than C-OGD1 (9.2 vs. 9.0, P 
<0.001). No significant differences in endoscopic view quality or any of the other 
technical variables were found (Table 6A).  
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Figure 18:   Box plots comparing preparation duration, procedure duration and recovery duration, 
(18A) and patient tolerance VAS tolerance scores, (18B) for C-OGD1 and C-OGD2 
procedures. Values are expressed as medians (horizontal lines) and 25
th
 and 75
th
 
percentiles (boxes) of the interquartile range (IQR). The whiskers of the box plots are set 
at 1.5x the 25
th
 and 75
th
 percentile respectively; *Mann-Whitney test. 
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Table 6:  Overall comparative study of variables between C-OGD1 and C-OGD2, (6A) and between T-OGD1 and T-OGD2, (6B); (Patient=patient’s VAS score; Nurse=Nurses 
VAS score; Endosc. =Endoscopist’s VAS score); IQR, interquartile range; †ANOVA, linear contrasts; ‡ Mann-Whitney test 
 6A                                      6B 
 
Variable C-OGD1 
Mean (SD) 
C-OGD2 
 Mean (SD) 
P-value†  T-OGD1 
(5.9mm) 
Mean (SD) 
T-OGD2 (4.9mm) 
Mean (SD) 
P-value† 
Lowest Systolic BP (mmHg) 122 (23) 128 (23) 0.23 97 (96, 99) 97 (96, 98) 0.17 
Highest Systolic BP (mmHg) 140 (26) 143 (19) 0.54  132 (20) 132 (27) 0.87 
Lowest Pulse Rate (beats per minute) 79.4 (11.7) 78.1 (13.0) 0.62  145 (23) 145 (31) 0.97 
Highest Pulse Rate (beats per minute) 91.0 (13.9) 87.6 (15.9) 0.24  74.7 (11.9) 78.6 (12.8) 0.13 
Lowest O2 Saturation (%) 98 (97, 99) 98 (95, 99) 0.10  97 (96, 99) 97 (96, 98) 0.17 
 C-OGD1 
Median (IQR) 
C-OGD2 
Median (IQR) 
P-value‡ T-OGD1 
(5.9mm) 
Median (IQR) 
T-OGD2 (4.9mm) 
Median (IQR) 
P-value‡ 
Nurse - Discomfort 
 
3.5 (1.3, 4.5) 2.2 (1.3, 4.5) 0.05 1.2 (0.5, 2.2) 1.4 (0.5, 2.2) 0.98 
Nurse – Anxiety 3.1 (1.2, 4.5) 2.0 (0.7, 4.3) 0.09 1.1 (0.7, 2.6) 1.3 (0.5, 2.3) 0.75 
Endosc. - Discomfort 4.2 (2.5, 7.3) 3.0 (0.5, 5.0) 0.03 0.8 (0.4, 1.5) 0.6 (0.4, 1.4) 0.65 
Endosc.  - Anxiety 4.4 (2.7, 7.5) 3.5 (1.2, 6.5) 0.05 1.0 (0.5, 2.2) 0.6 (0.4, 1.6) 0.13 
Endosc. - Ease of insertion 9.0 (8.6, 9.3) 9.2 (9.1, 9.5) <0.001 9.2 (8.8, 9.4) 9.1 (8.5, 9.3) 0.29 
Endosc. - Overall handling 9.2 (8.7, 9.4) 9.3 (9.0, 9.5) 0.07 9.2 (8.7, 9.4) 8.9 (7.7, 9.5) 0.10 
Endosc.  - D2 intubation 9.2 (8.6, 9.4) 9.2 (9.0, 9.5) 0.49 9.2 (8.7, 9.5) 8.8 (7.3, 9.4) 0.03 
Endosc. - Random biopsies 9.2 (8.9, 9.4) 9.2 (9.0, 9.5) 0.83  9.0 (8.6, 9.4) 9.0 (8.6, 9.4) 0.81 
Endosc. - Targeted biopsies 9.2 (8.8, 9.4) 9.2 (9.0, 9.5) 0.21  9.0 (8.5, 9.4) 8.8 (8.2, 9.2) 0.22 
Endosc - Feasibility 9.1 (8.6, 9.3) 9.2 (9.0, 9.5) 0.05  9.0 (8.9, 9.4) 8.9 (8.5, 9.1) 0.02 
Endosc. - View oesophagus 9.1 (8.6, 9.3) 9.0 (8.8, 9.4) 0.84  9.0 (8.5, 9.3) 9.0 (8.3, 9.3) 0.50 
Endosc. - View stomach (F) 9.2 (8.7, 9.3) 9.0 (8.8, 9.4) 0.64  9.0 (8.5, 9.2) 8.9 (8.0, 9.1) 0.21 
Endosc. - View stomach (R) 9.0 (9.0, 9.0) 9.0 (9.0, 9.0) 0.39  9.0 (8.0, 9.0) 9.0 (8.0, 9.0) 0.59 
Endosc. - View D1 9.1 (8.7, 9.2) 9.0 (8.7, 9.3) 0.34  9.0 (8.7, 9.2) 8.8 (8.0, 9.2) 0.04 
Endosc. - View D2 9.2 (8.9, 9.3) 9.0 (8.8, 9.3) 0.80  9.2 (8.7, 9.4) 8.7 (8.0, 9.2) 0.02 
Endosc. - Overall view quality 9.1 (8.5, 9.2) 9.0 (8.8, 9.4) 0.09  9.0 (8.5, 9.2) 8.7 (8.2, 9.2) 0.16 
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2.4.7 Comparison of T-OGD1 and T-OGD2 
Finally outcomes in T-OGD1 (n=48) and T-OGD2 (n=46) groups were examined 
(Figure 19, Table 6B). There was no difference between the groups for most outcomes 
however small but significant differences were observed in endoscopic view quality of 
the duodenum (D1 and D2), which appeared inferior for T-OGD2 compared with T-
OGD1 (8.8 vs. 9.0, P=0.02 for D1 and 8.7 vs. 9.2, P=0.02 for D2, respectively). There 
were also small but significant differences in technical feasibility and handling scores 
relating to the same anatomical location (9.2 vs. 8.8, P=0.03 for D2 intubation) and for 
overall feasibility (9.0 vs. 8.9, P=0.02) between T-OGD1 and T-OGD2. 
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Figure 19:   Box plots comparing preparation duration, procedure duration and recovery duration, 
(19A) and patient tolerance VAS tolerance scores, (19B) for T-OGD1 and T-OGD2 
procedures. Values are expressed as medians (horizontal lines) and 25
th
 and 75
th
 
percentiles (boxes) of the interquartile range (IQR). The whiskers of the box plots are set 
at 1.5x the 25
th
 and 75
th
 percentile respectively; *Mann-Whitney test. 
 
 
2.4.8 Level of patient satisfaction 
Although none of the patients expressed dissatisfaction with any of the procedures, 
patient satisfaction as obtained using a 5-point Likert scale (i.e. very satisfied, satisfied, 
neutral, dissatisfied and very dissatisfied) significantly favoured T-OGD as compared 
with C-OGD1 and C-OGD2 (Table 7). No differences in satisfaction scores were found 
within the T-OGD1 vs. T-OGD2 and C-OGD1 vs. C-OGD2 comparisons. 
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Table 7: Levels of patient satisfaction with procedures were obtained using a 5-point Likert scale 
(i.e. very satisfied, satisfied, neutral, dissatisfied and very dissatisfied); none of the 
patients expressed dissatisfaction with the procedure undertaken and therefore the last 2 
points on the scale have been omitted from the table. The results are expressed as the 
percentage of relative satisfaction for each group; *Fisher’s exact test.  
Variable Category C-OGD1 (%) T-OGD (%) P-value* 
Patient Satisfaction Very satisfied 40 64  <0.001 
 Satisfied 46 25   
 Neutral 14 4   
  T-OGD (%) C-OGD2 (%)  
Patient Satisfaction Very satisfied 69 47 0.03 
 Satisfied                   27 39  
 Neutral 4 14  
  C-OGD (unsedated) (%) T-OGD (%)  
Patient Satisfaction Very satisfied 39 69   0.004 
 Satisfied 58 27  
 Neutral 3 4  
  C-OGD (sedated) (%) T-OGD (%)  
Patient Satisfaction Very satisfied 29 69 <0.001 
 Satisfied 21 27  
 Neutral 50 4  
  C-OGD1 (%) C-OGD2 (%)  
Patient Satisfaction Very satisfied 36 47 0.52 
 Satisfied 48 39  
 Neutral 16 14  
  T-OGD1 (%) T-OGD2 (%)  
Patient Satisfaction Very satisfied 64 74 0.53 
 Satisfied 32 22  
 Neutral 4 4  
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2.4.9 Complications and other observations 
None of the patients suffered any epistaxis or other adverse event during the course of 
the study. The yield of positive findings (diagnostic yield) of C-OGD1 procedures using 
the 9.0mm endoscope was similar to that of T-OGD and C-OGD2 procedures with UT 
endoscopes; 72% vs. 70% respectively (P=0.71).  Biopsies for histopathological analysis 
were taken in 34 of the 50 patients in the C-OGD1 group (68%) and in 100 of the 150 
patients (67%) who underwent an OGD procedure using an UT endoscope (P=0.80). In 
98% of cases, the biopsies taken using UT endoscopes were adequate for analysis; in the 
2 cases where the biopsies were deemed to be too small for histological analysis, 
suspected antral gastritis (because of antral erythema) could not be confirmed. None of 
the biopsies taken with the 9.0mm endoscope were considered too small for histological 
interpretation (P=0.69). 
 
2.5 Discussion 
 
SCENT is the first prospective, randomized study to evaluate the role of unsedated 
transnasal OGD as an alternative to per-oral OGD in the UK. The study compared the 
latest available UT endoscopes with the larger (9.0mm) diameter conventional 
gastroscope most commonly used in current clinical practice. SCENT is also one of the 
most comprehensive T-OGD studies reported to date. While study parameters included 
an assessment of patient tolerance from multiple perspectives (patient, nurse and 
endoscopist), T-OGD feasibility (procedure preparation, duration and recovery times), 
safety and endoscopic view and biopsy quality, the protocol also allowed us to examine 
the use of UT endoscopes in several ways. Aside from comparing T-OGD with C-OGD1 
(OGD using 9.0mm endoscopes), we also examined insertion of UT endoscopes via both 
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the nasal and oral route (T-OGD compared with C-OGD2), T-OGD with C-OGD 
performed with and without (on-demand) sedation and T-OGD performed using 
different calibre UT endoscopes (T-OGD1 compared with T-OGD2). 
 
2.5.1 Evaluation of patient tolerance 
Our findings for the comparison of C-OGD1 (OGD using 9.0mm endoscopes) with T-
OGD are in keeping with those of others and show that T-OGD is significantly better 
tolerated than C-OGD1 performed under low dose sedation or without [8;9;11-
13;133;134].  All median VAS scores (patient, endoscopist and nurse derived) for patient 
discomfort, pain, gagging, nausea and anxiety significantly favoured T-OGD as the more 
comfortable procedure. The largest reductions in VAS scores were for gagging and 
nausea, which is likely to reflect the minimal stimulation of the pharyngeal reflex by T-
OGD.  These findings were mirrored by the Likert score comparisons showing that 
patients were significantly more satisfied with T-OGD.  
 
For the comparison of C-OGD2 to T-OGD using UT endoscopes via the oral and 
transnasal route respectively, although differences in VAS scores were smaller in 
magnitude than those seen for C-OGD1 (using the 9.0mm endoscope) vs. T-OGD, a 
general reduction in patient tolerance scores (lower scores = better tolerated) and 
significantly higher satisfaction scores were seen favouring T-OGD over C-OGD2. 
Interestingly the comparison of C-OGD1 with C-OGD2 (using UT endoscopes) also 
showed a significant reduction in overall patient discomfort VAS score relating to C-
OGD2, however this improvement appeared less substantial than that observed using UT 
endoscopes via the transnasal route. While use of UT endoscopes for C-OGD appeared 
to improve aspects of patient tolerance compared with C-OGD (using the 9.0mm 
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endoscope), our findings suggest that improved patient experience during OGD is more 
dependent upon the route used for the procedure than the endoscope calibre itself 
[2;12;13;16;135]. We found no difference in patient tolerance or satisfaction scores 
between either sized UT endoscope for T-OGD, however differences have been reported 
by others [136].  
 
When C-OGD with or without sedation was compared with T-OGD we found that 
median VAS scores for patient tolerance were significantly lower (indicating better 
tolerance) for T-OGD across multiple parameters. While direct comparisons were not 
made, C-OGD VAS scores by patients, nurses and endoscopists for C-OGD with 
sedation appeared inferior to those for C-OGD without sedation. Patient satisfaction 
levels (% of patients ‘satisfied’ and ‘very satisfied’) were similarly reduced. One 
possible explanation is that the patients who requested sedation during C-OGD found it 
more uncomfortable and painful to begin with and therefore reported it so. In adherence 
to unit policy and national guidance [137], we used low doses of sedation (midazolam, 
mean dose 2.5mg ±1mg) which was only given on demand, according to study protocol. 
The scores relating to the subset of patients who requested sedation may have therefore 
been confounded by the possibility that this subset was also likely to also represent a 
‘self-selected’ sub-group who had found the OGD procedure to be particularly 
uncomfortable. The benefit of on-demand sedation for GI endoscopy has recently been 
examined by Seip et al. [138] who found that giving sedation in this way (with median 
doses of 3mg midazolam and 50mg pethidine) was not associated with lower rates of 
painful colonoscopy or improved patient satisfaction despite accounting for factors 
related to more painful colonoscopy. This study did not examine the effect of pre-
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procedure sedation for C-OGD on VAS scores for patient tolerance, which is intended to 
be the purpose of a future study. 
 
2.5.2 Evaluation of endoscopic view and biopsy quality 
No significant differences in endoscopic view quality or diagnostic yield were detected 
when procedures using UT endoscopes were compared with those performed using the 
conventional 9.0mm endoscope. The only significant differences in view quality were 
detected within the comparison of 5.9mm and 4.9mm UT endoscopes for T-OGD1 and 
T-OGD2 procedures respectively where views of the first and second part of the 
duodenum using 4.9mm UT endoscopes were found to be of significantly inferior 
quality. This may relate to the one-way bending plane of this endoscope, which requires 
reliance on additional torquing of the instrument shaft in order to obtain the desired 
views [139]. Although our main objectives did not include a formal analysis of size and 
quality of biopsy specimens obtained, we performed a brief comparison of biopsy 
specimens taken with the UT and 9.0mm endoscopes and showed no significant 
difference.  This is in agreement with the findings of a recent large study dedicated to the 
quality of biopsies taken by small forceps used in UT OGD as compared with standard 
size OGD forceps which confirmed no overall difference in biopsy quality [140]. 
 
2.5.3 Evaluation of patient safety 
Although T-OGD is associated with epistaxis that has been reported to occur in up to 2% 
of cases [141] no significant adverse events or complications were observed during this 
study. An interesting, albeit clinically inconsequential finding was that the SBP was 
found to be lower in C-OGD1 patents who received sedation.  This observation may be 
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explained by pharmacologic effect of midazolam, which is known to lower the SBP even 
at the low doses used in this study [1;142;143].  
 
2.5.4 Evaluation of feasibility 
In our experience, T-OGD was technically possible in 94% of patients in whom it was 
attempted. The inability to pass the soft-silicone preparation catheter or UT endoscope 
through either of the patients’ nasal passages in the remaining 6% is similar to the 3-8% 
failure rate reported by others [2;10;13;144]. Although some studies have shown that 
failure rates relate to a wider UT endoscope diameter [12;136], this trend was not 
evident in our experience since our failure rate was higher in the 4.9mm group.  
Regarding preparation and procedure duration, we found that it took longer to prepare 
for and to perform T-OGD. This was however offset by a shorter recovery time for T-
OGD. As expected, this difference was greater when T-OGD was compared with C-
OGD under sedation. Although no formal cost-effectiveness analysis was performed, 
two studies have demonstrated that the enhanced recovery relating to unsedated OGD 
using UT endoscopes versus sedated C-OGD may facilitate reductions in personnel and 
facility costs in the order of 20-36% [145;146].  
 
2.5.5 Limitations of the study 
This study was conducted in single academic endoscopy institute and incorporated 
multiple group comparisons, using subjective measures (VAS and Likert scores). 
Furthermore, although sub-analysis of comparisons of various sub-groups yielded 
statistically significant results, the original power calculation was based only on 
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comparisons for the primary objective. Another potential limitation of the study was that 
sedation was only given on demand and this may have derived a self-selected sub-group. 
 
2.5.6 Conclusion 
In summary, this is the first prospective study to compare T-OGD using the latest 
available UT 5.9mm and 4.9mm endoscopes with C-OGD in the UK. We have 
confirmed that unsedated transnasal endoscopy is associated with significantly higher 
levels of patient tolerance and satisfaction compared with C-OGD. In addition, we have 
also confirmed that T-OGD is a highly feasible and safe alternative to C-OGD with 
similar diagnostic quality. Use of UT endoscopes via the oral but more so the nasal route 
is associated with improved patient tolerance compared with C-OGD. In our experience, 
the thinner 4.9mm UT endoscope in its current form, does not appear to offer a 
significant advantage over the 5.9mm UT endoscope and may be more difficult to use. 
The encouraging findings of our study, which in many respects echo the results of 
others, may help to support a wider acceptance of transnasal endoscopy into routine 
clinical practice in the UK. 
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3 An evaluation of performance, limitations and 
complications of double-balloon enteroscopy 
(DBE) in the United Kingdom 
  
 
3.1 Background 
 
Recent advances in endoscopic technology have revolutionized endoscopy of the small 
bowel (SB) [147;148]. Since the introduction of SB capsule endoscopy (SBCE) [23] and 
double-balloon enteroscopy (DBE) [20], clinicians are able to visualize the entire SB 
without recourse to surgical intervention. These two technologies complement each 
other [149], with SBCE, being less invasive often used to ‘scout’ for potential SB 
pathology and help determine the best route of insertion for subsequent DBE [150].  
DBE allows for controlled, direct endoscopic characterization of lesions, facilitates 
tissue biopsy and enables the application of endotherapy, such as argon plasma 
coagulation (APC), endoclipping and injection of vascular lesions; dilatation of 
strictures, polypectomy and direct percutaneous endoscopic jejunostomy (DPEJ) 
placement [20;21;24-49]. In selected cases, these endotherapeutic interventions may 
obviate the need for surgery [20;21;24-49]. Although initially described by Yamamoto et 
al. [20] a decade ago, there have been no published reports on the UK practice of DBE.  
 
 
76 
  
3.2    Aims 
 
To assess the performance, limitations and complications of DBE within the UK by the 
evaluation of data collected into a large multi-centre database.   
3.3 Methods 
 
Since the introduction of DBE in the UK in 2005, a total of 8 tertiary referral centres 
(The UK DBE Users Group) which perform DBE on a regular (at least 2-weekly) basis 
have collected data on DBE procedures performed. Data collected from each centre were 
recorded using a standardized, electronic spread-sheet designed by the author 
(Microsoft
®
 Excel 2003, Microsoft Corporation, WA, USA). These data were then 
collated into a dedicated database (by the author at St Mark’s Hospital) and analysed 
retrospectively. Data were collected for i) patient related and ii) DBE procedure details. 
i) Patient details 
Data for patient demographics (age and gender), past history of abdominal/pelvic 
surgery, indications for referral for DBE and pre-DBE investigations were recorded. 
ii) DBE procedure details   
Data collected in relation to DBE procedures included: number of DBEs performed per 
patient, route of approach i.e. per oral (anterograde), per rectal or per ileostomy 
(retrograde) and details of sedation or general anaesthesia (GA) used. The type of gas 
used for SB insufflation (i.e. carbon dioxide (CO2) or air), estimated depth of insertion, 
completeness of procedures, limitations encountered and time taken to perform DBE 
procedures were documented. Diagnostic findings, endotherapy applied and details of 
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DBE-related complications (including subsequent interventions/outcomes) were also 
collected.  
3.3.1 Definitions 
Diagnostic DBE procedures were defined as procedures performed with or without 
biopsy and with or without India ink tattooing (Spot
®
 GI Supply, PA, USA) of the SB 
sub-mucosa. Therapeutic DBE procedures were defined as procedures involving the use 
of any form of endotherapy, including: argon plasma coagulation (APC), application of 
endoclips (Resolution
®
, Boston Scientific, MA, USA or Quickclip
®
, Olympus, Tokyo, 
Japan), therapy of varices by injection of human thrombin (Tisseel
®
, Baxter, IL, USA), 
endoscopic balloon-dilatation using through-the-scope (TTS) controlled radial expansion 
(CRE) balloon dilators (Boston Scientific, MA, USA), snare polypectomy and direct 
percutaneous endoscopic jejunostomy (DPEJ) enteral tube placement.  
Pan-enteroscopy was defined as complete DBE examination of the SB, confirmed either 
by the identification of a submucosal India ink tattoo placed at a previous DBE done via 
the opposite end or by the identification of the ileo-caecal valve/colon during a 
procedure done via the oral route. 
A complication was defined as a procedure-related event which negatively affected the 
health of a patient post-procedure [30]. Unfortunately, due to the retrospective design of 
the study and tertiary nature of the referrals for DBE, data on longer-term complications 
could not be secured and therefore complication data should be considered to mainly 
represent immediate (peri-procedure) adverse events. Complications were graded as 
mild, moderate or severe as defined by American Society of Gastrointestinal Endoscopy 
(ASGE) lexicon for endoscopic adverse events [151]. Pancreatitis was defined as post 
procedural, abdominal pain associated with a ≥3 fold rise in serum amylase/lipase above 
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the upper limits of normal, associated with ≥2 days of unintended post-procedure 
hospitalization [30;39].  
 
3.3.2 DBE procedures 
DBE procedures were carried out using the EN-450P5 (8.5mm diameter, 200cm working 
length and 2.2mm instrument channel) or the EN-450T5 (9.5mm diameter, 200cm 
working length 2.8mm instrument channel) enteroscopes, both manufactured by Fujifilm 
(Saitama, Japan). In cases where CO2 was used as an insufflating agent, CO2Efficient
TM
 
systems (E-Z-EM Inc., NY, USA) were used. Patients having a DBE via the anterograde 
route were prepared with an 8-12 hour fast, while patients having a retrograde DBE 
received bowel preparation as per individual unit practice. Anterograde procedures were 
performed with the patient in the left lateral position. In DBEs performed via the rectal 
route, intubation of the colon was performed with the patient in the left lateral position; 
patients were then placed in the supine position for SB intubation. The route of DBE 
procedures was generally determined by the findings of pre-DBE investigations such as 
SBCE [150], barium follow-through (BaFT), computed tomographic enterography 
(CTE) and/or magnetic resonance enterography (MRE). Anti-foaming agent in the form 
of 1% simethicone suspension (Infacol
®
, Forest-Laboratories, Dartford, UK) was used as 
a wash to improve endoscopic view quality as required. 
Conscious sedation was administered using intravenous generic midazolam in addition 
to an intravenous opioid (in the form of either generic pethidine or fentanyl), as per local 
unit policy. Five centres had access to GA and monitored anaesthesia care (MAC, for 
propofol sedation) services, which were used at the discretion of endoscopists as an 
alternative to intravenous conscious sedation [142]. Antispasmodic agents in the form of 
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intravenous hyoscine-N-butylbromide (Buscopan
®
, Boehringer Ingelheim Gmbh, 
Germany) or generic glucagon were administered to reduce SB peristaltic activity as 
necessary. Enteroscope depth of insertion into the SB (from the pylorus, terminal ileum 
or ileostomy) was estimated using the method described by May et al. [51].  This 
method, which has been validated on Erlangen-type ex-vivo animal training models [51], 
uses an estimated depth of SB insertion of 20-40cm per DBE insertion cycle. 
3.3.3 Statistical analysis 
Data were collated into a dedicated computer database and analysed at the lead centre (St 
Mark’s Hospital and Academic Institute, Imperial College London) using Microsoft® 
Office 2010 (Microsoft Corporation, WA, USA) and GraphPad
®
 InStat, version 3.0 
software (GraphPad Software Inc., CA, USA). Descriptive statistics were used for 
examination of patient demographics and the Mann-Whitney U-test was used to compare 
independent ordinal variables such as SB insertion depths. Binomial distribution 
analyses were used to examine limitations encountered and diagnostic yields. A P value 
of <0.05 was regarded to be statistically significant. Two-tailed probability tests were 
used and data are presented as means ± SD, medians and ranges. Selected box-plots of 
medians and interquartile ranges (IQR) are also shown.   
 
3.4 Results 
 
3.4.1 Patient details 
Between February 2005 and February 2011, a total of 1000 DBE procedures were 
performed in 783 patients (439 men; 344 women). The mean age ±SD of patients was 54 
±18 (range 7-94) years. A past history of abdominal or pelvic surgery was present in 248 
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(31.7%) patients. Details regarding indications for DBE procedures are described 
(Figure 20). These data include those of 12 paediatric patients (mean age 14±3 (range 7-
18) years) who all underwent DBE for removal of SB polyps in the setting of Peutz-
Jeghers syndrome (PJS), and therefore a detailed evaluation of DBE procedures in this 
sub-group of paediatric patients is given in Chapter 6.   
Pre-DBE SB investigations in the form of SBCE and/or diagnostic imaging (MRE or 
computed tomographic enterography (CTE) or SB barium follow through (SBFT)) were 
carried out prior to 966 (96.6%) of procedures. 
Figure 20: Indications for DBE procedures and respective number of cases performed. IDA, iron 
deficiency anaemia; CD, Crohn’s disease; SB, small bowel; DPEJ, direct endoscopic 
percutaneous jejunostomy    
 
 
 
 
 
 
 
 
 
 
 
81 
  
3.4.2 Procedure details 
The number of DBEs performed per patient ranged from 1 (n=605) to 6 (n=1); full 
details are described (Table 8). The anterograde route of insertion was used for 682 
procedures while the retrograde route was used for 318 DBEs. In total, 113 patients 
underwent a DBE via both the anterograde and retrograde routes. Laparoscopic assisted 
DBE (lap-DBE) was used in 4 cases (for the removal of large duodenal polyps). 
 
Table 8: Number of DBEs performed per patient; OGIB, obscure (mid-gut) GI bleeding; IDA, 
iron-deficiency anaemia; CD, Crohn’s disease; PJS, Peutz-Jeghers syndrome 
 
 
 
 
 
 
 
 
 
 
 
Number of DBEs performed (n) Patients (n) Further details 
1 605 OGIB/IDA (n=336) 
Suspected CD (n=80) 
PJS (n=65) 
Suspected SB tumour (n=41) 
Strictures (n=31) 
Enteropathy (n=21) 
DPEJ (n=21) 
Intussusception (n=8) 
Post Roux-en-Y (n=2) 
2 150 OGIB/IDA (n=98) 
Suspected CD (n=20) 
PJS (n=14) 
Strictures (n=13) 
Suspected SB tumour (n=5) 
 
3 19 OGIB/IDA (n=10) 
Strictures (n=4) 
Suspected CD (n=2) 
Suspected SB tumour (n=2) 
PJS (n=1) 
 
4 8 OGIB/IDA (n=6) 
Strictures (n=2) 
6 1 OGIB/IDA (n=1) 
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Intravenous sedation was given for 650 DBEs (including 4 procedures performed under 
MAC using anaesthetist delivered propofol sedation); GA was used for the remaining 
350 procedures. Details of drug dosage for intravenous sedatives and antispasmodics are 
shown (Table 9). CO2 was used as an insufflating agent in 730 cases while air was used 
in the remaining 270 procedures. 
 
Table 9: Dosage details of drugs used during DBE procedures; *glucagon was used in patients 
who had contraindications to the use of hyoscine-N-butylbromide; mcg, micrograms; 
MAC, monitored anaesthesia care 
 
There was no significant difference in the median duration of DBEs performed via the 
anterograde route as compared with retrograde procedures (70 vs. 65 minutes 
respectively, P=0.36) (Figure 21A). However, the median estimated depth of insertion 
Dosage details of drugs used for intravenous sedation and analgesia 
Drug  Mean dose (±SD) Dose range 
Midazolam (used for 646 DBEs) 5.56 (±2.88) mg 1.25-10 mg 
Pethidine (used for 311 DBEs) 57.30 (±17.29) mg 12.5-100 mg 
Fentanyl (used for 335 DBEs) 74.29 (±33.83) mcg 25-200 mcg 
Propofol infusion by anaesthetist delivered MAC (used for 4 DBEs) 
Sedation maintained by intravenous infusion of propofol at a dose rate of 1.5-4.5mg/kg/hour (after 20-
40mg bolus induction) 
Dosage details of drugs used as antispasmodics 
Drug  Mean dose (±SD) Dose range 
Hyoscine-N-butylbromide (Buscopan
®
) (used for 526 DBEs) 21.62 (±8.65) mg 10-40 mg 
Glucagon* (used for 16 DBEs)  1.02 (±0.43) mg 0.5-2.0 mg 
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for anterograde DBEs was found to be twice that of retrograde procedures (240 vs. 120 
cm, respectively, P < 0.0001) (Figure 21B). Significant differences were also identified 
when median estimated insertion depths for procedures performed using CO2 insufflation 
were compared with those performed using air (220 vs. 180 cm, respectively, P=0.0001) 
(Figure 21C). The median insertion depth at DBE in patients without a history of 
surgery was significantly higher than that for patients who had undergone abdominal and 
/ or pelvic surgery (220 vs. 160 cm, respectively, P < 0.0001) (Figure 21D). Differences 
in median insertion depth relating to type of gas insufflation and past history of surgery 
were significant for both anterograde and retrograde DBE procedures (Figure 22A-D). 
 
3.4.3 Rate of pan-enteroscopy 
In the sub-group of 113 patients who underwent a DBE via both the anterograde and 
retrograde route patients, pan-enteroscopy was achieved in 20 (17.7%). In another sub-
group of 7 patients, pan-enteroscopy was achieved during DBE procedures done via the 
anterograde route alone; 5 of these patients had a history of short bowel syndrome 
secondary to extensive SB resection. 
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Figure 21: Duration of oral and rectal DBE procedures (A), Estimated depths of insertion for oral 
and rectal DBE procedures (B), Overall estimated depths of insertion (oral + rectal) in 
relation to a past history (Hx) of surgery (C) and Overall estimated depths of insertion 
(oral + rectal) in relation to the use of CO2 or air (D). Values are expressed as medians 
(horizontal lines) and the 25
th
 and 75
th
 percentiles, boxes of the interquartile range 
(IQR). The whiskers of the box plots are set at 1.5x the 25
th
 and 75
th
 percentiles 
respectively; *Mann-Whitney test. 
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Figure 22: Estimated depths of insertion in relation to a past history (Hx) of surgery for the oral 
route (A) or rectal route (B) or in relation to the use of CO2 or air; oral route (C), rectal 
route (D). Values are expressed as medians (horizontal lines) and the 25
th
 and 75
th
 
percentiles, boxes of the interquartile range (IQR). The whiskers of the box plots are set 
at 1.5x the 25
th
 and 75
th
 percentiles respectively; *Mann-Whitney test. 
 
86 
  
3.4.4 Diagnostic yield 
After exclusion of the 22 cases with an intrinsically therapeutic indication (DPEJ and 
ERCP in the setting of surgically altered anatomy), positive findings were identified in 
565/978 (57.8%) of the remaining DBE procedures. There was no significant difference 
between diagnostic yield for either route (anterograde, 56.7% vs. retrograde, 56%, 
P=0.82). However, in the subgroup of 113 patients who underwent both anterograde and 
retrograde procedures, the combined overall diagnostic yield was significantly higher for 
the 20 patients in whom pan-enteroscopy was achieved as compared with that for the 
remaining 93 (80% vs. 64.5% respectively, P=0.02) in whom it was not.  
 
3.4.5 Endoscopic therapy 
Therapeutic interventions took place in 383 DBE procedures (38.3%). Most commonly, 
argon plasma coagulation (APC) of SB angioectasias was applied in 239/383 (62.4%) 
cases. Polypectomy of clinically-significant SB polyps in the setting of Peutz-Jeghers 
syndrome (PJS) was performed in another 79/383 (21%) of therapeutic DBE and balloon 
dilatation of SB strictures in 38/383 (9.9%).  A total of 19/383 (5%) therapeutic DBEs 
involved direct percutaneous endoscopic jejunostomy (DPEJ) feeding tube placement 
(n=15), repositioning (n=2) or removal (n=2). The remaining 8/383 therapeutic 
procedures (2.1%) facilitated the application of other forms of haemostatic endotherapy, 
namely the deployment of endoclips (n=7) and thrombin injection of SB varices (n=1). 
In 2 of the cases where DPEJ placement was intended, the procedures were abandoned 
due to inability to achieve adequate trans-illumination. In the only case intended for 
facilitation of endoscopic retrograde cholangio-pancreatography (ERCP) in a patient 
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with altered SB anatomy (post-orthotopic liver transplantation); no ERCP was performed 
since SB tethering hindered effective DBE insertion. 
 
3.4.5.1 Factors identified by the endoscopists as having a negative 
effect on SB insertion depth 
Specific factors which were identified by endoscopists as having a negative effect on SB 
insertion depth included ‘SB tethering’ and ‘unfavourable SB looping’. These were 
encountered in 121 of 294 procedures (41.2%) in patients with a history of surgery and 
in 51 of 706 procedures (7.2%) done in surgically naïve patients (P < 0.0002). Other 
factors included ‘technical faults’, which occurred in 16 procedures (1.6%), ‘poor bowel 
preparation’ which caused ‘friction’ between the overtube and enteroscope in another 15 
(1.5%) of DBEs and a ‘retroverted (backward facing) or ileo-caecal valve’ which was 
described in 8 procedures (0.8%). The retrograde route itself was also identified as 
having a negative impact on SB insertion depth; 86 of the 318 retrograde DBEs (27%), 
failed to achieve an estimated SB insertion depth of 100cm as compared with 39 of the 
682 anterograde procedures (5.7%) which failed to achieve this (P < 0.0002). 
 
3.4.6 DBE related complications 
Unfortunately, due to the retrospective design of the study and tertiary nature of the 
referrals for DBE, data on longer-term complications could not be secured and therefore 
complication data should be considered to mainly represent immediate (peri-procedure) 
adverse events. Peri-procedure complications occurred in 9 DBE procedures involving 
endotherapeutic interventions and in 1 case where no endotherapy was applied. These 
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consisted of 4 perforations (2 post-polypectomy, 1 post-stricture dilatation and 1 
diagnostic procedure in a patient with actively inflamed Crohn’s disease distal SB 
strictures); 3 cases of mild post-polypectomy bleeding (requiring no transfusion), 1 case 
of acute coronary syndrome (ACS), 1 case of post-DBE pancreatitis and 1 case of a 
pelvic abscess related to an infected laparoscopy-port wound post lap-DBE. None of the 
complications was associated with mortality and all patients made a full recovery (Table 
11).  
Consequently, the overall DBE rate of adverse events in our experience was 1%. The 
complication rates for diagnostic and therapeutic DBEs were 1/617 (0.16%) and 9/383 
(2.35%) respectively. The overall post-polypectomy complication rate was 5/79 (6.3%); 
post-polypectomy bleeding and perforation occurred in 3/79 (3.8%) and 2/79 (2.5%) 
respectively. Perforation occurred in 1/38 cases (2.6%) of dilatation of SB strictures. 
Post-DBE pancreatitis occurred in 1/682 (0.15%) of anterograde procedures but none of 
the retrograde cases. 
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Table 10:  Full details of peri-procedure DBE related complications. CT, computed tomography; Hx, history; IHD, ischemic heart disease; Mx, management; ECG, electrocardiogram; NSTEMI, non-ST segment elevation myocardial 
infarction; Dx, diagnosis; MRI, magnetic resonance imaging. *Severity was graded according to the American Society of Gastrointestinal Endoscopy (ASGE) lexicon of adverse events (2010) [151] 
 
 
Patient details Indication for DBE /  
route of insertion / GA  
& sedation details 
Complication type Procedure/complication details Outcome Severity* 
Number Gender Age 
(years) 
1 F 49 Dilatation of Crohn’s disease (CD) 
small bowel (SB) strictures / oral 
route / general anaesthesia (GA) 
Perforation  
(post-SB stricture dilatation)  
Successful dilatation of 3 tight strictures in an angulated 
and adhered jejunal segment was followed by the 
development of severe abdominal pain 8 hours post 
procedure; Urgent CT confirmed delayed perforation of 
the jejunum. 
The patient underwent emergency laparotomy with 
resection of the diseased segment of jejunum and 
formation of a temporary jejunostomy which has 
since been reversed with good recovery. 
Severe 
2 M 17 Emergency polypectomy in the 
setting of intussusception of a large, 
semi-pedunculated duodenal Peutz-
Jeghers syndrome (PJS) polyp / oral 
route / GA 
Perforation 
(post-polypectomy) 
Emergency DBE was performed in attempt to avoid 
surgery in the setting of intussusception of a large semi-
pedunculated duodenal polyp; an immediate post-
polypectomy perforation occurred. 
The procedure was immediately converted to an IOE 
through the full-thickness defect by the observing 
surgeon. The duodenal polyp was resected and the 
patient made an uneventful recovery. 
Severe 
3 F 39 Polypectomy of large, semi-
pedunculated  jejunal PJS polyp / oral 
route / GA 
Perforation 
(post-polypectomy) 
Immediate perforation following elective polypectomy of 
a large semi-pedunculated jejunal polyp.  
The patient underwent emergency laparotomy and 
IOE with resection of the polyp through an 
enterotomy. Good recovery with no further 
complications. 
Severe 
4 M 42 Assessment of CD disease activity 
and evaluation of SB strictures / 
rectal route / GA 
Perforation  
(not related to endotherapy) 
The mesenteric wall of the distal ileum was involved by 
linear inflammation and stricturing with pre- and post-
stenotic saccular dilatation. None of these strictures 
required endotherapy. On withdrawal of the enteroscope 
however, a 2cm perforation was noted on the mesenteric 
border. This may have been caused by trauma from 
angulation of the tip of the enteroscope. 
At emergency laparotomy, the full-thickness 
perforation into the mesentery was confirmed and the 
diseased segment of ileum was resected without need 
for an ileostomy. The patient made a full recovery. 
Severe 
5 M 80 Argon plasma coagulation (APC) of 
SB angioectasias / oral route / 
sedation (5mg midazolam + 50mg 
pethidine) 
Acute coronary syndrome 
(ACS)  
The patient (who had a Hx of IHD) developed severe 
compressive chest pain during APC of jejunal 
angioectasias. The procedure was immediately aborted 
and the chest pain resolved after 30 minutes with medical 
Mx. ECG and serum troponin levels confirmed NSTEMI. 
The patient did not experience peri-procedure hypoxia or 
hypotension. 
The patient was admitted for percutaneous coronary 
intervention (with bare metal stenting) and was 
discharged 5 days later after a good recovery. 
Moderate 
6 M 46 Polypectomy of a large jejunal PJS 
polyp / oral route / sedation (8mg 
midazolam  + 100 mcg fentanyl) 
Post-DBE pancreatitis The patient (who had a Hx of laparotomy for PJS 
polyposis) underwent successful polypectomy of a large 
jejunal polyp. The procedure duration was 90 minutes 
and the estimated depth of insertion was 200cm; no 
significant procedure limitations were encountered. 
Shortly after the DBE, the patient developed moderately 
severe, persistent epigastric pain. Serum amylase and 
subsequent abdominal CT confirmed a Dx of 
pancreatitis.    
The patient was admitted and the pancreatitis resolved 
with conservative, medical management. The patient 
did not require admission to a high dependency or 
intensive care unit and was discharged 6 days later 
without further complications. 
Moderate 
7 M 16 Laparoscopically assisted DBE (Lap-
DBE) for polypectomy of a large 
duodenal PJS polyp / oral route / GA 
Pelvic abscess  
(post-Lap-DBE) 
Given the high risk nature of the duodenal polyp (large, 
sessile), a Lap-DBE was performed, during which 
successful polypectomy was undertaken. During post-op 
recovery, the patient developed signs of laparoscopic 
port-wound infection which eventually led to the 
development of a small pelvic abscess, as confirmed by 
MRI of the abdomen and pelvis.  
The patient was treated as an inpatient with 
intravenous antibiotics and radiologically guided 
drainage of the abscess. A good recovery without 
further complications was followed by discharge 
home 10 days after the procedure. 
Moderate 
8 F 21 Polypectomy of large jejunal PJS 
polyp / oral route / GA 
Mild bleeding 
(post-polypectomy) 
Successful polypectomy of a large semi-pedunculated 
jejunal polyp was followed by some mild post-
polypectomy bleeding.  
 
The bleeding was immediately controlled by the use 
of endoclips but the patient was admitted for 
overnight observation. The patient did not require 
blood transfusion and no further complications 
ensued. 
Mild 
9 M 43 Polypectomy of 3 large jejunal PJS 
polyps / oral route / sedation (5mg 
midazolam  + 100 mcg fentanyl) 
Mild bleeding 
(post-polypectomy) 
Successful polypectomy of 3 large pedunculated jejunal 
polyps was followed by mild post-polypectomy bleeding 
from 1 of the polyp stalks. 
The bleeding was controlled by endoclip deployment 
and the patient was discharged home after uneventful 
overnight observation without transfusion. 
Mild 
10 M 76 Polypectomy of a large jejunal PJS 
polyp / oral route / sedation (5mg 
midazolam  + 100 mcg fentanyl) 
Mild bleeding 
(post-polypectomy) 
Successful polypectomy of a large pedunculated polyp in 
the jejunum resulted in mild post polypectomy bleeding. 
Successful haemostasis was achieved by endoclip use. 
The patient was admitted for overnight observation. 
There was no transfusion requirement and recovery 
was uneventful. 
Mild 
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3.5 Discussion 
 
3.5.1 Performance 
Median depth of SB insertion during DBE was influenced by the route of approach, type 
of gas used for insufflation and the patients’ past surgical history. The anterograde route 
was associated with significantly deeper SB insertion compared to the retrograde 
approach. Other investigators have also demonstrated lower insertion depths with 
retrograde procedures [39;152] which is likely to reflect the more technically 
challenging nature of retrograde DBE [152;153]. The use of CO2 as an insufflating agent 
was also associated with deeper SB insertion, in keeping with the findings of Domagk et 
al. [154] whose two-centre randomized controlled study of CO2 compared with air for 
SB insufflation at DBE showed a 30% increase in insertion depth associated with the use 
of CO2.    
Our overall diagnostic yield of positive findings at DBE was 57.8%. This is comparable 
to the overall pooled detection rate of 68.1%, reported by Xin et al. [148], in their recent 
systematic review including 45 studies with a total of 5615 patients.  In our experience, 
there was no difference in diagnostic yield for procedures performed via the anterograde 
or retrograde approaches, however in the subgroup of patients where pan-enteroscopy 
was successful, the diagnostic yield increased significantly. This supports the view that 
although challenging, particularly in patients with a history of laparotomy, an attempt at 
achieving pan-enteroscopy in selected patients may be worthwhile [155].  
3.5.2 Limitations of DBE  
DBE procedures performed in patients with a history of abdominal or pelvic surgery 
were associated with a significantly lower median SB insertion depth as compared with 
procedures performed in surgically naïve patients. SB tethering and unfavourable 
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looping were reported more often in patients with a history of surgery. Our experience 
mirrors that of others [27;152;156;157]. Adhesive disease may account at least in part, 
for our pan-enteroscopy rate of 17.7%, which although similar to the pan-enteroscopy 
rate of 21%, reported by a prospective German database [39], is at the lower end of the 
range of pan-enteroscopy rates (8-66%) described by other European series 
[30;155;158].  
 
3.5.3 Complications 
The overall peri-procedure complication rate of 1% is well within the range (0.72-1.2%) 
reported by other international series [27;30;38;39;148]. Importantly, none of these 
complications was associated with mortality. Also, similar to other reports 
[27;30;38;39;148] most adverse events (9/10) related to use of endotherapy. The patient 
who suffered a perforation during diagnostic DBE (0.1% of all DBE procedures; 0.16% 
of diagnostic DBEs), had actively inflamed CD-related stricturing and it is suspected that 
trauma to the friable SB wall from angulation of the tip of the enteroscope (due to ‘high 
stretch’/pressure during unfavourable looping) contributed to this unfavourable outcome. 
Complications relating to endotherapy (0.9% of all DBE procedures; 2.35% of 
endotherapeutic DBEs) consisted of perforations (n=3), mild post-polypectomy bleeding 
(n=3), ACS (n=1), pancreatitis (n=1) and a post-laparoscopic wound related infection, 
following laparoscopic assisted DBE (n=1). The endotherapeutic procedures carrying the 
highest risk were polypectomy of large PJS polyps (3.80% risk of bleeding and 2.53% 
risk of perforation) and dilatation of SB strictures (2.63% risk of perforation). The 
presence of active inflammation within strictures should alert the endoscopist to avoid 
proceeding with dilatation in patients with SB CD. In our experience, post-DBE 
pancreatitis only occurred during 1 anterograde case (0.1% of all DBE procedures, 0.l5% 
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of anterograde DBEs); this compares favourably to figures reported by others (0.2%-
0.49%) [27;30;38;39;148]. It must be re-iterated that the retrospective design of the 
study and tertiary nature of the referrals for DBE, data on longer-term complications 
could not be secured reliably. In view of this limitation, our complication data should be 
considered to mainly represent immediate (peri-procedure) adverse events, and may 
have therefore potentially underestimated the overall procedure-related complications. 
 
3.5.4 Limitations of the study 
This was a retrospective study and the intrinsic limitations of this design (such as the 
absence of a pre-data collection study protocol) should be borne in mind. The 
retrospective design and tertiary nature of DBE referrals also led to challenges in 
securing longer-term complication data. We consider this to be a major limitation and 
have therefore accepted that our complication data is more likely to represent peri-
procedure (immediate) complications and that this may have potentially underestimated 
overall post-procedure complications. The collation of multiple data-sets from different 
centres across the country also has its limitations and challenges and although every 
effort was made to ensure that the data collected were complete and accurate, the 
absence of an audit mechanism may have allowed room for potential error. Since the 
establishment of DBE services in the UK has developed over the course of the last few 
years, it is also possible that cases performed by newer services were not included in this 
report. Another potential limitation may relate to heterogeneity of DBE user experience 
which may have confounded some of the results obtained. However, given these inherent 
limitations, our results are compatible with reports of other similar databases published 
to date [27;30;38;39;148]. 
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3.5.5 Conclusion 
In summary, our data from the first UK multicentre experience shows that DBE has an 
important role in the diagnosis and management of SB pathology. Factors which 
influence successful performance include the route of insertion, the presence or absence 
of intra-abdominal adhesive disease and the type of gas used for SB insufflation. 
Although pan-enteroscopy may be a challenge to achieve, it may help to increase the 
diagnostic yield.  In our experience, DBE in the UK has an overall immediate 
complication rate of 1%, although SB polypectomy and stricture dilatation are associated 
with higher risks of complications which is in accordance with the findings of other large 
series [27;30;38;39;148]. 
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4 Description of two original, alternative DBE 
insertion techniques 
 
4.1 Background 
 
Although DBE has the potential to facilitate deep enteroscopy without the need for 
surgical intervention, the procedure is labour-intensive and requires dedicated training. 
While some reports on DBE learning-curves have suggested that proficiency may 
improve after the performance of between 20 and 35 procedures [152;159], the author 
agrees with the findings of Gross et al. [160] who report that expertise in the procedure 
may require significantly more experience to be achieved (>100 – 150 procedures). 
Although competency in endoscopy should ideally be assessed by dedicated and 
validated competency assessment tools [161-165] (rather than the use of numbers of 
procedures performed as a surrogate marker of competency) this reported data suggests 
that training in DBE may best be achieved through dedicated, lengthy advanced 
endoscopy fellowships in specialist centres.  
Furthermore, our experience and that of others [27;152;153;156;166] has found that SB 
insertion depth may be limited during procedures performed via the retrograde route or 
in the presence of SB tethering (e.g. secondary to post-surgical adhesive disease). In an 
attempt at overcoming these potential limitations, we developed 2 original, alternative 
DBE insertion techniques which are designed to enable deeper SB insertion during 
retrograde DBE and for the management of ‘unfavourable’ SB looping as caused by the 
presence of SB tethering, respectively [167;168].  
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4.2 Achieving successful ileal intubation during retrograde DBE: 
description of an original alternative technique 
 
The retrograde approach is considered technically more challenging in DBE and failure 
rates for ileal intubation of up to 30% have been reported [152]. The original ileal 
intubation technique at DBE as described by Yamamoto et al. [20;123] involves a 
‘forward view’ approach to the ileo-caecal valve (ICV) while the overtube (with its 
balloon inflated) is pulled-back within the ascending colon (Figure 7B) which helps to 
reduce the ‘ileocolic’ angle enabling improved visualisation and intubation of the ICV 
and the terminal ileum (TI) [123]. In our experience and that of others, ileal intubation 
can still fail despite the use of this technique [152;153]. 
We subsequently proposed an original, alternative method for ileal intubation when the 
standard manoeuvre [123] is unsuccessful. Our technique enables ileal intubation in 
situations where the ‘ileocolic’ angle cannot be reduced sufficiently by pull back of the 
overtube balloon or when the ICV is retroverted (i.e. backward-facing, away from direct 
endoscopic view).  
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4.2.1 Diagrammatic, step-wise description of the technique: 
 
Figure 23: Step 1: Both the enteroscope and overtube are passed into the caecum, the overtube 
balloon is inflated and the ICV visualised by the enteroscope in the retroflexed view; the 
enteroscope balloon remains deflated.  
 
 
 
Figure 24: Step 2: The enteroscope is advanced into the terminal ileum (TI), while in the 
retroflexed position. The enteroscope balloon is then inflated, allowing the enteroscope 
balloon to apply gentle traction to the TI in preparation for step 3. 
 
 
97 
  
Figure 25: Step 3:  While the enteroscope balloon is inflated in the TI, the overtube balloon is 
deflated and the enteroscope and overtube are pulled back together, straightening the 
enteroscope in preparation for advancement of the overtube into the TI. 
 
 
 
Figure 26: Step 4: The overtube is advanced across the ICV into the TI and the overtube balloon is 
inflated. 
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Figure 27: Step 5: With enteroscope balloon deflated, the enteroscope is advanced deeper into the 
ileum while the overtube balloon remains inflated. The usual DBE insertion method 
[123] can then be resumed. 
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4.3 Management of deep looping when failing to progress at DBE: 
description of an original alternative technique 
 
The key principles of deep intubation of the SB by DBE as described by Yamamoto et 
al. [20;54;123] involve minimal SB stretching and loop reduction. This relies on gentle 
traction of the SB provided by the enteroscope and overtube balloons, and a “pull-back” 
manoeuvre which allows loop resolution and straightening of the mobile and un-tethered 
SB [123]. In patients with underlying SB tethering (e.g. due to intra-abdominal 
adhesions) (Figure 28), our experience and that of others [156] has found that this 
insertion method may be limited by the formation deep ‘s-shaped’ loops that are difficult 
to reduce during enteroscope insertion, resulting in decreased insertion depth and 
procedure failure.  We therefore developed an original adaptation of the conventional 
insertion method designed to improve SB insertion depths during DBE when such deep, 
unfavourable looping occurs.  
 
 
Figure 28: Photograph (courtesy of Dr Edward C. Klatt MD, ‘WebPath’, The Internet Pathology 
Laboratory for Medical Education, Mercer University School of Medicine, Savannah, 
Georgia, USA (http://library.med.utah.edu/WebPath)), demonstrating adhesions (blue 
arrow) of the SB (green arrow) as seen at laparotomy (A) and cartoon illustrating how 
adhesive disease (blue arrow) causes tethering of the SB (green arrow) (B) 
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4.3.1 Diagrammatic, step-wise description of the technique: 
 
Figure 29: Step 1A: Failure to progress with enteroscope (a) as SB tethering (b) forms a deep loop 
Step 1B:  The enteroscope balloon is inflated (a), the overtube balloon is deflated (b) 
and the overtube advanced (c). 
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Figure 30: Step 2: The overtube balloon is inflated (a) while the enteroscope balloon is deflated (b). 
The enteroscope is then advanced as the overtube pulled back (c). 
 
 
Figure 31: Step 3: The enteroscope balloon is inflated (a) and the overtube balloon deflated (b). 
The overtube is then advanced as the enteroscope is pulled back (c). This step is 
fundamental to the success of this variation in insertion method and relies on the use of 
the enteroscope balloon alone (which is not available in other deep enteroscopy 
techniques such as single balloon or spiral enteroscopy). 
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Figure 32: Step 4: The overtube balloon is inflated (a) and the enteroscope balloon deflated (b). 
The enteroscope is then advanced as the overtube pulled back (c). 
 
 
4.4 Summary 
 
 
Despite the ability of DBE in achieving effective, minimally invasive deep enteroscopy 
[27;152;153;156;166], it is a labour-intensive procedure which requires dedicated 
training. Although procedure proficiency may improve after the performance of the 
initial 35 procedures [152;159], it is likely that expertise in DBE may potentially only be 
achieved through the acquisition of significantly more experience [160].  Furthermore, 
SB insertion depth may be reduced during procedures performed via the retrograde route 
or in the presence of SB tethering. To address these limitations, we have developed 2 
original, alternative DBE insertion techniques that may be applied when needed, in order 
to achieve successful intubation of the ICV and during looping, particularly when SB 
tethering due to adhesions is suspected [167;168].  
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5 Effectiveness and safety of DBE facilitated 
dilatation of Crohn’s disease SB strictures 
 
5.1 Background 
 
Idiopathic inflammatory bowel disease (IBD) is classified into ulcerative colitis (UC) 
and Crohn’s disease (CD), two major chronic inflammatory disorders of the 
gastrointestinal (GI) tract which are hallmarked by significant morbidity relating to 
frequent relapses [169]. Although both these conditions are lifelong disorders, each has 
its own distinct pathological and clinical features: UC is characterised by diffuse 
inflammation of the colonic mucosa while CD is heterogeneous, affecting any part of the 
GI tract with varying degrees of inflammation [170;171]. CD is also associated with 
transmural inflammation that may result in stricturing and penetrating disease [170] and 
a tendency for progression in severity with time [172]. CD most commonly affects the 
ileo-colic region, with SB involvement affecting up to 80% of cases and in about 30% of 
patients, the disease is limited to the SB alone [31;170;173].  
Stricture formation in CD constitutes a major part of the disease burden and is a leading 
indication for surgical intervention and hospitalisation for patients with this condition1. 
The distal small bowel (SB) and ileo-colic anastomosis are the most common sites of 
involvement while colonic stricturing may occur in up to 17% of patients and proximal 
SB and upper gastrointestinal strictures occur in up to 5%.2  Although it is unclear why 
some patients develop stricturing disease while others are spared this complication, 
several factors such as the severity of CD, its duration, ileal involvement and the 
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presence of certain NOD2/CARD15 genetic polymorphisms appear to be linked with an 
increased risk of stricture development.3-5 There is also a tendency for the CD 
phenotype to worsen over time; one large series showed that up to 27% of patients 
progressed from a non-stricturing/non-penetrating phenotype to stricturing disease over a 
period of 10 years.6 Despite recent advances in the medical management of CD, 
stricturing disease remains a challenging issue since most strictures eventually develop a 
significant fibrostenotic component that is refractory to medical therapy and requires 
endoscopic or more invasive surgical intervention. 
Stricturing disease causes gradual narrowing of the intestinal lumen that may remain 
clinically silent but often manifests itself sub-acutely with post-prandial bloating, colicky 
abdominal pain  or with the signs and symptoms of frank, acute intestinal obstruction 
(frequently precipitated by a fibre-rich meal). Three types of CD related strictures are 
described: inflammatory, fibrostenotic and anastomotic.7 The inflammatory and 
fibrostenotic types illustrate the natural history of CD itself and represent the two ends of 
a progressive continuum; often there is co-existence of inflammation and fibrosis within 
the same CD stricture. Although an attempt at quantification of the inflammatory and 
fibrotic components can prove to be a challenging task, every effort should be made to 
rule out active inflammation, as this has the potential to respond (at least in part) to 
medical therapy. Post-surgical anastomotic strictures are often very short, frequently 
occur in the absence of CD recurrence and tend to be more amenable to endoscopic 
therapy.8 Pointers to active disease may be sought from C-reactive protein (CRP) levels, 
diagnostic imaging and endoscopic evaluation. While the CRP is usually raised in active 
CD, a rise in its level may be caused by inflammation elsewhere and corroboration with 
other investigations is advised; also the CRP level may be normal in the face of active 
disease in up to 10% of patients.9 Radiological investigations (Figure 33) that may 
demonstrate disease activity include barium studies and contrast enhanced computed 
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tomographic (CT) enterography/colonography.  Contrast enhanced ultrasound scanning 
(with Doppler) may also help to clarify the scenario but the quality of this test relies 
heavily on a high level of operator expertise.8 Dynamic gadolinium enhanced magnetic 
resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography 
(FDG-PET), have also been shown to be excellent at highlighting active inflammation 
within a given stricture.10 Diagnostic imaging also provides additional information on 
the length and complexity of any stricturing disease; characteristics that will also 
influence the management strategy in their own right. Direct endoscopic visualisation of 
a stricture and its surrounding mucosa is also a key part of the assessment process; 
endoscopic findings that strongly support active disease include the presence of marked 
mucosal ulceration and sloughing (Fig. 2); endoscopic assessment also provides the 
opportunity to take biopsies for histopathological analysis. During the initial clinical 
work-up of patients who present with sub-acute symptoms associated with SB strictures, 
it is also important to consider the frequently overlooked co-existence of small intestinal 
bacterial overgrowth (SIBO) since treatment of this condition may have a significant 
impact on symptom alleviation.11 
The acute or sub-acute symptomatic manifestation of a stricture is usually related to the 
plugging of the stenosis by indigestible dietary fibre or the presence of on-going mucosal 
oedema secondary to active inflammation. Unless the clinical scenario dictates 
otherwise, a conservative approach with medical and supportive therapy should be the 
first line strategy. The response to medical therapy is however dependent on the 
inflammatory component within the stricture and strictures that are actively inflamed 
have a greater potential to respond to steroids and immunomodulatory agents than 
lesions that are already significantly fibrosed. Strictures that are likely to have a 
significant inflammatory component should therefore be managed with high dose 
systemic steroids in the first instance; responders should then be maintained on long-
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term immunomodulators. Although the subject remains controversial, concerns 
regarding the potential for anti-tumour necrosis factor-α (anti-TNF-α) agents to worsen 
or induce fibrostenotic disease may be unfounded as the findings of several small series 
show.8, 12  These data suggest that anti-TNF-α drugs may have a role to play in the 
management of active strictures that are refractory to initial treatment with steroids.  
Although surgery is often unavoidable in the management of stricturing CD, it may be 
associated with significant morbidity and high post-operative recurrence rates. Up 70% 
of patients develop endoscopic recurrence within 1 year of surgery and up to 40% of 
patients will be symptomatic again within 4 years [174].  Apart from the inherent risks of 
surgery, up to 20% of patients may suffer serious postoperative complications [174]. 
One large series quoted a 30-day postoperative mortality rate of 3.2%
 
[175]. Patients also 
face the hazard of loss of significant lengths of SB with the potential development of 
short bowel syndrome [176] and dependence on parenteral nutrition. In addition, 
surgically treated patients have an increased likelihood of further episodes of intestinal 
obstruction due to post-surgical SB adhesive disease [177] or to re-stricturing at 
anastomotic or stricturoplasty sites [174]. This has encouraged the development of 
surgical techniques such as stricturoplasty in order to preserve SB length by minimising 
the need for bowel resection. The length of stenosis that can be repaired by 
stricturoplasty is usually between 10 and 25cm17. The Heinecke-Mikulicz and Finney 
methods are the two most common techniques of stricturoplasty performed in current 
practice.  In the Heinecke-Mikulicz technique, a linear incision is made through the 
antimesenteric border of the stricture; this is extended by about 3cm on either side of the 
stricture and then sutured transversely with interrupted sutures in order to widen the SB 
lumen at the anastomosis. The Finney method is useful for longer strictures and involves 
the arrangement of the affected SB into a ‘U’-shape, incising the stricture at the 
antimesenteric margin and closing this in a side-to-side fashion. A meta-analysis 
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comparing these two methods, reported a lower re-operation rate in patients treated with 
the Finney method.18 Traditionally, long strictures have been dealt with small bowel 
resection but in expert hands long stricturoplasties (Michelassi) have been associated 
with good long term success rates but can be associated with a higher rate of anastomotic 
leakage.19 Stricturoplasty is contraindicated in patients with on-going sepsis or in the 
presence of a fistula and is generally reserved for strictures involving the SB rather than 
the colon since colonic strictures are deemed to be at higher risk of harbouring the 
potential for malignant transformation in long-standing CD of the colon.20 
Since its introduction in the early 1980s, endoscopic balloon dilatation (EBD) has been 
shown to be a suitable alternative to surgery for selected patients with CD related 
strictures. Most published series describing EBD relate to its use at colonoscopy for the 
management of ileo-colic anastomotic, terminal ileal and colonic strictures. Long-term 
follow-up data from the largest such series published to date (138 patients, 237 
dilatations) demonstrate that after a median follow-up of 5.8 years, 76% of patients 
avoided the need for surgery and only 46% required repeat EBD.13  
The introduction of DBE has made previously difficult to reach parts of the SB more 
accessible to endoscopic therapy
 
[20;45;54;123;178;179] providing a potential 
alternative to surgery for selected CD patients with SB strictures
 
[42]. We here describe 
our experience of DBE facilitated SB stricture EBD in a series of patients with CD 
referred to our unit. 
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5.2    Aims 
 
The aim of this series was to assess the effectiveness and safety of DBE facilitated CD 
SB stricture EBD in routine clinical practice. 
 
5.3 Methods 
 
Data from patients with CD referred for SB stricture EBD was prospectively collected. 
Almost all patients presented with obstructive-type symptoms: abdominal pain and 
bloating with chronic dietary restriction. The following information was recorded: 
stricture characteristics, route of procedure, EBD success, symptom resolution and 
change in diet post EBD, need for repeated EBD, complications and surgery. Follow-up 
was carried out by telephone consultation. A total of 13 DBE procedures were done in 
11 consecutive patients (4 males; mean age 46.4±7.8 years). Decisions relating to EBD 
management were undertaken through the institution’s multi-disciplinary team and on-
going medical management of these was determined by the patients’ referring medical 
teams. Patient characteristics and details pertaining to each case are summarised (Table 
12). In 9 patients, their CD was considered to be stable and no changes had been made to 
their medication regimens in the preceding year. One of the patients (Patient 9) had 
refractory CD requiring the on-going use of steroids and in another patient (Patient 10), 
the diagnosis of CD was made at DBE. The mean duration of CD in the 10 patients with 
a prior diagnosis of CD was 24 years (range 13-31 years). 
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Table 11: Patient characteristics and case details 
Patient 
number 
Age(years)/Gender History of CD and medical therapy 
at the time of referral 
Previous surgery Findings at BFT 
or CTE 
1  42/M 17-year history of  ileocolonic CD; on 
longstanding AZA and mesalasine  
Right hemicolectomy 
and ileal resection 
BFT showed 2 
short strictures in 
the distal ileum 
2  52/F 21-year history of SB CD; on 
mesalasine only 
Jejunal and ileal 
resection; right 
hemicolectomy 
CTE showed a 
short mid-jejunal 
stricture 
3  47/F 28-year history of ileocolonic CD; on 
no regular medical therapy  
Right hemicolectomy 
and ileal resection 
CTE showed a 
tight short stricture 
in the distal ileum 
4  52/M 25-year history of SB CD; on 
longstanding AZA and mesalasine 
1 ileal resection BFT showed a 
mid-jejunal 
stricture 
5  44/F 23-year history of SB; on mesalasine 
only 
2 ileal resections and a 
jejunal stricturoplasty 
BFT showed 2 
jejunal strictures  
6  49/F 30-year history of ileocolonic CD; on 
longstanding 6-MP and steroids 
End ileostomy;  
3 ileal resections and 1 
ileal stricturoplasty 
No lesions seen on 
BFT but CTE 
showed 2 distal 
ileal strictures 
7  42/F 19-year history of ileocolonic CD; on 
longstanding AZA  
4 ileal resections  CTE showed a 
mid-ileal stricture 
8  30/M 13-year history of ileocolonic CD; on 
mesalasine only 
Right  hemicolectomy 
and ileal resection; 1 
ileal stricturoplasty 
BFT showed 2 
distal ileal 
strictures 
9  47/F 31-year history of SB CD; on 
longstanding AZA and steroids 
5 SB resections (jejunal 
and ileal); end ileostomy 
in situ 
BFT showed 3 
strictures in the 
jejunum with 
likely adhesions 
10  59/M Referred for investigation of non-
specific abdominal pain, minimally 
elevated inflammatory markers; normal 
OGD and colonoscopy but video-
capsule retention; No history of NSAID 
use 
No previous surgery Plain abdominal 
radiograph 
revealed a retained 
video-capsule  
11 58/F 37-year history of SB and colonic CD; 
on longstanding AZA 
Jejunal resection, ileal 
resection and right 
hemicolectomy 
BFT showed 2 
jejunal strictures 
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The anatomy of the SB strictures considered for EBD was determined by diagnostic 
imaging i.e. barium follow through (BFT) or computerised tomographic enterography 
(CTE) in the work-up before DBE in all but 1 patient (Figure 33); fluoroscopy during 
procedures was not required. All SB strictures were short (<5cm) and were additionally 
classified as predominantly fibrotic or inflammatory based on endoscopic appearance 
(Figure 34). Longer (>5cm) strictures were considered unsuitable for EBD. As it was 
generally difficult to determine with certainty either by diagnostic imaging or 
endoscopically, which strictures were ‘de novo’ or primary CD in nature or due to post-
surgical recurrence this was not recorded. 
 
Figure 33: Barium follow through (A) and CT enterography (B) showing a SB stricture (black and 
white arrows, respectively; different patients) 
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Figure 34: CD related SB strictures; mainly fibrotic (A); severely inflamed with evidently active 
disease (B).  
 
 
Patients were fasted for 8 hours pre-procedure and in cases where the rectal route for 
DBE was used, additional bowel preparation was administered in the form of 13g of 
senna granules and 3 sachets of magnesium citrate (Citromag, Bioglan Laboratories, 
Hertfordshire, UK) on the day before and morning of the procedure. Nine of the 
procedures were performed under general anaesthesia, 2 procedures under conscious 
sedation with midazolam and pethidine and one case was done under Monitored 
Anaesthesia Care (MAC) (anaesthetist-delivered propofol sedation). Hysoscine-N-
butylbromide (Buscopan
®
, Boehringer-Ingelheim, Germany) was used as an anti-
peristaltic agent in each procedure. The procedures were performed using the therapeutic 
EN-450T5 double balloon enteroscope (Fujifilm, Saitama, Japan). Carbon dioxide gas 
(CO2Efficient
®
, E-Z-EM, NY, USA) was used for SB insufflation and stricture EBD was 
performed using Controlled Radial Expansion (CRE) wire-guided balloon dilators 
(Boston Scientific, Natick, Mass, USA). The balloon dilators were inflated with water to 
the appropriate pressure (ATM) and balloon diameter as per instructions; EBD was 
maintained for 60 seconds once or twice per stricture under direct vision (Figure 35).  
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Figure 35: Through-the-scope endoscopic balloon dilatation (EBD) of a short, fibrotic CD related 
SB stricture; deflated CRE-balloon catheter passed through stricture (A); stricture EBD 
with CRE-balloon insufflated under direct endoscopic vision (B). 
 
 
A standardised proforma was used to characterise the severity of symptoms (abdominal 
pain and bloating) including degree of dietary restriction present before DBE stricture 
EBD using a 10cm standard visual analogue scale (VAS). An identical proforma was 
used to collect data post-stricture EBD (by telephone consultation). At follow-up the 
requirement for interim, post-EBD surgical intervention was also noted. DBE procedures 
and stricture EBD were performed after written informed consent was obtained from the 
patients. The patients were informed about the risks of the endoscopic procedure itself, 
the risks of general anaesthesia or conscious sedation and the risks associated with 
endoscopic balloon EBD of CD SB strictures. On consultation with the regional and 
institutional review boards, it was deemed that no further dedicated ethics approval was 
required, since EBD of strictures is considered to be standard of care and that 
symptomatic follow-up of these patients post-EBD is part of the routine clinical 
paradigm. 
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5.3.1 Statistical analysis 
Descriptive analysis was used for the patient demographic and clinical data. The t-Test 
(two-tailed) was used to analyse data collected from the VAS scores of patients before 
and after treatment. 
 
5.4 Results 
 
Overall in the 13 DBE procedures which were done during the period of study (February 
2005 to October 2008), 18 SB stricture EBDs were performed in 9 of 11 patients. The 
mean stricture EBD diameter was 15.4mm (range 12-20mm). In the 2 patients in whom 
stricture EBD was not performed, DBE proved to be technically challenging. The 
presence of severe SB tethering secondary to adhesions from previous surgery and 
possibly also from the underlying CD itself, meant it was not possible to reach the 
strictures in these patients who subsequently went on to have successful surgical 
stricturoplasties. One of our patients in whom successful EBD of a complex set of 
strictures in a tethered and angulated segment of jejunum was achieved, developed sharp 
abdominal pain 8 hours post-procedure. An urgent CT scan of the abdomen and pelvis 
confirmed the presence of a perforation close to one of the dilated strictures. The patient 
underwent a laparotomy during which the diseased segment was resected and a 
defunctioning temporary jejunostomy was fashioned. Histopathological examination of 
the excised specimen confirmed the presence of active CD. The patient made a good 
recovery and the jejunostomy has since been reversed. 
In the other 8 patients, successful DBE assisted SB stricture EBD was achieved, 
obstructive symptoms improved dramatically and by the end of November 2008 none of 
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these patients has required surgery with a mean follow-up 20.5 months (range 2-41 
months). During follow-up 2 of the patients who had undergone stricture EBD required a 
repeat EBD of the same strictures due to recurrence of symptoms. The first of these 2 
patients had a modest recurrence of symptoms at 6.5 months after the initial EBD and 
the second patient had a significant recurrence of her symptoms 13 months post-EBD. 
Both these patients proceeded to have straightforward repeat EBDs. In the penultimate 
patient in the series (Patient 10; Tables 11, 12), the diagnosis of CD only became clear 
at DBE. This patient was originally referred for further investigation of non-specific 
right iliac fossa abdominal discomfort, raised inflammatory markers and SB capsule 
endoscopy retention (Figure 36) in the setting of normal upper GI endoscopy and 
colonoscopy and no history of NSAID use. At DBE, two short ileal strictures were found 
and dilated, biopsies were taken and the retained capsule retrieved (Figure 37). 
Histopathology of the biopsies and a subsequent CT enterography were consistent with a 
new diagnosis of CD. 
Although the numbers in this series are small, clinical improvement in pre- and post-
EBD VAS scores (mean) was significant: 8.8 vs. 1.8, respectively (P <0.001). The 
procedure related details including VAS scores are shown (Table 12, Figure 38). None 
of the patients who underwent successful EBD required changes to their immuno-
modulatory drug regimens during the follow-up period. 
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Figure 36: Plain abdominal X-ray showing the retained video capsule (black arrow) 
 
 
Figure 37: Retained capsule endoscope at a short CD SB stricture (A); retrieval of the capsule with 
a Roth™ net (US Endoscopy, USA) after successful EBD of the culprit stricture, (B). 
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Table 12: Intervention details and VAS symptom scores before and after DBE facilitated SB CD 
stricture EBD 
Patient 
number 
Technical 
difficulties 
relating to 
adhesions 
DBE 
stricture 
EBD 
performed 
DBE route 
used 
Number and 
type of 
strictures 
dilated 
VAS 
symptom 
score before 
stricture 
EBD 
VAS 
symptom 
score at latest 
post-
procedure 
follow-up* 
Need for a 
second DBE 
EBD 
procedure 
Surgery 
required by 
latest  
follow-up 
1  Minimal Yes Rectal 2 distal ileal;        
(fibrotic) 
8.9 4.7 No No 
2  Significant No Oral Not dilated 9.3 N/A No Surgical 
stricturoplasty 
3  Minimal Yes Rectal 1distal ileal  
(fibrotic) 
10 0.8 Yes                    
(13 months 
after initial 
EBD) 
No 
4  Minimal Yes Oral 1 jejunal  
(fibrotic) 
9.6 2.3 No No 
5  Minimal Yes Oral 3 jejunal                
(1 inflammatory 
and 2 fibrotic) 
9.8 1.1 No No 
6  Minimal Yes Through 
end 
ileostomy 
2 ileal  
(fibrotic) 
10 0.7 No No 
7 Significant No Through 
transverse 
colostomy 
Not dilated 9.5 N/A No Surgical 
stricturoplasty 
8  Minimal Yes Rectal 2 ileal  
(Fibrotic) 
9.2 1.3 Yes                 
(6.5 months 
after initial 
EBD) 
No 
9  Moderate Yes Oral 3 jejunal  
(2 inflammatory 
and 1 fibrotic) 
10 N/A N/A Emergency 
laparotomy due 
to perforation 
10  None Yes Rectal 2 ileal        
(fibrotic); 
Retained video 
capsule retrieved 
by DBE; 
Biopsies of the 
stricture 
confirmed CD 
5.2 1 
 
 
 
 
No No 
11 None Yes Oral 2 jejunal    
(fibrotic) 
8 2.2 No No 
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Figure 38: VAS scores for obstructive symptoms/dietary restriction before stricture EBD and at 
follow-up (where 0=no symptoms/restriction and 10=severe symptoms/restriction). 
*P <0.001 
 
 
5.5 Discussion 
 
EBD of CD associated strictures has been used since the late 1980s [180] but the 
technique has been mainly applied to upper GI, ileo-colic or colonic strictures [181-183] 
since most of the SB has remained inaccessible to conventional flexible endoscopy. The 
ability to reach and dilate strictures deep within the SB endoscopically is now possible 
with DBE. Our case series adds to the currently small body of published evidence [42] 
which shows that DBE assisted SB stricture EBD in CD is feasible and effective. Our 
mean follow-up period of 20.5 months is among the longest published periods of follow-
up to date. Morini et al. [184] showed that the first few months of follow-up after CD 
stricture EBD is an accurate predictor of long-term success, however EBD with DBE can 
be repeated if strictures recur. However, this should not be regarded as a failure, 
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particularly since the need for repeat surgery after stricturoplasty may be as high as 25% 
over a follow-up of 30 months
 
[185].  
In our series, 1 patient unfortunately developed a delayed perforation requiring a 
temporary jejunostomy. The patient suffered from long-standing active CD that failed to 
respond to aggressive medical therapy with immunosuppressive drugs. As the patient 
had already lost significant lengths of SB from previous resections, stricture EBD with 
DBE was attempted with caution. The procedure was technically difficult due to 
adhesion related angulation and tethering of the affected segment of SB which contained 
several closely related, significantly ulcerated strictures. This case highlights the fact that 
although EBD of strictures is considered a relatively safe procedure, the risk of 
perforation in certain cases may be as high as 11% [186;187]. SB strictures that are long 
(>5cm), severely inflamed and ulcerated should therefore be considered high-risk and a 
potential contraindication to DBE assisted EBD [42]. However our series also shows that 
a history of previous surgery is not a contraindication to DBE: 10 of our patients had 
undergone previous surgery (often multiple) but the procedure was straightforward in 
most of them (both via the oral and rectal routes).  
It is worth noting that 10 of the 11 patients in our series had undergone SB resections 
and/or stricturoplasties in the past. It is therefore possible that a significant number of the 
dilated strictures were post-surgical rather than primary in nature. Fifteen of the 18 
strictures were considered predominantly fibrotic and the remainder inflammatory in 
appearance which may support this view. However in the series by Pohl et al. [42]
 
all SB 
strictures in CD patients undergoing dilation were reported as fibrotic while 50% of 
patients had never undergone surgery. Therefore we would argue the exact aetiology of a 
fibrotic stricture i.e. whether it is of primary or post-surgical origin, is not particularly 
relevant if it is causing symptoms and can be successfully dilated by DBE. We recognise 
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that our study has its own limitations. One of these limitations relates to the small 
number of patients studied, while other limitations relate to the fact that ‘a snapshot’ of 
subjective measures was used (VAS scores) and that the follow-up questionnaire was 
completed at a long and variable time after EBD (mean follow-up 20.5 months (range 2-
41 months) and this may have therefore been confounded by other variables which were 
not taken into account.  
In summary, despite these recognised limitations, this series has shown that the 
technique of DBE facilitated SB stricture EBD for selected patients with CD is of 
significant benefit and may be considered an alternative to surgical resection or 
stricturoplasty.  Since the publication of our series [188], a further study from Japan 
[189] has confirmed our findings. In their study, Hirai et al. showed that DBE facilitated 
EBD was successful in 18 of 25 cases; 2 patients suffered complications (bleeding and 
pancreatitis) and the cumulative surgery-free rates for all subjects were 83% and 72% at 
6 and 12 months respectively [189]. In view of the growing evidence in support of the 
usefulness of EBD for CD SB strictures we propose an algorithm for the clinical 
management of patients afflicted by this condition (Figure 39). In the future, research 
into the use candidate molecules that may arrest or reverse fibrogenesis hold promise to 
expand the medical armamentarium available for this condition. Early work on 
removable self-expanding metal, plastic and biodegradable stent placement may also 
provide the foundations for additional alternative endoscopic options in the years to 
come; until then, EBD is likely to have an on-going role to play in the management of 
these patients.  
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Figure 39: Proposed algorithm for the management of stricturing SB CD; *multiple strictures may 
predispose to surgical management (stricturoplasty/resection); 
**
MDT, multi-
disciplinary team meeting, comprising gastroenterologists, surgeons, radiologists and 
specialist nurses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Features mainly 
suggestive of active 
inflammation 
Clinical suspicion of  
CD stricturing 
Evaluation with laboratory inflammatory 
markers, diagnostic imaging & endoscopy 
Medical and supportive 
management  
Features mainly suggestive 
of fibrotic or anastomotic 
stricturing 
Surgery  
(stricturoplasty/resection) 
 
Endoscopic 
balloon dilatation  
Residual fibrosis may persist 
after medical management 
of inflamed strictures 
 
Characterise: 
1. Location of the stricture(s) (colon/ileo-colic/small bowel) 
2. Number of strictures*  
3. Degree of likely active inflammation/fibrosis within the stricture(s) 
4. Length of the stricture(s) 
5. Suitability for medical / biological, endoscopic or surgical therapy should be discussed at MDT
** 
 
 
 
 
Long (>5cm) 
or endoscopically 
inaccessible stricture 
Short (<5cm) 
and endoscopically 
accessible stricture 
Good response? 
Continue maintenance 
Medical therapy   
No Yes 
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6 Effectiveness and safety of DBE facilitated 
polypectomy of clinically significant SB polyps 
in patients with PJS 
 
6.1 Background 
 
Peutz-Jeghers syndrome (PJS) is a high penetrance, autosomal dominant polyposis 
syndrome that is associated with a germline mutation in the STK11 (serine/threonine 
kinase 11) gene (19p13.3) in 80% - 94% of cases [190]. PJS has an incidence of about 1 
in 50,000 to 1 in 200,000 live births [191;192] and is characterized by mucocutaneous 
melanin pigmentation (Figure 40), gastrointestinal (GI) hamartomatous polyps [193] 
and an increased risk of GI and extra-GI neoplasia [190;194-197]. SB polyposis forms a 
major part of the disease burden that often manifests itself early-on in life [191;198-200], 
leading to obstruction secondary to intussusception or bleeding and iron deficiency 
anaemia (IDA) [192;196;201]. The cumulative risk of SB intussusception may be as 
high as 50% at age 20 years [196]. Until recently, laparotomy with intraoperative 
enteroscopy (IOE) was the sole option available for removal of PJS polyps deep within 
the SB [202;203].  This intervention however, exposes patients to the hazards inherent to 
major surgery and may lead to post-operative complications such as intra-abdominal 
adhesions and short-bowel syndrome [177;204-206]. Double-balloon enteroscopy (DBE) 
permits endoscopic removal of SB polyps in adults and children [20;44;45;207;208] and 
potentially offers a lower morbidity alternative to surgery for patients with PJS [207-
212]. This combined prospective series, which includes both an adult and a paediatric 
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cohort for the first time, examines the feasibility, efficacy and safety of DBE facilitated 
SB polypectomy.  
 
Figure 40: Macular melanin pigmentation of the lips and peri-oral region in one of our patients 
with PJS undergoing SB polypectomy by DBE 
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6.2    Aims 
 
To assess the effectiveness and safety of DBE facilitated polypectomy of clinically 
significant SB polyps in patients with PJS. 
 
6.3 Methods 
 
6.3.1 Patients 
Patients were referred from the St Mark’s Hospital Polyposis Registry, London and a 
paediatric tertiary referral centre, the Centre for Paediatric Gastroenterology, Sheffield 
Children’s Hospital NHS Foundation Trust, Sheffield, which together manage the largest 
cohort of PJS patients in the UK. Since the introduction of the DBE service to our 
institutions, data for all patients with PJS [213] referred for SB polypectomy have been 
prospectively collected. As part of our PJS surveillance program, patients undergo a SB 
capsule endoscopy (SBCE) and/or radiological imaging (magnetic resonance 
enterography (MRE), computed tomographic enterography (CTE) or rarely SB barium 
follow-through (BFT)) triennially [191;194;195] for early detection of polyps deemed to 
be large enough to warrant prophylactic removal (Figure 41).  As is the practice at our 
institutions [214] patients found to have SB polyps with an estimated diameter ≥1.5cm at 
surveillance were referred for DBE in the first instance. 
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Figure 41:       Large (>1.5cm) PJS SB polyp as seen at SBCE (blue arrow), (A) and at MRE (white 
arrow), (B) 
 
 
Adult (>18 years of age) and paediatric patient characteristics (including past history of 
abdominal surgery) are shown (Table 13). Since endoscopic polypectomy is a well-
established technique with good efficacy, DBE facilitated SB polypectomy was 
considered clinically appropriate for suitable patients. Procedures were performed after 
routine written informed consent was obtained. The patients or parents/guardians were 
informed of the risks of the procedure and endoscopic polypectomy (including the 
potential need for surgery) and general anaesthesia. All PJS patients were kept under 
regular follow-up with prospective data collection. Final follow-up (for symptoms and 
complications) was carried out by another endoscopy research fellow (at St Mark’s 
Hospital) and by a paediatric gastroenterology registrar (at the Sheffield centre) by 
review of the medical notes and if necessary by telephone consultation. The data was 
then analysed retrospectively. On consultation with the regional and institutional review 
boards, it was deemed that no further dedicated ethics approval was required, since 
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endoscopic polypectomy is considered to be standard of care and that symptomatic 
follow-up of these patients post-polypectomy is part of the routine clinical paradigm. 
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Table 13: Paediatric (in grey) and adult (in white) patient characteristics; *patients with negative  
or unavailable genetic test results, fulfilled other World Health Organization criteria for  
PJS [213]; N/A: not available; +ve or –ve: positive or negative genetic testing 
 
6.3.2 DBE procedures 
All DBE procedures were performed using the 2.8mm working channel Fujifilm EN-
450T5 therapeutic double-balloon enteroscope (Fujifilm, Saitama, Japan), under general 
anaesthesia (GA). The route of approach for DBE (i.e. per-oral vs. per-rectal route), was 
determined by SBCE [150] and/or radiological findings [214]. All patients fasted for 
eight hours before the procedure and if the DBE was being performed through the rectal 
Patient  
N
o. 
Gender Age at 
diagnosis 
(years) 
 
Initial presentation Genetic 
testing 
Upper GI  
polyps 
Colonic 
polyps 
N
o. 
of pre-DBE  
SB 
surgeries 
N
o. 
of SB 
resections 
   Age 
   at 1
st
  
  DBE 
Other PJS related 
comorbidities 
13 F 16 Intussusception +ve Yes Yes 4 2 46 Breast cancer 
14 F 5 Intussusception +ve Yes Yes 1 1 37 No 
15 F 4 IDA and Abdominal 
pain 
+ve Yes Yes 1 0 20 No 
16 M 41 Abdominal pain +ve Yes Yes 2 2 54 No 
17 F 11 Genetic testing +ve Yes Yes 0 0 19 No 
18 M 14 Intussusception +ve Yes Yes 2 2 34 No 
19 F 28 Abdominal pain +ve Yes Yes 0 0 43 No 
20 F 5 Genetic testing +ve Yes Yes 1 1 39 Sex cord ovary tumour 
21 M 27 Abdominal pain +ve Yes Yes 1 1 43 No 
22 M 10 IDA +ve Yes Yes 1 1 42 No 
23 F 37 Abdominal pain +ve Yes Yes 3 1 63 No 
24 M 14 Intussusception +ve Yes Yes 3 2 19 No 
25 M 18 Intussusception +ve Yes Yes 1 1 26 No 
26 F 15 Intussusception +ve Yes Yes 2 1 26 No 
27 F 5 Intussusception +ve Yes Yes 5 5 33 No 
28 M 14 IDA+ Intussusception +ve Yes Yes 1 1 30 No 
29 F 4 Intussusception +ve Yes Yes 6 6 40 No 
30 F 23 Intussusception +ve Yes Yes 1 1 31 No 
31 F 8 Intussusception    N/A* Yes Yes 3 3 52 Thyroid cancer 
Breast cancer 
32 M 22 IDA    N/A* Yes Yes 1 1 36 No 
33 F 25 Abdominal pain +ve Yes Yes 2 2 38 No 
34 F 18 Intussusception    -ve * No No 3 1 31 No 
35 F 37 Intussusception +ve Yes Yes 2 1 37 No 
36 M 2 Intussusception +ve Yes Yes 5 4 45 No 
Patient  
N
o. 
Gender Age at 
diagnosis 
(years) 
Initial presentation Genetic  
testing 
Upper GI  
polyps 
Colonic 
polyps 
N
o. 
of pre-DBE  
SB 
surgeries 
N
o. 
of SB 
resections 
   Age 
   at 1
st
  
  DBE 
Other PJS related 
comorbidities 
1 M 5 Genetic testing +ve Yes Yes 0 0 15 No 
2 M 5 Intussusception +ve Yes Yes 1 1 7 No 
3 F 16 Genetic testing +ve No No 0 0 16 No 
4 M 9 Genetic testing +ve No Yes 0 0 13 No 
5 M 11 Genetic testing +ve Yes No 0 0 12 No 
6 M 16 Genetic testing +ve Yes No 0 0 16 No 
7 M 10mths Intussusception +ve Yes No 0 0 11 No 
8 M 6 Genetic testing +ve Yes Yes 0 0 16 No 
9 F 15 Intussusception N/A* Yes No 1 1 18 No 
10 F 7 Intussusception N/A* Yes No 1 1 14 No 
11 F 13 Genetic testing +ve Yes Yes 0 0 16 No 
12 F 10 Genetic testing +ve Yes No 0 0 12 No 
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route, adults received prior bowel preparation with three sachets of magnesium citrate 
(Citromag; Bioglan Laboratories, Hertfordshire, UK) and generic senna granules (13g by 
weight) while children received sodium picosulfate (Picolax; Ferring Pharmaceuticals, 
West Drayton, UK) 2.5-10g (depending on age) and Senokot (Reckitt Benckiser, 
Kingston-upon-Thames, UK) 1-2mg/kg (max 30g). The depth of SB insertion by DBE 
was estimated as described by May et al [51].  
Prior to endoscopic snare resection, in order to minimize the risk of immediate bleeding 
or SB perforation, the stalks of pedunculated polyps were injected with a dilute solution 
of adrenaline (1 in 200,000) and methylene blue (0.025%) in normal saline; semi-
pedunculated and sessile polyps were lifted using submucosal injection of the same 
solution (Figure 42A,B). Simple snare or endoscopic mucosal resection was performed 
using the VIO
® 
200D or ICC
®
 200 EA diathermy units (ERBE Elektromedizin GmbH, 
Tübingen, Germany) on Swift Coag
™ 
mode (maximum power: 40W, effect 2) or Endo 
Cut
™
 mode (maximum power: 120W, effect 2) for adults and children, respectively. If 
required, endoscopic haemostatic clips (either Resolution
® 
(Boston Scientific, Natick, 
MA, USA) or Quick Clip
®
 (Olympus Medical, Tokyo, Japan)) were applied to the 
resection site to reduce the risk of post-polypectomy bleeding. In several cases, polyps 
required debulking by piecemeal resection to improve access and whenever possible, the 
resected polyps or their fragments were retrieved for histopathological analysis (Figure 
42C). All DBE procedures were carried out with expert surgical support available if 
needed.   
 
Figure 42:  Large semi-pedunculated PJS SB polyp as seen at DBE, (A); injection of the polyp stalk 
and base with a dilute solution of adrenaline (1 in 200,000) and methylene blue 
(0.025%) in normal saline prior to snare resection, (B); retrieval of the resected polyp  
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using a Roth™ net (US Endoscopy, USA), (C) 
 
 
6.4 Results 
 
Between February 2005 to April 2011, 36 patients with PJS (17 males, median age 30.5 
years; range: 7-63 years) were referred for SB polypectomy by DBE (Figure 1). All 
patients had at least 1 pre-DBE evaluation by SBCE (86%) or diagnostic imaging (75%) 
or both (58%). In the adult cohort, 92% of patients had a history of SB surgery (an 
average of 2 laparotomies per patient) with 87% having undergone a partial SB 
resection. In contrast only 25% of paediatric patients had a history of SB surgery (an 
average of 0.3 laparotomies per patient). A total of 53 DBE procedures were performed 
with the number of procedures required per patient ranging from 1 (n=22) to 4 (n=1). 
Twelve patients required 2 procedures each while another 1 patient required 3 DBEs. 
Forty DBE procedures were performed via the oral route and the remainder via the rectal 
approach. Estimated mean depth of insertion was 186±65cm post-pylorus and 93±61cm 
proximal to the ileo-caecal valve for oral and rectal procedures, respectively. Pan-
enteroscopy, confirmed by visualization of a submucosal tattoo of sterile India ink 
(Spot
®
, GI Supply, Camp Hill, PA, USA) when placed at previous DBE via the opposite 
route, was achieved in 2 adult patients. In 2 paediatric patients who underwent DBE via 
the oral route, pan-enteroscopy was confirmed by visualization of the ileo-caecal valve. 
Mean duration for DBEs done via the oral and rectal routes was 91±19 minutes and 
83±35 minutes respectively. Details of DBE procedure are shown (Table 14). 
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Table 14:  Paediatric (in grey) and adult (in white) patient DBE details; N/A not applicable  
 
Patient  
N
o.
 
Route Depth of 
insertion (cm) 
 
Significant 
polyps 
Polyps 
removed 
Maximum 
size 
(mm) 
Limitations Major 
Complications 
1 PO 
PR 
220 
70 
1 
1 
1 
1 
20 
20 
No None 
2 PO 120 7 4 20 No None 
3 PO 
PR 
200 
100 
0 0 N/A No None 
4 PO 220 1 1 20 No None 
 PR 35 0 0 N/A No None 
5 PO 
PR 
250 
45 
5 1 20 No None 
6 PO  
 
200 7 7 30 lap-DBE Pelvic abscess 
7 PO 250 6 6 50 No None 
8 PO 120 1 1 20 Emergency setting Perforation 
9 PO Complete enteroscopy 3 3 15 No None 
10 PO Complete enteroscopy 2 2 40 No None 
11 PO 320 1 1 10 No None 
 PR 140 0 0 N/A No None 
12 PO 
 
230 1 1 50 lap-DBE None 
13 PO 190 2 2 35 No None 
14 
 
PR 200 2 2 25 No None 
 PO 160 2 2 25 No None 
15 PO 250 3 3 35 Adhesions None 
16 PO 150 1 1 30 Adhesions None 
17 PO 140 1 5 40 None None 
18 
 
PO 310 3 4 25 Adhesions None 
 PR 60 2  20 Adhesions None 
19 PO 170 1 1 25 No None 
20 PO 220 0 0 N/A Adhesions None 
21 
 
PO 
PR 
250 
50 
2 
4 
3 
4 
30 
20 
Adhesions 
Adhesions 
None 
None 
22 
 
 
PO 200 3 2 30 Sessile duodenal polyp None 
 PR 100 1 2 20 No None 
 PO 100 1 1 30 lap-DBE None 
 PO 100 0 0 N/A No None 
23 PR 
PO 
80 
220 
1 
14 
1 
12 
20 
30 
Retroverted ICV 
Severe adhesions 
 
None 
None 
24 PO 200 1 1 40 Severe adhesions None 
25 PO 240 5 5 30 Adhesions None 
26 
 
PO 120 1 6 20 Adhesions None 
 PR 60 0 0 0 Adhesions None 
27 PR 75 0 0 0 Adhesions None 
28 PO 260 1 0 20 Adhesions + sessile polyp-
endoscopically unresectable 
None 
 PO 160 0 0 N/A Adhesions None 
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Table 14 (continued):         Paediatric (in grey) and adult (in white) patient DBE details; N/A not applicable 
 
 
6.4.1 Successful clearance of large polyps by DBE or laparoscopic- 
assisted DBE  
The aim at DBE was to attempt polypectomy of all significant polyps found (as detected 
by SBCE and/or SB radiology) in all 36 patients. Two patients (patients 3 and 20) did 
not undergo polypectomy at DBE as their polyps were considered non-significant due to 
likely overestimation of size at SBCE. Therefore 34 patients were considered suitable 
for DBE facilitated polypectomy. Of these, 25/34 patients (74%) underwent successful 
polypectomy by DBE alone (n=22) or else by lap-DBE facilitated polypectomy (n=3; 
patients 6, 12 and 22) for large, sessile duodenal polyps that were deemed high-risk for 
polypectomy by DBE alone. On average, 4 polypectomies per patient (range: 1-13 
polypectomies) were performed. A total of 132 polyps were resected; the majority of 
these were stalked (85%) while the remainder were semi-pedunculated or sessile. The 
median diameter of excised polyps was 41mm (range: 10-50mm). Sixty-six per cent of 
polyps were located within the jejunum while 19% and 15% were located within the 
Patient  
N
o.
 
Route Depth of insertion (cm) 
 
Significant polyps Polyps removed Maximum size 
(mm) 
Limitations Major 
Complications 
29 
 
 
PR 240 1 1 40 Adhesions None 
PO 260 1 2 30 Adhesions None 
30 PO 140 0 0 N/A Adhesions-altered bowel anatomy None 
31 PO 160 10 13 25 Adhesions None 
32 
 
 
 
PO 160 2 4 40 Large sessile polyp in distal duodenum None 
 PO 45 1 0 70  None 
PO 45 1 0 70 lap-DBE: difficulty in laparoscopic visualization None 
33 PO 150 8 6 30 Adhesions None 
34 PO 150 2 2 30 Adhesions None 
35 PO 160 7 11 30 No None 
36 PO 
PR 
 
100 
50 
0 
0 
0 
0 
0 
0 
Adhesions 
Adhesions 
None 
None 
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ileum and duodenum respectively. The histopathology of all retrieved polyps confirmed 
their hamartomatous nature although a sessile duodenal polyp was also found to contain 
a small adenomatous component (low grade dysplasia); details of SB polyps including 
their location are described (Table 15).  
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Table 15: Paediatric (in grey) and adult (in white) patient polyp location and characteristics; N/A  
not applicable; LGD, low grade dysplasia  
 
 
 
Patient N
o.
 Significant 
polyps 
removed 
DD PJ DJ PI DI Peduncul
ated 
Semi-
peduncul
ated 
Retrieved Hamartomas Mixed 
1 2 0 2 0 0 0 2 0 2 2 0 
2 2 0 2 0 0 0 1 1 0 N/A N/A 
3 0 0 0 0 0 0 0 0 0 0 0 
4 1 0 1 0 0 0 0 1 1 0 1 
5 1 0 0 1 0 0 0 1 1 1 0 
6 7 2 1 2 2 0 3 4 7 4 3 
7 6 1 2 3 0 2 3 3 6 4 2 
8 1 0 1 0 0 0 1 1 1 1 0 
9 1 0 0 0 0 1 0 1 1 1 0 
10 2 0 0 1 0 1 1 1 2 2 0 
11 1 0 1 0 0 0 1 0 1 1 0 
12 1  1 0 0 0 0 1 0 1 1 0 
13 2 1 1 0 0 0 1 1 2 2 0 
14 2 0 0 0 2 0 2 0 2 2 0 
15 3 0 3 0 0 0 3 0 3 3 0 
16 1 1 0 0 0 0 1 0 1 1 0 
17 5 0 5 0 0 0 5 0 1 1 0 
18 4 0 0 0 2 2 4 0 4 4 0 
19 1 0 0 1 0 0 1 0 1 1 0 
20 0 0 0 0 0 0 0 0 0 N/A N/A 
21 7 0 3 0 0 4 7 0 7 7 0 
22 5 1 2 2 0 0 4 1 3 2 
1(LGD
) 
23 1 0 0 0 0 1 1 0 1 1 0 
24 13 0 0 8 5 0 12 1 1 1 0 
25 5 1 2 2 0 0 5 0 0 N/A N/A 
26 6 0 3 3 0 0 6 0 6 6 0 
27 0 0 0 0 0 0 0 1 0 N/A N/A 
28 2 0 1 0 0 1 2 0 0 N/A N/A 
29  1 0 0 0 1 0 1 0 1 1 0 
30 0 0 0 0 0 0 N/A N/A N/A N/A N/A 
31 13 5 5 2 1 0 13 0 1 1 0 
32 5 5 0 0 0 0 4 0 4 4 0 
33  6 0 6 0 0 0 5 1 1 0 0 
34 2 2 0 0 0 0 0 2 2 0 0 
35 7 0 6 1 0 0 7 0 0 0 0 
36 0 0 0 0 0 0 N/A N/A N/A N/A N/A 
133 
  
6.4.2 Need for additional laparotomy with intraoperative enteroscopy 
Nine of the 34 patients with significant SB polyps (26%) required subsequent 
laparotomy with intraoperative enteroscopy (IOE) following incomplete DBE which in 
most cases was due to inadequate insertion depth. Small bowel tethering (causing tight 
angulation and unfavourable looping) likely due to adhesional disease was considered 
the main reason for this. In 7 of these patients, who were all adults (patients 24, 26, 27, 
28, 29, 30, 36); none of the target polyps were reachable by DBE alone. Another patient 
(patient 32) required conversion of a lap-DBE to laparotomy, since adequate 
laparoscopic views of the duodenal wall involved by a large sessile polyp could not be 
obtained. Emergency DBE was performed for an episode of intussusception in 1 
paediatric patient (patient 8) due to a large semi-pedunculated polyp; however an 
immediate post-polypectomy perforation occurred, necessitating conversion of the DBE 
into an IOE through the defect by the endoscopist and observing surgeon. The patient 
recovered fully and was subsequently discharged. The only other complication identified 
in the series, occurred in a paediatric patient after successful polyp clearance by lap-DBE 
(patient 6) who developed a pelvic abscess related to an infected laparoscopy-port 
wound that responded to well to drainage and conservative management. Although 
formal 30-day complication data was not actively pursued, long-term complication and 
outcome data was compiled at final follow-up (through case-note review and telephone 
consultation if required)). 
6.4.3 Follow-up 
At a median follow-up period of 24 months (range: 2-50 months); 25 of the 34 patients 
(74%) who underwent successful DBE or lap-DBE polypectomy without the need for a 
post-DBE laparotomy and IOE, remained asymptomatic, without need of further 
intervention. They continue with triennial surveillance (or earlier if symptoms develop) 
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by SBCE and/or MRE. Follow-up data for adult and paediatric patients are shown 
(Table 16). 
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Table 16: Paediatric (in grey) and adult (in white) patient follow-up details; N/A, not applicable; 
*Symptoms in this patient are likely to be related to adhesions since polyp size was 
deemed to be overestimated at SBCE (as confirmed by subsequent MRE and DBE) 
Patient 
N
o.
 
Symptoms  
pre-DBE 
Months of F/U after DBE Additional surgery/IOE  after DBE Symptoms  
post-DBE 
1 None 12 No No 
2 None 12 No No 
3 None N/A No No 
4 None 20 No No 
5 None 26 No No 
6 None 50 No No 
7 Abdo pain 26 No No 
8 Abdo pain N/A Yes-DBE converted immediately  
to IOE due to perforation 
N/A 
9 Abdo pain 24 No No 
10 None 17 No No 
11 None 2 No No 
12 None 4 No No 
13 None 34 No No 
14 None 35 No No 
15 Abdo pain 30 No No 
16 Abdo pain 29 No No 
17 Abdo pain 23 No No 
18 None 28 No No 
19 None 31 No No 
20 Abdo pain N/A No Yes* 
21 None 38 No No 
22 None 21 No No 
23 Abdo pain 25 No No 
24 Abdo pain N/A Yes N/A 
25 Abdo pain 25 No No 
26 Abdo pain N/A Yes N/A 
27 Abdo pain N/A Yes N/A 
28 Abdo pain N/A Yes N/A 
29 Abdo pain N/A Yes N/A 
30 Abdo pain N/A Yes N/A 
31 None 10 No No 
32 Abdo pain N/A Yes N/A 
33 Abdo pain 9 No No 
34 None 9 No No 
35 None 7 No No 
36 None N/A Yes N/A 
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6.5 Discussion 
 
This study showed that DBE facilitated polypectomy can provide an effective alternative 
to laparotomy and IOE for selected adult and paediatric patients with PJS and significant 
SB polyposis. DBE (with or without  laparoscopic assistance) facilitated significant 
polyp clearance in 74% of patients (Figure 43) who remain symptom and intervention 
free at a median follow-up of 2 years.  
 
Figure 43: STROBE [215] Flow-diagram representing the outcome of the original 36 patients with 
PJS referred for double-balloon enteroscopy (DBE); SBCE (small bowel capsule 
endoscopy); Lap-DBE (laparoscopic assisted DBE); IOE (intraoperative enteroscopy) 
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DBE procedures were incomplete in several cases. SB tethering causing tight 
angulations and irreducible looping, resulting in inadequate depth of insertion was 
encountered solely in adults but none of the children. Ninety-two per cent of adults had a 
history of previous, often multiple laparotomies, compared with just 25% of children. 
Laparotomy is a recognized cause of SB adhesional disease and therefore tethering. The 
findings suggest that removal of significant SB polyps for selected patients with PJS by 
DBE is likely to be more successful earlier-on in life, before multiple surgeries have 
been performed and should be considered where possible. 
 A limited endoscopic view caused by the presence of large, sessile polyps particularly 
within the duodenum reduces the ability to perform polypectomy safely by DBE. These 
are high risk lesions to and overcome this limitation; we employed the use of 
laparoscopic assistance [216]. Although more invasive than DBE alone, lap-DBE is less 
invasive than laparotomy and was successful in 3 of 4 patients undergoing this 
procedure. The other patient in whom lap-DBE facilitated polypectomy was attempted, 
required conversion to laparotomy since adequate laparoscopic visualisation of the 
involved duodenal wall was unobtainable. 
Due to the limitations of DBE (26% of patients in our cohort ultimately required 
surgery) as well as the natural history of PJS, laparotomy with IOE has and will continue 
to have a major role in the therapeutic management of PJS SB polyposis. In addition the 
necessity to ensure expert surgical back-up in case of DBE induced complications is 
highlighted. Patient 8 suffered an acute post-polypectomy perforation during emergency 
DBE for intussusception which was rapidly converted to an uneventful laparotomy and 
IOE by the attending surgeon. We recognise that our study has its own limitations. One 
of these limitations relates to the absence of formal 30-day complication data and that 
follow-up regarding longer-term complications and recurrence of symptoms was 
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completed at a long and variable time after polypectomy 24 months (range: 2-50 
months). Although we are confident that no longer-term procedure related complications 
were missed by our follow-up process, we recognise that symptom recurrence may have 
potentially been under-reported.  
 
In summary, this combined series of adult and paediatric patients with PJS (the largest 
such series reported to date) demonstrates that DBE facilitated polypectomy can provide 
an effective therapeutic alternative to laparotomy with IOE for selected patients [207-
210;212]. The introduction of a DBE-based approach to therapy earlier-on in life to 
remove SB polyps will help to avoid the need for future surgery and the risk and 
complications associated with this. Nevertheless ideal management of patients affected 
by this condition requires a dedicated, multi-disciplinary approach that is individualized 
according to the needs of each patient. 
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7 Feasibility and safety of DBE facilitated direct 
percutaneous endoscopic jejunostomy (DPEJ) 
tube placement  
 
7.1 Background 
 
In clinical scenarios where long-term enteral nutritional support is required, access to the 
GI tract is usually provided by an endoscopically placed percutaneous endoscopic 
gastrostomy (PEG) feeding tube [217;218]. In patients with previous gastric surgery 
however, where PEG tube placement is not possible or in circumstances where PEG 
feeding is associated with recurrent aspiration of gastric contents (such as in patients 
with chronic gastroparesis or gut dysmotility), jejunal feeding may be preferred [219-
221].  
 
Long-term jejunal feeding is frequently provided through a percutaneous endoscopic 
gastrostomy with a jejunal tube extension (PEG-J). The PEG-J relies on a narrow bore 
(size 9 Fr, 1.9mm internal diameter) feeding tube extension that passes via a standard 
PEG tube and through the pylorus to deliver enteral feed into the distal duodenum or 
proximal jejunum [222-227]. Due to its narrow calibre, the jejunal extension is prone to 
frequent blockage; there is also a tendency for the extension tube to ‘flip-back’ into the 
stomach by retrograde migration [217;221;228;229].   
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Direct percutaneous endoscopic jejunostomy (DPEJ) tube feeding is an alternative to the 
PEG-J method that allows the endoscopic placement of a wider bore feeding tube 
directly into the jejunum [217;224;228;230-232]. Unlike a PEG-J, the intrinsic jejunal 
location of the DPEJ tube eliminates the possibility of retrograde migration into the 
stomach while the wider calibre makes occlusion less likely [228;229]. A recent study by 
Panagiotis et al. from the University of Utah [233] has also shown that DPEJ placement 
appears to significantly decrease recurrent aspiration pneumonia; this has not been 
shown to be the case with PEG-J. 
 
The original DPEJ technique which was first described by Shike et al. [232] more than 
20 years ago, relies on push enteroscopy (PE) to facilitate DPEJ placement and is 
therefore considerably more technically challenging than PEG-J insertion. The key to 
successful placement is endoscopic intubation of a suitable superficial loop of jejunum. 
The chosen jejunal loop should allow adequate trans-illumination and digital indentation 
as this minimizes the risk of inadvertently “skewering” other loops of bowel that may be 
interspersed between the chosen jejunal loop and the abdominal wall [232;234]. The 
inability to intubate a suitable jejunal loop with these desired characteristics accounted 
for 95% of the failed procedures in one series with a reported overall success rate of 
DPEJ placement of 68% [231].  Double-balloon enteroscopy (DBE) which has the 
ability to apply light traction to the small bowel and move along its length using 
inflatable balloons, allows the operator to identify a superficial loop of jejunum easily 
[20;54;123]; this capability, along with the relative stiffness provided by the overtube is 
likely to improve control of jejunal intubation, potentially facilitating DPEJ placement. 
Although a retrospective case note review presented by Orlando-Lopez et al. at digestive 
disease week in San Diego, USA, 2008 [235] described that DBE assisted DPEJ 
placement had been successful in 5 of 6 cases where the PE technique had failed and 
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Mehdizadeh et al. [152] reported 2 cases of successful DBE assisted DPEJ placement as 
part of a general DBE experience, at the time of our study, there were no published 
dedicated reports on prospectively collected cohorts; this prospective series aimed to 
address this. 
 
7.1 Aims 
 
The aim of this series was to assess the feasibility and safety of DBE facilitated DPEJ 
placement for enteral nutrition. 
 
7.2 Methods 
 
Since the start of the DBE service at our institution in February 2005, data on DBE 
assisted DPEJ tube placement was prospectively collected. We report a case series of 10 
consecutive patients (done between February 2005 and July 2009) highlighting the 
feasibility of the technique.  The procedure is described in an illustrated step-by-step 
format and the underlying indications and management of each case are summarised 
(Table 17). Post-procedure, patients were observed for the occurrence of immediate 
complications and patients remained under the long-term care and follow-up by our 
nutrition team. 
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Table 17: Patient characteristics and indications for DBE facilitated DPEJ insertion; NJ, Naso-
jejunal 
Case 
Number 
Gender Age 
(years) 
Underlying Condition Management of patients before 
DBE assisted DPEJ insertion 
Indication for DBE assisted 
 DPEJ insertion 
1 F 64 
Chronic pseudo-obstruction and 
vagotomy and pyloroplasty 
Persistent vomiting and aspiration 
with PEG feeding  PEG-J 
Repeated blockage of   
PEG-J extension 
2 M 32 
Neurogenic dysphagia due to 
Pelizaus-Merzbacher disease 
Persistent regurgitation and aspiration 
with PEG feeding  PEG-J 
Repeated retrograde migration of 
 PEG-J extension 
3 M 47 
Chronic gastroparesis due to 
diabetic autonomic neuropathy 
Gastroparesis with persistent 
regurgitation and aspiration  PEG-J 
Repeated retrograde migration of 
 PEG-J extension 
4 M 39 
Partial gastric resection and 
Roux-en-Y due to recurrent 
peptic ulcer disease 
Delayed gastric emptying with 
persistent regurgitation and aspiration 
 surgical jejunostomy 
Repeated displacement of surgically 
placed jejunostomies 
5 M 64 
Neurogenic dysphagia due to 
intra-cerebral haemorrhage and 
Bilroth I partial gastrectomy 
Persistent regurgitation and aspiration 
with PEG feeding  PEG-J 
Repeated blockage and retrograde 
migration of PEG-J extension 
6 F 40 
Idiopathic gastroparesis and 
chronic dysmotility 
Persistent regurgitation and aspiration 
with PEG feeding PEG-J 
Repeated blockage of PEG-J 
extension 
7 M 46 
Neurogenic dysphagia 
secondary to cerebral trauma in 
a road traffic accident 
PEG feeding complicated by 
persistent regurgitation and aspiration 
Persistent regurgitation and 
aspiration with PEG feeding 
8 M 26 
VATER syndrome requiring 
gastric transposition; 
complicated by severe dumping 
syndrome 
Trial of NJ feeding with a view to 
long term jejunal feeding via DPEJ 
NJ feeding was well tolerated, with 
weight gain, a long term jejunal 
feeding method was sought 
9 F 68 
Chronic pseudo-obstruction 
secondary to visceral 
neuropathy 
Complete gut amotility necessitated 
TPN and the insertion of a venting 
PEG 
Venting PEG not providing adequate 
drainage of enteral contents 
10 F 18 
Neurogenic dysphagia 
secondary to basilar artery 
thrombosis syndrome (BATS) 
Persistent regurgitation and aspiration 
with PEG feeding trial of NJ 
feeding 
As the patient tolerated NJ feeding 
well, and gained weight, a long term 
jejunal feeding method was sought 
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Since DPEJ tube placement is a well-established technique, the procedures were 
performed after routine written informed consent was obtained; patients were informed 
of the risks of the endoscopic procedure itself, the risks of general anaesthesia or 
conscious sedation and the risks associated with jejunal feeding tube placement. On 
consultation with the regional and institutional review boards, it was deemed that no 
further dedicated ethics approval was required, since DPEJ feeding tube insertion is 
considered to be standard of care and that follow-up of these patients post-procedure is 
part of the routine clinical paradigm. DPEJ feeding tube insertions were performed using 
a 9.4mm diameter 200cm EN-450T5 DBE enteroscope (Fujifilm, Saitama, Japan) and a 
commercially available size 15 Fr Freka
®
 (3.6mm internal diameter, 35cm length) PEG 
feeding tube (Fresenius Kabi AG, Germany). All patients with impaired gastric 
emptying had extended fasting for 12 hours and received antibiotic cover in the form of 
1.2g of co-amoxiclav intravenously 30 minutes before the procedure, to reduce the risk 
of infection at the site of skin puncture as per the American Society of Gastrointestinal 
Endoscopy guidelines [236]. Skin puncture was performed using strict aseptic 
conditions. All patients were given an anti-peristaltic agent, 20mg of hyoscine-N-
butylbromide, intravenously during the procedure and the skin wound was infiltrated 
with 2mls of the long-acting local anaesthetic bupivocaine (0.25%) to reduce post-
procedural pain. All cases were performed under general anaesthesia by 2 experienced 
endoscopists. Although lateral fluoroscopy guidance was used for the first 4 cases, in our 
experience this did not convey any more useful information than trans-illumination and 
digital indentation of the small bowel alone; it was therefore not used for the remaining 6 
cases. 
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7.2.1 Step-wise description of DBE facilitated DPEJ placement 
technique 
 
Step 1: Localisation of superficial loop of jejunum 
The DBE is inserted orally post-pylorus into the distal duodenum. The insertion is 
continued past the ligament of Treitz (LoT) into the proximal jejunum using the standard 
technique as described by Yamamoto et al [20]. Our technique for identifying the correct 
site for jejunal DPEJ insertion is to first fully confirm the position of the LoT – this 
includes insertion and withdrawal of the enteroscope and overtube across the distal 
duodenum and proximal jejunum on a number of occasions until the location is clear. 
Slow insertion of the enteroscope from the LoT into the proximal jejunum is then 
combined with frequent trans-illumination with digital indentation to identify a 
superficial loop. The quality of trans-illumination is very similar to that seen during PEG 
insertion and visibility is improved by dimming the external lighting as much as possible 
(Figure 44). DPEJ placement should be avoided if trans-illumination cannot be 
achieved.  In our series, the mean depth of insertion of the endoscope was calculated as 
86±20cm from the pylorus using the method described by May et al [51]. 
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Figure 44: Trans-illumination and digital indentation (room view) 
 
 
 
Step2: Cleansing of the abdominal wall skin and insertion of ‘seeker’ needle 
The site for insertion of a 19 gauge seeker needle is marked and the overlying abdominal 
wall skin is cleaned with a chlorohexidine or povidone-iodine solution as per local 
hospital policy. The seeker needle is then inserted into the jejunum as described by 
Baron [234] (Figure 45). 
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Figure 45: Seeker needle inserted into jejunum (DBE view) 
 
 
 
Step 3: Snaring of seeker needle, insertion of trocar and retrieval of DPEJ thread 
The seeker needle is grasped and held in place endoscopically using a 25mm snare 
(Olympus, Tokyo, Japan). Snaring of the needle allows anchoring of the jejunum to the 
abdominal wall, minimising the risk of displacement of the jejunal loop during insertion 
of the trocar and sheath alongside the seeker needle (Figure 46) [234]. Once the trocar 
and sheath are inserted into the jejunum the snare is transferred over to the trocar sheath 
to secure it in place during passage of the double thread (120cm length, supplied with the 
Freka® PEG kit) and the trocar is withdrawn. The thread is then passed into the jejunum, 
snared and pulled out though the mouth by withdrawal of the enteroscope.  
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Figure 46: Insertion of trocar and sheath alongside seeker needle (held in place by snare), room 
view (A); DBE view (B) 
 
 
 
Step 4: DPEJ tube pull-through, bumper site check and aftercare 
The distal end of the Freka
®
 PEG tube is attached to the thread by the fashioning of a 
simple loop and thread and feeding tube pulled through the skin puncture site, as per 
original PEG tube pull-through technique as described by Ponsky and Gauderer [237]. 
After pull-through, the position of the internal bumper is confirmed by direct 
enteroscopic visualisation (Figure 47); the distance between the internal bumper and 
skin exit site is noted (range 2-4cm) and the feeding tube external tip connectors applied. 
The tube is then clearly marked “PEJ tube” to avoid confusion with any PEG tube (if in 
situ) as the external appearances are identical. 
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Figure 47: DPEJ tube bumper in situ within the jejunum (DBE view) 
 
 
 
 
 
 
 
 
 
7.3 Results 
 
            DPEJ tube insertion by DBE was successful in 9 of 10 cases. In the first case that was 
attempted, the procedure was abandoned due to inadequate trans-illumination; this 
patient went on to have a surgically placed jejunostomy feeding tube. In the other 9 
cases, DBE facilitated DPEJ insertion without difficulty. In each of these cases, a 
suitable superficial loop of jejunum was easily identified and by gentle pull-back of the 
DBE endoscope and overtube (with both balloons inflated), the jejunal loop could be 
straightened to ensure a stable endoscopic platform throughout the procedure. The mean 
time taken to complete the procedure was 35 minutes (range 25-50 minutes) and there 
were no immediate procedure related complications. Although no formal 30-day 
complication data were collected, these patients remained under regular follow-up (mean 
follow-up 14 months, range: 3-24 months) by our specialist nutrition team. During this 
time, no serious DPEJ related complications were identified and enteral feeding by DPEJ 
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was well tolerated and uncomplicated, avoiding the need for surgical jejunostomy or 
parenteral nutrition.  
 
7.4 Discussion 
 
This case series is the first prospective series focused on the feasibility and technique of 
DBE assisted DPEJ insertion. Although similar in principle to the original method 
described by Shike et al. [232], we consider the use of DBE rather than push enteroscopy 
to facilitate jejunal access as an improvement in the technique.  Successful DPEJ 
placement relies on the ability to reach, identify and stabilise a suitable superficial 
segment of jejunum. This is likely to be easier to achieve by DBE as more controlled 
endoscopic insertion is possible with prevention of looping and stretching of the small 
bowel [20;45;54;152]. Although our experience was not associated with major 
complications, we recognize the limitations of this series in that it is a report of a small 
cohort, in a single tertiary referral institution and that we have no formal data of 30-day 
follow-up. It is likely that DBE assisted DPEJ placement may be linked with similar 
major complications that have been associated with the PE technique from which it is 
derived. These complications (which have been reported to be as high as 10%), include 
small bowel perforation, major bleeding, fistula formation and small bowel volvulus 
[231].  Although our cohort illustrates feasibility of DBE assisted DPEJ placement as an 
alternative technique, larger comparative studies are required to clearly illustrate any 
potential advantages or improvement in success rates compared with PE. 
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8 A direct (back-to-back) comparative study of 
the performance of DBE and manual spiral 
enteroscopy (SE) in the same cohort of patients 
8.1 Background 
 
Since the introduction of DBE in 2001 [20], two other forms of device assisted 
enteroscopy have become available: single-balloon enteroscopy (SBE) [55;56] and spiral 
enteroscopy (SE) [57]. For DBE and SBE an inflatable balloon is incorporated onto an 
overtube (Figure 6B), whereas SE uses a raised soft-plastic spiral in order to provide 
traction for plication of the SB onto the overtube [1-4] (Figure 9). Although DBE is a 
safe and useful modality and facilitates complete enteroscopy [20;33-39;41;45;50-
54;147;148;154;155;178;179;188;210;211;220;235;238-261], procedures may last over 
60 minutes [61]. Studies which have compared DBE with SBE have demonstrated 
similar duration for SBE procedures [155;262;263].  
The more recently developed SE, with its use of rotation of a soft-plastic spiral as an 
alternative to balloon-assisted traction appears to enable faster enteroscopy than the DBE 
technique [57-59;62;264;265], however it remains uncertain if SE in its current form can 
achieve equivalent insertion depth. Estimation of SB insertion depth is somewhat 
subjective but perhaps more reliable for DBE using the method described by May et al. 
[51], since this is based on step wise advancement during insertion through the SB of a 
measured length of enteroscope, while insertion depth at SE is estimated during 
withdrawal according to number of SB folds visualised [57]. Although two prospective 
studies [60;61] have directly compared SE to DBE, both of these studies have used 
151 
  
different methods to estimate SB insertion depths achieved during SE and DBE. 
Following a literature review and based on our centre’s deep enteroscopy experience 
[59], we conducted the SPiral Enteroscopy Comparative Study (SPECS); a prospective, 
back-to-back study comparing insertion depths achieved at SE and DBE respectively. In 
this study, both types of enteroscopy procedures were carried out in tandem (during the 
same session), in the same cohort of patients, using the same method for SB insertion 
depth estimation [51]. 
 
8.2  Aims 
 
The primary end-point of the study was to compare SB insertion depths by SE and DBE 
procedures performed in immediate succession, in the same cohort of patients, using the 
same method of SB insertion depth estimation. The secondary end-points included 
comparisons of procedure duration and procedure difficulty (based on the VAS score 
recorded by the endoscopist performing the enteroscopy). 
 
8.3 Methods 
8.3.1 Patients 
The study was conducted between August 2010 and September 2011. All patients ≥18 
years of age referred to our institution for oral deep enteroscopy under GA were 
considered for recruitment. Exclusion criteria included: unwillingness of patients to 
undergo deep enteroscopy or to take part in the study, contraindications to deep 
enteroscopy (bleeding tendency, pregnancy); contraindications to GA and latex allergy 
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since the balloons used by the DBE system are made of latex). All patients who 
participated in the study gave their written informed consent.  
The research protocol and conduct of the study was approved by the regional research 
ethics committee and by the institution’s research and development review board (North 
London REC 3 Ref. 10/H0709/48; RD 10/32). The study was carried out in accordance 
with the World Medical Association Declaration of Helsinki, 1964 (incorporating all 
later amendments) [129]. 
 
8.3.2 Procedures and equipment 
Deep enteroscopy procedures were carried out by two experienced enteroscopists. 
Although both enteroscopists primarily employed the DBE technique in their routine 
clinical practice (and had therefore acquired more experience with this modality), both 
of them had also received dedicated training in SE [59]. All procedures were performed 
via the oral route with patients in the left-lateral position under GA after a 6 to 8 hour 
fast. Carbon dioxide (CO2), (CO2Efficient
TM
 systems, E-Z-EM Inc., NY, USA) was used 
for SB insufflation.  
The Endo-Ease Discovery
®
 SB overtube (Spirus Medical, LLC, MA, USA) over the EN-
450T5 (9.5mm, 200cm working length and 2.8mm instrument channel) enteroscope 
(Fujifilm Inc., Saitama, Japan) were used for SE procedures. The Endo-Ease Discovery
®
 
SB is 118cm long with an outer diameter of 16mm. The oral-end incorporates a 21cm 
long, soft-plastic (compressible) spiral, 5.5mm in profile in order to ‘engage’ the SB and 
provide gentle-traction. Insertion and withdrawal are achieved by respective clockwise 
and counter-clockwise rotation of the overtube handle [4] (Figure 9).  
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The EN-450P5 (8.5mm diameter, 200cm working length and a 2.2mm instrument 
channel) enteroscope, also manufactured by Fujifilm Inc., was used for DBE. During 
DBE, the two balloons which are attached to the tip of the overtube and enteroscope 
respectively, are inflated or deflated sequentially using a dedicated pressure-controlled 
pump and DBE insertion is achieved using the push-and-pull technique as described by 
Yamamoto et al. [20] (Figure 7A). 
Each patient first underwent a SE procedure immediately followed by a DBE. Although 
we recognise that this may have introduced the potential for intrinsic bias, our rationale 
for this, rather than a randomised procedure order was to enable us to use a single 
method for estimation of SB insertion depth (as described by May et al. [51;61]), which 
would in turn provide us with a more reliable comparison of insertion depths for both 
procedures. Maximal SB insertion depth at SE was considered to have been achieved 
when further SB intubation was not possible despite rotation of the overtube or use of 
ancillary techniques such as the ‘Cantero manoeuvre’ (an ancillary measure designed to 
reduce enteroscope and overtube looping within the stomach) [57;58;264] (Figure 48), 
the ‘over-the-scope manoeuvre’ (another alternative technique involving separate 
advancement of the enteroscope and overtube) [57;58;264] and the use of external 
abdominal counter-pressure [59]. The deepest point of SB insertion reached at SE was 
marked by a submucosal tattoo of sterile India ink (Spot
®
, GI Supply, PA, USA). 
Maximal SB insertion depth at DBE was considered to have been reached when 
enteroscope insertion was no longer possible despite manoeuvres for managing deep 
looping [168]. Estimated SB insertion depth was calculated using the method described 
by May et al. [51;61]. Procedure duration and other related details were recorded in real-
time on a specially designed proforma by 1 of 3 other designated endoscopy research 
fellows. Start and end of procedures were defined by entry or exit of the enteroscope 
into/from the patient’s mouth respectively with exclusion of time spent applying 
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endotherapy (all endotherapy was applied only during DBE procedures). As per standard 
practice for deep enteroscopy in our unit, fluoroscopy was not used for any of the 
procedures. 
 
Figure 48: The ‘Cantero’ manoeuvre. Looping within the stomach (A) is reduced by a combination 
of gentle traction (red arrow) and clockwise rotation (green arrow) of the overtube (B) 
(Images courtesy of Spirus Medical, LLC, MA, USA) 
 
 
8.3.3 Collected data 
Data collected included: demographics (age and gender), indications for deep 
enteroscopy, history of abdominal or pelvic surgery, estimated insertion depth, time to 
reach maximal insertion depth, time to reach the tattoo placed during the preceding 
procedure; total procedure duration, limitations encountered, estimation of procedure 
difficulty using a 10cm visual analogue scale (VAS) (where 0=very easy and 10=very 
difficult). Enteroscopic findings, including evidence of procedure-related mucosal 
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trauma, which was graded according to the 6 point trauma score described by Buscaglia 
et al [264] and immediate complications, were also recorded. 
8.3.4 Statistical analysis  
The study was powered to detect a difference in insertion depth between the two 
methods. Based on experience, the within-subject standard deviations were considered to 
be 0.75m. A difference of 0.5m in insertion depth between methods was arbitrarily 
considered to be of clinical importance. Although it was initially calculated that 24 
patients were required to achieve a 5% significance level and 90% power, analysis of the 
results from the first 15 patients (30 procedures) at 13 months, demonstrated highly 
statistically significant differences between SE and DBE procedures; it was therefore 
considered ethically justified to conclude the study at that point. 
Data were collated into a computer database (Microsoft Office
®
 2010, Microsoft 
Corporation, WA, USA) and analysed using GraphPad
®
 InStat, version 3.0 (GraphPad 
software Inc., CA, USA) software. Descriptive statistics were used to examine patient 
demographics. Two-sided non-parametric testing (Mann-Whitney U test) was used to 
examine for differences in SB insertion depths and procedure duration. VAS scores for 
procedure difficulty were examined using a two-sided t test. Binomial statistics were 
used to assess for differences in diagnostic yields. Results are presented as means ± 
standard deviation (SD) and medians (with 95% confidence intervals (CI)) and ranges. 
Selected box-plots illustrating medians and interquartile ranges are also presented. 
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8.4 Results 
 
Fifteen patients (10 women, 5 men; mean age 51.4 ±15.4, range 24-74 years), only 4 of 
whom had a history of abdominal or pelvic surgery, were recruited (Table 18). The 
indications for deep enteroscopy are described (Figure 49).   
Table 18: Patient characteristics 
Patient 
number 
Age (years) Gender History of abdominal/pelvic 
surgery 
1 61 F No 
2 38 F Yes 
3 72 M Yes 
4 50 F No 
5 54 F Yes 
6 51 F No 
7 39 F No 
8 24 M No 
9 45 F No 
10 49 F No 
11 27 M No 
12 59 M No 
13 74 M No 
14 74 F No 
15 54 F Yes 
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Figure 49:  Indications for deep enteroscopy procedures 
 
 
The tattoo placed at SE was visualised and passed by DBE in 14 patients. In patient 11, 
the sub-mucosal tattoo placed during SE could not be reached by DBE after an estimated 
final SB insertion depth of 160cm. Analysis after exclusion of patient 11, found 
significantly deeper SB insertion for DBE as compared with SE; median (95% CI) 
insertion depths for DBE vs. SE were 265 (227-324) cm vs. 175 (132-212) cm, 
respectively, representing an increase in median SB insertion depth of 51% for DBE, 
P=0.004 (Figure 50A). Conversely, the median time taken to reach the deepest point of 
insertion was significantly shorter for SE as compared with that for DBE procedures; 
median (95% CI) times for SE vs. DBE were 24 (20-28) minutes vs. 45 (35-53) minutes 
respectively, P=0.0005 (Figure 50B).  
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Figure 50: Estimated small bowel insertion depth (A) and time taken to reach the deepest point of 
insertion (B) for manual spiral enteroscopy and double-balloon enteroscopy procedures. 
Two-sided Mann-Whitney U test, values are expressed as medians (horizontal lines) and 
the 25
th
 and 75
th
 percentiles of the interquartile range (boxes). The whiskers are set at 
1.5x the 25
th
 and 75
th
 percentiles respectively. *Insertion depths were estimated at DBE 
using the method described by May et al. [51]. 
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The median total-duration of deep enteroscopy procedures (excluding time taken to 
apply endotherapy at DBE) was also significantly shorter for SE (median (95% CI) 
duration of SE vs. DBE was 28 (27-36) minutes vs. 54 (45-62) minutes respectively, 
P=0.0002 (Figure 51A). In the 14 patients where the comparison was possible, the 
median time taken by SE to reach maximal depth of insertion was not significantly 
different to the time taken by DBE to reach the submucosal tattoo placed at SE (median 
(95% CI) times for SE vs. DBE were 24 (20-28) minutes vs. 19 (14-26) minutes 
respectively, P=0.28) (Figure 51B).  
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Figure 51: Time taken to complete manual spiral enteroscopy (SE) and double-balloon enteroscopy 
(DBE) procedures (A) and time taken to reach the deepest point of insertion by SE as 
compared with time taken to reach SE tattoo by DBE (B). Two-sided Mann-Whitney U 
test, values are expressed as medians (horizontal lines) and the 25
th
 and 75
th
 percentiles 
of the interquartile range (boxes). The whiskers are set at 1.5x the 25
th
 and 75
th
 
percentiles respectively. 
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There were no significant differences between the mean VAS procedure difficulty scores 
for the 2 types of enteroscopy (the mean VAS ±SD (95% CI) procedure difficulty score 
for SE vs. DBE was 5.3 ±2.3 (4.0-6.6) vs. 5.2 ±2.4 (3.9-6.5) respectively, P=0.86). 
Endoscopists reported that the main limiting factors which prevented deeper SB 
insertion during SE procedures were ‘lack of SB engagement’ and ‘SB tethering’ which 
occurred in 73% and 27% of SE respectively. The main factors which prevented deeper 
insertion at DBE were ‘unfavourable looping’ (tight angulations and deep looping which 
hindered deeper insertion) and ‘SB tethering’ (a fixed and immobile SB) which occurred 
in 53% and 20% of DBE procedures respectively.  ‘SB tethering’ which was presumed 
to arise from underlying post-surgical adhesional disease occurred in all procedures 
relating to patients who had undergone previous abdominal or pelvic surgery.  
Although this was not one of the study end-points, we also made a comparison of 
diagnostic yields and found that these were similar for both procedures (diagnostic yield 
SE vs. DBE, 46.7% vs. 53.3% respectively, P=0.4). However, in 1 case, deeper SB 
insertion at DBE (median SB insertion at DBE vs. SE, 270cm vs. 150cm respectively) 
led to the identification of the suspect SB lesion seen at preceding SBCE (a SB lipoma) 
which had not been reached by SE. 
Mild SE-related mucosal trauma was observed in 9 patients (60%). The observed 
mucosal trauma was all located in the oesophagus and at the ligament of Treitz and 
consisted of grade 1 (oedema/erythema) or grade 2 (superficial hematoma/erosion) 
lesions [264] in 7 and 2 patients respectively. No additional complications [151] were 
observed with any of the DBE procedures. 
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8.5 Discussion 
 
Since the introduction of SE in 2008 [57], while several reports have suggested that this 
technology allows deep enteroscopy procedures to be performed more rapidly [57-
59;62;264-266], only two studies (both from Germany) [60;61] have prospectively 
compared SE and DBE performance. 
The first of these 2 studies, performed by Frieling et al. [60] was a non-randomised study 
performed in a cohort of 35 patients assigned to either SE (n=18) or DBE (n=17) which 
showed no difference between the 2 modalities for procedure duration or depth of SB 
insertion. The second study was a cross-over study performed by the Wiesbaden group 
[61] in a cohort of 10 patients which showed that although procedure duration was 
significantly shorter for SE, significantly deeper SB insertion was achieved by DBE.  
The use of different methodologies for the estimation of SB insertion depth achieved 
during SE and DBE procedures however potentially confounds the results these 2 studies 
and a conclusive answer to the question of whether SE and DBE enable similar insertion 
SB depths has been lacking. 
In order to try to avoid this confounding factor, we performed a prospective, back-to-
back comparative study of SE and DBE performance, using the same method of SB 
insertion depth estimation. In our study, SB insertion depth was estimated during DBE 
procedures using the method described by May et al. [51], since its step-wise estimation 
of advancement of the enteroscope into the SB appears to be less susceptible to bias [61] 
than the method described for SE procedures [57]. Our preliminary experience has 
suggested that DBE was more likely to facilitate deeper SB insertion than SE [59], we 
therefore elected not to randomise the order in which deep enteroscopy procedures were 
performed and in all cases SE procedures preceded DBE. This rationale was used with 
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the aim of facilitating the use of the same methodology [51] for SB insertion depth 
estimation.   
 
8.5.1 Estimated SB insertion depth  
Our study demonstrates that DBE facilitates deeper SB intubation than SE overall. In 
14/15 patients enrolled, the DBE procedure, not only enabled visualisation of the sub-
mucosal tattoo placed at SE but also facilitated significantly deeper enteroscopy, with an 
overall increase in estimated median SB insertion depth of 51% for DBE as compared 
with SE. In the 10
th
 patient, unfavourable SB looping hindered the DBE procedure 
despite the use of alternative ancillary techniques [168] and the tattoo placed at SE could 
not be reached at an estimated final SB insertion depth of 160cm (during DBE). Since 
we were unable to estimate the SB insertion depth achieved during SE, no comparison 
with that attained during DBE could be performed in this particular case.   
Our results here, support the findings of the Wiesbaden group [61] whose study of 10 
patients showed that in all cases where SE procedures were performed first (n=4), 
subsequent DBE allowed deeper SB insertion than the submucosal tattoo placed at SE 
(increase in estimated depth of SB insertion: median 100cm, range 40-80cm). In the 
other 6/10 patients enrolled in the Wiesbaden study [61], SE either failed to reach the 
tattoo placed at a previous DBE (n=3) or allowed tattoo visualisation but was unable to 
facilitate deeper SB insertion (n=3). 
 
8.5.2 Deep enteroscopy procedure duration 
The median time taken to reach maximal SB insertion depth (defined as the point when 
no further enteroscope advancement into the SB could be made despite the use of 
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ancillary measures [57-59;168;264] was significantly shorter for SE as compared with 
DBE. Although these findings are also similar to results of the Wiesbaden [61] study 
where the investigators reported significantly shorter insertion times for SE procedures 
as compared with DBE, our study design, also allowed for a comparison of the time 
taken to achieve maximal insertion depth at SE with the time taken for DBE procedures 
to reach the sub-mucosal tattoo placed at SE. In the 14/15 patients where this 
comparison was possible, we found that the median times taken were similar for both 
procedures, suggesting that the two technologies afford a comparable rate (‘speed’) of 
advancement into the SB.  
The non-randomised study by Frieling et al. [60], did not report details of the time taken 
to reach maximal SB insertion depth but showed a similar total-duration for SE and DBE 
procedures. Our findings in relation to total procedure duration in contrast, were similar 
to those reported by the Wiesbaden group [61] and showed that SE procedures were 
completed in a shorter time as compared with DBE. When considering our finding that 
SE and DBE procedures appear to facilitate a similar ‘speed’ of enteroscope 
advancement into the SB, the longer duration of DBE procedures is therefore likely to 
relate to the time taken to achieve deeper SB insertion by this technology. 
 
8.5.3 Factors identified by the endoscopists as having a negative effect 
on SB insertion depth 
No significant differences were detected between the difficulty scores of the 2 
enteroscopy techniques. ‘Lack of SB engagement’ and ‘SB tethering’, were identified as 
the main limiting factors to deeper SB insertion at SE.  Although efforts to counteract 
these limiting factors were undertaken using the ‘Cantero manoeuvre’ [57;58;264], the 
‘over-the-scope manoeuvre’ [57;58;264] and abdominal counter-pressure [59], these 
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factors eventually prevented further enteroscope insertion at SE. These factors which 
limited deeper SB insertion at SE have also been reported by others [60;264]. Deeper SB 
insertion during DBE was limited by ‘unfavourable looping’ and ‘tethering’ of the SB, 
two phenomena which are also well recognised and as shown in our experience and that 
of others [123;156]. Although these limiting factors are often encountered in the setting 
of a past history of abdomino-pelvic surgery, our study was not designed to detect 
significant differences in this regard. 
 
8.5.4 Diagnostic yield  
Although our study was also not sufficiently powered to detect differences in diagnostic 
yields, our findings here are similar to those of the other 2 comparative studies from 
Germany [60;61] which found no differences in diagnostic yield (although it is likely 
that these 2 studies were also underpowered and therefore confounded by a type II error 
in this regard). However, our 1 case (patient 6) where the suspected SB lesion was 
detected by DBE only on deeper SB insertion than SE, supports the findings of our 
preliminary experience [59] and the notion that deeper enteroscopy may influence yield 
[61]. Studies designed specifically to detect differences in diagnostic yields may 
therefore be worthwhile.  
 
8.5.5 SE related tissue trauma 
Although no clinically significant immediate post-procedure complications [151] such as 
bleeding, perforation or pancreatitis were observed in any of our patients, SE-related 
mild mucosal trauma of the oesophagus and at the ligament of Treitz was observed in a 
total of 9 cases. As has also been shown by others [57;264], mucosal trauma is a 
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recognised potential complication of SE. In most cases, this manifests itself as mild, 
mucosal oedema/erythema or as superficial haematomata/erosions but deeper injury such 
as lacerations [264] and perforations (up to 0.34%) [58] have also been reported. Tissue 
trauma during SE may be chiefly related to the wide plastic helical projection (5.5mm 
profile) [58;60] and the relatively stiff design of the plastic overtube; however, a recent 
laparoscopic evaluation of DBE and SE in a small study of live porcine models [267], 
has suggested that the SE technique itself may also contribute to this trauma. The animal 
model study by Soria et al. [267] showed that unlike DBE, SE may lead to ‘twisting’ of 
vessels at the root of the SB mesentery with resultant transient disturbances of the 
vascular supply, ecchymosis and small peritoneal tears. These findings suggest that the 
SE technique itself may induce more iatrogenic injury than originally indicated by 
Akerman et al. [57] who described that SB pleating during SE occurs without apparent 
twisting of the SB and its mesentery. 
 
8.5.6 Limitations of the study 
This was a small prospective study conducted in a tertiary referral centre for advanced 
endoscopy where operators had more experience with DBE than with SE. However, the 
investigators had undertaken multiple dedicated training sessions in SE [59] and as 
shown by Buscaglia et al. [264] in their report on the SE training initiative, this 
procedure is considered easy to learn and proficiency can be achieved after the 
performance of about five supervised-training enteroscopies. Although the order of 
procedures was not randomised in order to facilitate the use of a single method for the 
estimation of SB insertion depth [51], we recognise that this may have led to intrinsic 
bias and therefore constitutes another limitation of the study. It may also be argued that 
the investigators may have achieved greater SB insertion depths at DBE by pursuing 
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DBE procedures for a longer period of time. In this study, insertion duration at 
enteroscopy was however governed by insertion progress and the point of ‘failure-to-
progress’ was achieved sooner with SE (despite the use of dedicated ancillary 
manoeuvres) than with DBE; our results here are also similar to the findings of May et 
al. [61]. Although the highly significant differences detected at interim analysis were 
deemed to provide ethical justification to conclude the study at that point, we also 
recognise that early closure of the study may represent another limitation by ‘swinging’ 
the data towards bias. 
8.5.7  Conclusion 
Our study showed that DBE achieved significantly deeper SB insertion than SE 
procedures. Although the maximal insertion depth was achieved sooner with SE 
procedures, in the majority of cases (14/15), the time taken to reach the same SB 
insertion depth was not significantly different for the two procedures, suggesting that the 
actual speed of SE insertion (in its current, manual form) may be similar to that achieved 
at DBE. It remains uncertain as to whether this may translate into improved diagnostic 
yields and improved outcomes in routine clinical practice and further larger studies 
which are adequately powered to address these questions are required. 
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9 Comparison of double-balloon colonoscopy 
(DBC) and conventional colonoscopy (CC) 
performance in pre-defined technically difficult 
(TD) cases 
9.1  Background 
 
Colonoscopy is considered the gold-standard procedure for the diagnosis, management 
and prevention of colorectal disease [268-270]. However, failure to reach the caecum is 
reported to occur in up to 10% of attempted cases [63;64;66;117]. This often results in 
the need for further investigation, additional risks, inconvenience for patients and cost 
[66]. A technically difficult (TD) colon with characteristics that are typically 
unfavourable to colonoscopy (e.g. the presence of tight sigmoid angulations or 
dolichocolon), not only increases the risk of failure [66] but may also result in a 
prolonged and painful procedure [69;71;73;74;77;85]. TD colonoscopy may result in 
failure to reach the caecum despite the use of good colonoscopy technique and the use of 
ancillary equipment such as magnetic endoscopic imaging (MEI), a paediatric 
colonoscope, an upper GI endoscope, and/or a plastic cap attached to the tip of the 
chosen endoscopic instrument [66;113]. In recent years, endoscopists have therefore 
turned their attention to balloon assisted colonoscopy, double-balloon colonoscopy 
(DBC) in particular, as potential alternatives technology for the intubation of a TD colon 
[66;92-97;100;122;271].   
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DBC is a technology which is directly derived from DBE and uses a similar system of 
two latex balloons and a stabilising overtube for insertion and withdrawal of a dedicated, 
slim colonoscope. Although several series on the use of DBC for TD colonoscopy have 
been published, only one randomised study has prospectively compared its performance 
with conventional colonoscopy (CC) for this indication to date [113]. This study from 
Japan showed a faster and higher caecal intubation rate for DBC but the definition of a 
TD case was subjectively defined by time taken to achieve caecal intubation (>30 
minutes) during previous colonoscopy [113].  
In order to circumvent this potential confounding factor, our prospective, randomised 
comparative study of DBC with CC for TD cases used a set of pre-determined, evidence-
based, minimal criteria for patient recruitment. These minimal criteria were in turn 
determined by an original, evidence-based scoring system designed at our unit, 
specifically for this purpose.   
 
9.1.1 Development and validation of an original, evidence-based 
scoring-system for TD colonoscopy 
Several studies have identified a number of patient-related factors which may be 
associated with TD colonoscopy. These factors include: female gender [63;65;67;68;70-
74;76;77;80-85], increasing age (>60 years) [68-72;74;83], a history of abdominal/pelvic 
surgery [63;65;69;72;73;77;80;83;84] chronic constipation [71;77](often in the setting of 
a dolichocolon [65;66;75;76;84;86-91]), small body habitus  (BMI<22 or W/H ratio <1) 
[67-70;72;73] and previously failed colonoscopy [65;66;84;92-100].  In an attempt to 
pre-define TD cases, we proposed an original scoring-system, incorporating these factors 
which have been shown to be associated with TD colonoscopy (Table 20).  
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In this proposed cumulative scoring-system, the total-score is calculated by simple 
addition of individual patient-related factors. Since the scoring-system also takes into 
account the association of female gender with TD colonoscopy [63;65;67;68;70-
74;76;77;80-85], the total-score range for a given patient would be: 1-8 in the case of a 
woman and 0-7 in the case of a man (Table 19). While female gender, age >60 years, 
small body habitus and a history of previous abdominal/pelvic surgery were each given a 
score of 1, a history of chronic constipation (as defined by the Rome III criteria [272]) 
and failed colonoscopy (defined as a failed colonoscopy by a consultant 
gastroenterologist), were arbitrarily each given a score of 2. 
 
Table 19: A proposed original, evidence-based cumulative scoring-system incorporating factors 
which have been shown to be associated with TD colonoscopy. The total-score is 
calculated by simple addition of individual patient-related factors (i.e. the total score 
range for a given patient would be: 1-8 in the case of a woman and 0-7 in the case of a 
man). 
*As defined by the ‘Rome III criteria’ [272]; Failed colonoscopy by a consultant 
gastroenterologist 
 
 
 
 
 
 
 
 
Patient-related factor Score 
Female gender 1 
Age ≥ 60 years 1 
Small body habitus  
(BMI <22 or W/H ratio <1) 
1 
Previous abdominal/pelvic surgery 1 
Chronic constipation
*
 2 
History of failed colonoscopy 2 
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9.1.2 Prospective pilot study to assess the correlation of the proposed 
scoring-system for TD colonoscopy with the time taken for 
colonic intubation by experienced colonoscopists 
 
9.1.2.1 Aims  
In the absence of a universally accepted measure of technical difficulty at colonoscopy, 
the time taken for colonic intubation (time taken to reach the caecum) is often used as a 
surrogate marker for this [67;68;70-77;79]; we therefore assessed the correlation of our 
proposed scoring-system for TD colonoscopy with the time taken to reach the caecum at 
colonoscopy. This pilot study was conducted with the significant help and collaboration 
of two of the author’s research fellow colleagues, namely Dr Masanao Nakamura and  
Dr Alberto Murino. 
 
9.1.2.2  Methods  
The prospective pilot study was performed in a cohort of 30 patients (all-comers), who 
were referred to our unit for a colonoscopy.  Prior to colonoscopy, patients received 
bowel preparation in the form of 13g of senna granules and a total of 3 sachets of 
magnesium citrate (Citromag, Bioglan Laboratories, Hertfordshire, UK), 2 sachets given 
on the day before and 1 given on the morning of the procedure. Carbon dioxide (CO2), 
(CO2Efficient
TM
 systems, E-Z-EM Inc., NY, USA) was used for colonic insufflation and 
all procedures were performed by 1 of 5 experienced colonoscopists.  Although all 5 
colonoscopists had performed >1000 colonoscopies each, it must be stated that 
colonoscopists 1 and 2 were considerably more experienced and had performed >3000 
and >7000 cases, respectively. The colonoscopists’ relative experience and their 
respective contribution to the pilot study are shown (Table 20). Colonoscopy procedures 
172 
  
were performed using our unit’s standard (12.2mm external diameter) variable-stiffness 
adult colonoscope (EVIS Lucera™ CF-Q260, Olympus, Tokyo, Japan).  
Table 20: Respective experience and relative contribution of colonoscopists involved in the pilot 
study  
 
 
 
 
 
 
The colonoscopist was allowed to switch to the use of ancillary equipment in the form of 
a MEI (ScopeGuide
®
 UPD, Olympus, Tokyo, Japan) and/or a paediatric colonoscope 
(EVIS Lucera™ PCF-Q260, Olympus, Tokyo, Japan) when failing to progress with the 
standard colonoscope.  The use (and respective doses) of sedation (midazolam and 
pethidine) and smooth muscle relaxant (hyoscine-N-butylbromide, Buscopan
®
, 
Boehringer, Ingelheim Gmbh, Germany) was left to the colonoscopists’ clinical 
judgement (not standardised) and no formal comparisons relating to drugs/doses used, 
were made. Data on patient characteristics relating to our proposed scoring-system (i.e. 
gender, age, BMI, W/H ratio, history of abdominal/pelvic surgery, chronic constipation, 
dolichocolon and previously failed colonoscopy) were collected pre-procedure and the 
patient’s TD score was calculated; the colonoscopist performing the procedure was 
blinded to the patient’s TD score. The time taken for colonic intubation (excluding any 
time taken for endotherapy) use of ancillary equipment, and adequacy of bowel 
Colonoscopist Respective experience 
(colonoscopies previously performed (n)) 
Relative contribution to pilot study 
(colonoscopies performed(n)) 
1 >3000 16 
2 >7000 2 
3 >1000 7 
4 >1000 3 
5 >1000 2 
173 
  
preparation (adequate or inadequate, as subjectively judged by the endoscopist), were 
also recorded. Data were collated into a computer database (Microsoft Office
®
 2010, 
Microsoft Corporation, WA, USA) and analysed using GraphPad
®
 InStat, version 3.0 
(GraphPad software Inc., CA, USA) software. Correlation between time taken for 
colonic intubation and the magnitude of the proposed TD score was examined non-
parametrically using Spearman’s rank correlation coefficient (rs); a P value of <0.05 was 
regarded to be statistically significant. 
 
9.1.2.3 Results  
Thirty patients (18 women, 12 men; mean age 58 ±16, range 21-86 years) were enrolled. 
One patient had to be excluded from the pilot study since the colonoscopy had to be 
stopped due to the presence of a colonic stricture; the results of the other 29 patients 
were analysed as planned. The median TD score was 3 (range 0-6) (Figure 52) while the 
median time taken for colonic intubation to the caecum was 9 minutes (range 3-23 
minutes). A switch to ancillary equipment (a paediatric colonoscope) was required in 
three cases. The TD scores in these three cases were 3, 4 and 6 and the switch to a 
paediatric colonoscope was made at 4, 8 and 6 minutes respectively. The overall time 
taken for colonic intubation to the caecum was in turn 8 minutes for the first of these 3 
cases and 14 minutes for the other 2. Examination of the overall time taken for colonic 
intubation (to the caecum) vs. TD score magnitude for the pilot cohort using Spearman’s 
rank correlation coefficient, showed a significant positive correlation between the  
two variables (rs=0.6; 95% CI 0.29-0.80, P=0.0006) (Figure 53).  In order to assess the 
impact of colonoscopist experience on caecal intubation time, a comparison of the caecal 
intubation times of the more experienced colonoscopists (i.e. those who had performed 
>3000 cases (n=2)) and the less experienced colonoscopists (i.e. those who had 
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performed <3000 cases (n=3)) was also made. This comparison showed no differences in 
median (95% CI) time taken for caecal intubation between the 2 groups, 9 (8.1-13.5) vs. 
8 (5.0-8.2) minutes respectively, P= 0.34. The median (95% CI) doses for midazolam 
and pethidine were 1.25 (0.5-1.1) and 0 (4.8-14.2) mg, respectively. The median (95% 
CI) dose of hyoscine-N-butylbromide (Buscopan
®
, Boehringer, Ingelheim Gmbh, 
Germany) used was 20 (16.3-19.5) mg. All but 3 patients were considered to have 
adequate bowel preparation; no further analysis relating to this was possible. 
 
Figure 52: Range of distribution of the proposed TD score magnitude for patients enrolled in the 
pilot study. *Since none of the enrolled patients had a TD score of 7 or 8, these two 
values were omitted from the figure. 
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Figure 53: Scatter plot of the time taken to intubate the colon (caecum) at colonoscopy vs. TD score 
magnitude; rs, Spearman’s rank correlation coefficient (non-parametric testing was used 
since the distribution of TD scores was non-Gaussian)  
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9.1.2.4  Discussion  
This pilot study demonstrated a significant positive correlation between our proposed 
scoring-system for TD colonoscopy and our surrogate marker of technical difficulty 
(time taken to reach the caecum).  
One potential limiting factor of this pilot study aimed at assessing the construct-validity 
of our proposed scoring-system for TD colonoscopy, was that the study used an 
arbitrarily chosen ‘marker’ for technical difficulty. However, in our experience and that 
of others [67;68;70-77;79], the time taken for colonic intubation to the caecum is fairly 
reflective of the technical difficulty of procedures. We also recognise that the validation 
pilot study was also potentially confounded by non-standardisation of sedation and 
smooth muscle relaxant administration, the adequacy (or inadequacy) of bowel 
preparation and the heterogeneous group of colonoscopists with varying experience. It is 
likely however that relative experience may not have had such a confounding impact, 
since the comparison of caecal intubation times for colonoscopists with greater (having 
performed >3000 colonoscopies) experience was similar to that of those who were 
considered less experienced (having performed <3000 colonoscopies). 
Bearing these limitations in mind, in the absence of any other evidence-based, objective 
predictive scores of TD colonoscopy, we proceeded to use this proposed scoring-system 
for the purpose of selection of appropriate patients for our prospective randomised study 
comparing DBC to CC in patients with TD colonoscopy. 
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9.2 Prospective, randomised study comparing DBC to CC in TD 
colonoscopy  
 
9.2.1 Aims 
The main study pursued a prospective comparison of the performance of DBC with CC 
for TD cases. The primary objective was to determine whether any of the two types of 
colonoscopy (i.e. DBC vs. CC) would enable faster colonic intubation (to the caecum) in 
patients who were deemed to have TD colons. The secondary objectives were to 
determine whether any of the two types of colonoscopy (i.e. DBC vs. CC) would: i) 
enable a higher caecal intubation rate and ii) facilitate a more comfortable procedure in 
patients with TD colons. 
 
9.2.2 Methods 
9.2.2.1 Patients 
During the period of study, request-forms of patients (both genders, ≥18 years of age) 
who were referred to St Mark’s Hospital for a routine (diagnostic) colonoscopy were 
‘screened’ for parameters predictive of TD colonoscopy using our original scoring-
system (Table 20), once every 4-6 weeks. TD colonoscopy was considered more likely 
to occur in patients with a TD score ≥3. Patients who fulfilled this criterion were then 
contacted by telephone for confirmation of their calculated TD colonoscopy score. 
Potential participants with confirmed TD scores score ≥3 were then provisionally invited 
(pending exact BMI and W/H ratio measurements) to take part in the study. The 
exclusion criteria were unwillingness to undergo colonoscopy or to participate in the 
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study, lack of capacity, a history of colonic resection and contraindications to 
colonoscopy or conscious sedation.  
 
All patients fulfilling the study entry criteria gave their written informed consent to 
participate. The research protocol and conduct of the study was approved by the regional 
research ethics committee and by the institution’s research and development review 
board (Outer West London REC Ref. 10/H0709/12; RD 10/003) and registered with the 
International Standard Randomised Controlled Trial Number Register 
(ISRCTN77510548). The study was carried out in accordance with the World Medical 
Association Declaration of Helsinki, 1964 (incorporating all later amendments) [129]. 
 
9.2.2.2 Study design 
This was a prospective, randomized, comparative study (of parallel design). Participating 
patients were randomized 1:1 using opaque sealed envelopes, to either a DBC or a CC 
procedure by our endoscopy unit’s research administrator. 
 
9.2.2.3 Colonoscopy procedures and equipment 
Prior to colonoscopy, patients received bowel preparation in the form of 13g of senna 
granules and three sachets of magnesium citrate (Citromag, Bioglan Laboratories, 
Hertfordshire, UK), two sachets on the day before and one on the morning of the 
procedure. CO2 (CO2Efficient
TM
 systems, E-Z-EM Inc., NY, USA) was used as an 
insufflating agent and all colonoscopies were performed by one of two experienced 
endoscopists (CF and EJD) each of whom had performed >1000 colonoscopies. Both 
endoscopists were also proficient in the double-balloon technique (having performed 
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>200 double-balloon endoscopies each). Caecal intubation was defined as passage of the 
tip of the colonoscope into the caecal pole; this was photo and video documented.   
As per approved study protocol, patients agreed to commence their procedure without 
sedation and sedation was administered during the procedure, on demand, as necessary, 
in the form of low dose generic intravenous midazolam and pethidine. Supplemental 
oxygen was used routinely. An antispasmodic agent in the form of intravenous hyoscine-
N-butylbromide (Buscopan
®
, Boehringer Ingelheim Gmbh; Germany) was also used, 
unless contra-indicated. Anti-foaming agent (bubble-breaker) in the form of 1% 
simethicone suspension (Infacol
®
, Forest Laboratories, Dartford, UK) was sprayed down 
the colonoscope working channel to improve endoscopic view quality as required. 
CC procedures were commenced with the patients in the left lateral decubitus position, 
while DBC procedures were begun with the patient in a supine position (as per standard 
unit practice); during colonoscopy, the study protocol allowed the endoscopist to change 
patient position as necessary. CC procedures were performed using our unit’s standard 
(12.2mm external diameter) variable-stiffness adult colonoscope (EVIS Lucera™ CF-
Q260, Olympus; Tokyo, Japan). DBC procedures were performed with the EC-450BI5 
(9.4mm external diameter, 152cm working length) double-balloon colonoscope 
(Fujifilm, Saitama, Japan) equipped with dedicated overtube and 2 latex balloons, using 
the standard double-balloon technique [20;123] as described in Chapter 1 (Figure 7B). 
Colonoscopists were allowed to switch to the use of ancillary equipment in the form a 
MEI (ScopeGuide® UPD, Olympus, Tokyo, Japan) and/or a paediatric colonoscope 
(EVIS Lucera™ PCF-Q260, Olympus, Tokyo, Japan) in the event of failing to progress 
with the designated colonoscope. Fluoroscopy was not used. 
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9.2.2.4 Collected data 
Data collected included: patient demographics (age and gender), indications for 
colonoscopy and TD score (including BMI and W/H ratio measurements). The time 
taken to intubate the colon (from rectal insertion to caecal intubation) and to complete 
colonoscopy (from rectal insertion of the colonoscope to its withdrawal from the 
patient’s body) was recorded.  Any time taken for endotherapy was excluded from the 
record and details relating to the use of ancillary equipment were also recorded. Doses of 
any sedative or antispasmodic drugs used during the procedure were documented. 
At the end of the colonoscopy, patients were assessed on their tolerance to the procedure 
by marking a 10cm VAS (0, non-existent; 10, unbearable) to quantify overall discomfort 
and pain. Similar VAS’s for perceived overall patient discomfort and pain were 
completed by the endoscopist and the attending nurse.  
Measurements of patient vital parameters (lowest and highest systolic blood pressure 
(SBP), lowest and highest pulse rates and lowest oxygen saturations) taken by attending 
nurses during the endoscopy were recorded. Patient recovery was defined objectively 
using the modified Aldrete scoring system [273-275] (Table 20); recovery duration 
(from withdrawal of the colonoscope from the patient’s body to the time when the 
patient achieved a modified Aldrete score ≥9 [273-275]) and any immediate 
complications [151] were also recorded.  
Patient satisfaction with the procedure was recorded on a 5-point Likert scale (5=very 
satisfied, 4=satisfied, 3=neutral, 2=dissatisfied or 1=very dissatisfied) and patients were 
asked whether or not they would opt to undergo the same type of colonoscopy again 
should this be required in the future. Technical ease was evaluated by the endoscopist at 
the end of the procedure using a 10cm VAS (0, very easy; 10, very challenging). 
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Table 21: The modified Aldrete Recovery Scoring System [273-275]; patient recovery is confirmed 
by a total score of ≥9 
Modified Aldrete Recovery Scoring System
* 
Respiration Score 
Able to breathe deeply and cough freely 2 
Dyspnoea, shallow or limited breathing 1 
Apnoea 0 
Oxygen saturation  
Saturation > 92% 2 
Needs supplemental oxygen to maintain saturation >90% 1 
Saturation <90% with oxygen 0 
Circulation  
Systolic blood pressure within 20mm Hg of pre-operative level 2 
Systolic blood pressure within 20-50mm Hg of pre-operative level  1 
Systolic blood pressure +/- 50mm Hg of pre-operative level 0 
Consciousness  
Fully awake 2 
Arousable on calling 1 
Unresponsive 0 
Activity: able to move voluntarily or on command  
Four extremities 2 
Two extremities 1 
No extremities 0 
*
Recovery is confirmed when the patient achieves a total score of  ≥9 
 
 
9.2.3 Statistical analysis 
The power calculation and statistical analyses were performed with the assistance of a 
nominated consultant medical statistician. The main objective measure of the study was 
to detect a difference in colonic intubation time between the two types of colonoscopy. 
Considering an estimated SD of 10 minutes, a total of 44 patients (i.e. 22 patients in each 
group), was required for the study to have 90% power to detect a difference of 10 
minutes between groups. A P value of <0.05 was regarded to be statistically significant.  
Data were collated into a computer database (Microsoft Office
®
 2010, Microsoft 
Corporation, WA, USA) and analysed using GraphPad
®
 InStat, version 3.0 (GraphPad 
software Inc., CA, USA) software. The unpaired t test (two sided) and Fisher’s exact test 
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were used to examine patient demographics. Two-sided non-parametric testing (Mann-
Whitney) was used to examine for differences in TD scores, procedure duration and 
VAS scores and satisfaction scores between the two groups; Fisher’s exact test was used 
to examine for differences caecal intubation rates and patient’s future choice of 
procedure. Results are presented as means ± SD and medians (with 95% confidence 
intervals (CI)) or ranges. Selected box-plots illustrating medians and interquartile ranges 
are also presented. 
 
9.2.4 Results 
The study was performed between May 2010 and November 2011; over this 18 month 
period, of a total number of 2249 patient referrals assessed for eligibility, 2205 were 
excluded since their TD scores were ≤3.  The remaining 44 patients were prospectively 
recruited and randomised (DBC, n=22; CC, n=22) as shown in the CONSORT [132] 
study flowchart (Figure 54). Patient demographics and indications for colonoscopy are 
described (Table 22); there were no significant demographic differences among the 
patients in the 2 study groups. There was no difference in the total number or type of 
colonoscopies performed by each endoscopist: CF (number of colonoscopies), n=25 vs. 
EJD (number of colonoscopies), n=19, P=0.58 and CF (DBC) n=12 vs. EJD (DBC) 10, 
P=1.0. 
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 Figure 54: DBC vs. CC for technically difficult (TD) colonoscopy study flow diagram (CONSORT 
[132]) 
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Table 22: Patient demographics and indications for colonoscopy *unpaired t test; **Fisher’s exact 
test; no significant differences in demographic variables were detected between the 2 
study groups  
Patient demographics and indications for colonoscopy 
 
 DBC CC  
Patients (n) 22 22  
Age (mean ± SD)( years) 68 ± 10 65 ± 12 P=0.29* 
Gender (men/women) 7/15 12/10   P=0.22** 
 
Indications (n)    
Polyp follow-up 11 2  
Family history of colorectal cancer 4 4  
Iron deficiency anaemia 2 3  
Rectal bleeding 3 7  
Ulcerative colitis (surveillance) 1 3  
Diarrhoea 1 2  
 
The median calculated pre-procedure TD scores were the same for both groups; median 
(95% CI) for DBC vs. CC was 4.0 (3.6-4.4) vs. 4.0 (3.9-4.8) P=0.27; the distribution of 
scores for the two study groups is shown (Figure 55). The number of patients with a 
history of previously failed colonoscopy was also similar in both groups; DBC vs. CC: 
13/22 (59.1%) vs. 12/22 (54.5%), respectively, P=1.0. 
 
Figure 55: Range of distribution of TD scores for patients randomised to the DBC group (A) and 
CC group (B) 
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9.2.4.1 Time taken to achieve caecal intubation respective caecal 
intubation rates 
While DBC facilitated total colonoscopy in all 22 cases without requiring the use of 
ancillary equipment, within the CC group, the use of additional equipment (MEI and/or 
paediatric colonoscope) was required in 9 cases (41%), after a median time of 12 (range: 
7-22) minutes  of failing to progress. In 3 of these CC cases, caecal intubation failed to 
be achieved (after a median time of 38 minutes of failing to progress) despite the use of a 
MEI and a switch to a paediatric colonoscope.  
Analysis of the time taken for caecal intubation to be achieved during the 22 DBC cases 
as compared with that for the remaining 19 completed CC cases, did not reveal a 
statistically significant difference between the two procedures: median time (95% CI) 
taken for caecal intubation at DBC vs. CC: 17.5 (16.0-23.7) vs. 14.0 (13.0-20.1) minutes 
respectively, P=0.18 (Figure 56). The median time (95% CI) taken for colonoscopy 
completion was longer for DBC, although this difference did not reach statistical 
significance: DBC vs. CC: 31.3 (28.8-36.6) vs. 23.0 (22.7-32.9) minutes respectively, 
P=0.08. 
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Figure 56: Comparison of time taken to achieve caecal intubation at DBC vs. CC. Two-sided Mann-
Whitney U test; values are expressed as medians (horizontal lines) and the 25
th
 and 75
th
 
percentiles of the interquartile range (boxes). The whiskers are set at 1.5x the 25
th
 and 
75
th
 percentiles respectively.  
 
 
Examination of the unassisted caecal intubation rates (where no ancillary equipment was 
used to facilitate caecal intubation) showed that this was significantly higher for DBC 
than that achieved during CC: 22/22 (100%) vs. 13/22 (59%), respectively, P=0.019. 
The median (95% CI) TD score for the 9 CC cases where ancillary equipment was 
required was significantly higher than that for the remaining 13 CC cases where no 
ancillary equipment was required: 5 (4.5-5.5) vs. 4 (3.3-4.4), respectively, P=0.006. In 5 
of these cases, the endoscopist identified “tight angulation of the sigmoid colon” as the 
main limiting factor to successful progress; in the remaining 4 cases “excessive looping” 
appeared to be the major limiting factor. In the 3 CC cases where caecal intubation failed 
despite the use of a MEI and a switch to a paediatric colonoscope, 2 of the cases had a 
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TD score of 6 while the remaining case had a TD score of 5; in all these 3 cases, “tight 
angulation” was identified as the main limiting factor. 
 
9.2.4.2 Patient comfort, sedation requirements, recovery duration, vital 
parameters and adverse events 
Median (95% CI) patient discomfort and pain scores were significantly lower for DBC 
as compared with CC, 2.3 (1.9-3.3.2) vs. 5.5 (3.5-6.1), P=0.01 and 2.0 (1.5-3.2) vs. 5.9 
(3.6-6.2), P=0.005 respectively (Figure 57). These results were mirrored by significant 
differences in median VAS scores for patient discomfort and pain as perceived by the 
attending nurse and the endoscopist. The median (95% CI) VAS scores for DBC vs. CC 
as recorded by the attending nurse for perceived patient discomfort and pain were: 1.6 
(1.3-2.5) vs. 4.5 (2.8-5.3), P=0.013 for patient discomfort and 1.5 (1.2-2.5) vs. 5.0 (3.0-
5.7), P=0.014 for patient pain (Figure 58).  The median (95% CI) VAS scores for DBC 
vs. CC as recorded by the endoscopist for perceived patient discomfort and pain were: 
1.4 (1.3-2.5) vs. 6.3 (4.6 -6.6), P < 0.0001 and 1.4 (1.3-2.8) vs. 6.1 (4.6-6.6), P < 0.0001, 
respectively (Figure 59).  
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Figure 57: Comparisons of patient VAS scores at DBC vs. CC for patient discomfort (A) and pain 
(B). Two-sided Mann-Whitney U test; values are expressed as medians (horizontal lines) 
and the 25
th
 and 75
th
 percentiles of the interquartile range (boxes). The whiskers are set 
at 1.5x the 25
th
 and 75
th
 percentiles respectively.  
 
 
 
 
189 
  
Figure 58: Comparisons of VAS scores at DBC vs. CC for patient discomfort (A) and patient pain 
(B) as perceived by the attending nurse. Two-sided Mann-Whitney U test; values are 
expressed as medians (horizontal lines) and the 25
th
 and 75
th
 percentiles of the 
interquartile range (boxes). The whiskers are set at 1.5x the 25
th
 and 75
th
 percentiles 
respectively.  
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Figure 59: Comparisons of VAS scores at DBC vs. CC for patient discomfort (A) and patient pain 
(B) as perceived by the endoscopist. Two-sided Mann-Whitney U test; values are 
expressed as medians (horizontal lines) and the 25
th
 and 75
th
 percentiles of the 
interquartile range (boxes). The whiskers are set at 1.5x the 25
th
 and 75
th
 percentiles 
respectively.  
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The dose of antispasmodic in the form of hyoscine-N-butylbromide (Buscopan
®
, 
Boehringer Ingelheim Gmbh; Germany) was the same for both groups: median dose 
(95% CI) for DBC vs. CC: 20 (19.2-24.4) vs. 20 (19.2-23.4) mg, respectively, P=0.98. 
However, the median doses of sedative drugs used were significantly lower for DBC 
than for CC procedures.  The median (95% CI) midazolam dose for DBC vs. CC was 0 
(0.2-1.1) vs. 1.25 (0.9-2.1) mg, P=0.023 while that for pethidine was 0 (5.7-20.4) vs. 25 
(19.4-39.6) mg P=0.014, respectively.   
Patient recovery time was also significantly shorter for DBC procedures; median (95% 
CI) recovery time for DBC vs. CC: 5 (7.4-14.4) vs. 20 (13.8-23.5) minutes, P=0.014, 
respectively (Figure 60).  No differences in patient vital parameters i.e. median levels of 
oxygen saturation, SBP or pulse rate readings were detected between the two groups 
(Table 22) and none of the procedures was associated with any adverse events [151]. 
 
Table 23: Patient vital parameters for DBC vs. CC procedures; *Mann-Whitney U test (two-sided), 
bpm, beats per minute 
 
 
 
Patient vital parameters 
 DBC CC P
*
  
Oxygen saturation: median (95% CI), % 97 (95.9-97.4) 98 (95.7-98.3) 0.21 
Highest SBP: median (95% CI), mmHg 146 (140.4-160.4) 140.5 (132.1-154.2) 0.23 
Lowest SBP: median (95% CI), mmHg 77 (74.1-83.8) 74 (71.4-82.6) 0.48 
Highest pulse rate: median (95% CI), bpm 99 (92.6-106.2) 92.5 (89.3-100.3) 0.44 
Lowest pulse rate: median (95% CI), bpm 77 (74.1-83.8) 74 (71.4-82.6) 0.48 
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Figure 60: Comparisons of patient recovery duration: DBC vs. CC Two-sided Mann-Whitney U 
test; values are expressed as medians (bold horizontal lines) and the 25
th
 and 75
th
 
percentiles of the interquartile range (boxes). The whiskers are set at 1.5x the 25
th
 and 
75
th
 percentiles respectively.  
 
 
9.2.2 Patient satisfaction and technical ease of procedure performance  
Examination of the 5-point Likert satisfaction scores (5=very satisfied, 4=satisfied, 
3=neutral, 2=dissatisfied or 1=very dissatisfied), showed that patients from the DBC 
group expressed significantly higher levels of satisfaction than patients from the CC 
group; DBC vs. CC median (95% CI) satisfaction score: 5.0 (3.6-4.8) vs. 3.0 (2.7-3.8), 
P=0.006, respectively (Figure 61).  
When asked about whether or not they would opt to have the same type of colonoscopy 
again or consider an alternative option in the future, all patients in the DBC group said 
that would have a DBC again, while 9 patients (41%) in the CC group said that they 
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would consider an alternative procedure in the future if they were given a choice,  
P < 0.0001. 
 
Figure 61: Comparisons of patient satisfaction 5-point Likert scores (5=very satisfied, 4=satisfied, 
3=neutral, 2=dissatisfied or 1=very dissatisfied) for DBC vs. CC. Two-sided Mann-
Whitney U test; values are expressed as medians (bold horizontal lines) and the 25
th
 and 
75
th
 percentiles of the interquartile range (boxes). The whiskers are set at 1.5x the 25
th
 
and 75
th
 percentiles respectively.  
 
 
Examination of the endoscopist’s VAS score for perceived procedure difficulty (0, very 
easy and 10, very challenging) showed that DBC procedures were found to be 
significantly easier to perform than CC procedures; median (95% CI) technical difficulty 
VAS score (where a ↑score represents ↑difficulty) for DBC vs. CC: 3.6 (3.5-5.2) vs. 6.6 
(6.1-7.7), respectively, P =0.0005.  
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9.2.5 Discussion 
Since the introduction of DBC, although several series have reported on the utility of the 
technology for achieving caecal intubation in previously incomplete or TD colonoscopy 
[66;96;117-120;122;123] only one study [113] has prospectively compared DBC with 
CC date. This study by Suzuki et al. [113] which was performed in a cohort of 94 
patients with a history of TD colonoscopy who were randomly assigned to DBC (n=47) 
or CC (assisted by MEI + transparent cap) (n=47), demonstrated that caecal intubation 
was achieved in a shorter time and at a higher rate in the DBC group. The definition of 
TD colonoscopy used by this Japanese study was however based on the time taken to 
achieve caecal intubation (>30 minutes) at previous colonoscopy.  
In our prospective, randomised comparative study of DBC vs. CC for TD cases we 
attempted to objectively define TD colonoscopy according to a proposed original; 
evidence based a cumulative scoring system incorporating the various factors which 
have been shown to be associated with a TD procedure (female gender, ↑age, small body 
habitus and a history abdominal/pelvic surgery, chronic constipation and previous failed 
colonoscopy) [63;65-68;70-77;80-100] (Table 20).  
In order to assess the construct validity of our proposed scoring system, we performed a 
pilot study in a cohort of 29 patients, in order to examine the correlation of our proposed 
TD score with the time taken to achieve caecal intubation (a frequently used surrogate 
marker of technical difficulty [67;68;70-77;79]).  Accepting the limitations, examination 
of the data from our pilot study showed a significant positive correlation (rs=0.6, 
P=0.0006) between the TD score magnitude and the time taken to achieve caecal 
intubation. Although we recognise the limitations and potentially confounding factors 
(heterogeneity of colonoscopist experience, adequacy/inadequacy of bowel preparation, 
and non-standardised administration of sedative and antispasmodic agents) of this pilot 
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study, preliminary validation of our original TD colonoscopy score enabled us to 
objectively recruit patients for the main study as initially intended. More formal 
validation of the scoring system for TD colonoscopy (which will also address all other 
potentially confounding factors) may also facilitate its use as a ‘predictive’ risk-
stratification tool for TD cases in clinical practice; potentially allowing clinicians to 
strategically plan endoscopy lists by allocating extended time-slots and preparing 
dedicated equipment for patients with a high TD score. 
 
9.2.5.1 Time taken to achieve caecal intubation and respective caecal 
intubation rates 
Examination of the time taken to achieve caecal intubation (the main objective measure 
of the study) was only possible in 19/22 (86%) of CC cases vs. 22/22 (100%) of DBC 
cases, since caecal intubation was unsuccessful in 3 CC cases, despite the use of 
ancillary equipment. Unlike the findings of the study by Suzuki et al. [113] who showed 
a shorter caecal intubation time for DBC, our comparison of the time taken to achieve 
caecal intubation in the remaining cases where total colonoscopy was successful showed 
no significant difference between the 2 groups. 
Since the availability of ancillary equipment (such as a MEI) for CC may not be 
routinely available in clinical practice, we elected to commence all procedures 
unassisted; ancillary equipment was therefore only used on demand in the setting of 
failure to progress at colonic intubation. A comparison of the unassisted caecal 
intubation rates (i.e. where no ancillary equipment was required) showed that this was 
significantly higher for DBC (22/22, 100%) as compared with CC (13/22, 59%) and 
caecal intubation at CC failed, despite the use of ancillary assistance in 3 cases. The 
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findings of the Suzuki et al. for this outcome [113] also showed a significantly higher 
caecal intubation rate for DBC, even though the Japanese investigators used ancillary 
assistance with a MEI + transparent cap for all their CC cases from the start.  In our 
study, a higher TD score (≥5) was associated with a requirement for ancillary assistance 
in CC. Also in keeping with the findings of Suzuki et al. [113], the main factors which 
appeared to have a negative effect on colonic intubation in the 9 CC cases where 
ancillary equipment was required were “tight angulation of the sigmoid colon” (which 
affected 5 of these cases, including the 3 cases where CC remained incomplete despite 
ancillary assistance) and “excessive looping” (which affected the remaining 4 cases). 
These findings, which are also similar to those reported in another case series [122] 
suggest that the slimmer DBC colonoscope coupled with the stability and gentle-traction 
provided by its overtube and balloons may facilitate successful negotiation of tight 
angulations and improved control of looping, potentially accounting for the higher caecal 
intubation rate achieved by DBC. 
 
9.2.5.2 Patient comfort, sedation requirements, recovery duration, vital 
parameters and immediate adverse events 
Patient discomfort and pain VAS scores were significantly lower for DBC as compared 
with CC procedures. This outcome was also mirrored by significantly lower VAS scores 
for perceived patient pain and discomfort as recorded by the attending nurse and 
endoscopist. Sedation requirements were significantly lower for DBC and this was 
associated with a shorter recover period after DBC procedures. Both procedures 
appeared to be equally safe; no significant differences in patient vital parameters or 
immediate adverse events were observed. Our findings here also support the results of 
Suzuki et al. [113] who reported that DBC was associated with lower VAS scores for 
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pain and lower sedation requirements; similarly, no adverse events were reported in the 
Japanese study.  
 
9.2.5.3 Patient satisfaction and technical ease of procedure performance 
Our analysis of patient satisfaction with the colonoscopy they had just undertaken 
showed significantly higher levels of satisfaction in the DBC group. Also, while all the 
patients in DBC group said that they were ready to undergo the same type of procedure 
again, 41% of patients in the CC group said that they would consider an alternative 
option, should they require a further colonoscopy in the future. These findings parallel 
the outcomes relating to the VAS scores for discomfort and which suggested that overall, 
patients found DBC to be the more comfortable of the 2 procedures. Examination of the 
VAS scores for technical performance also showed that the endoscopists found DBC 
easier to perform than CC procedures. 
 
9.2.5.4 Limitations of the study 
This was a small prospective study, performed in a single tertiary referral centre. Other 
limitations of the study include the use of subjective scores (VAS and Likert scores) to 
measure some of the outcomes and the absence of longer term (30 day) complication 
data. We also recognise that comfort-score data from patients who have received 
sedation may have been potentially confounded by the amnesic effects of the sedatives 
used. 
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 9.2.5.5 Conclusion 
Our study is the first study relating to TD colonoscopy, where ‘technical difficulty’ was 
defined by the use of an evidenced based, cumulative scoring system, incorporating 
patient characteristics which have been shown to be associated with a TD procedure. The 
construct validity of our proposed scoring system for TD colonoscopy was confirmed by 
a pilot study, allowing us to use it to recruit patients for the main study according to their 
TD score. More formal evaluation (which is planned) of our original scoring system may 
permit its use in routine clinical practice, potentially allowing endoscopists to pre-plan 
their lists according to the TD score of patients. Our randomised comparative study of 
DBC vs. CC for TD cases generally confirms the findings of others [92;113;117;122] 
and suggests that DBC may be a superior instrument for achieving successful caecal 
intubation in technically difficult cases compared to unassisted CC. DBC is also 
associated with a better patient experience during colonoscopy performed in this setting. 
Larger multicentre studies are required to confirm our findings. 
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10 Discussion 
 
 
10.1 Summary of findings and potential impact on current clinical 
practice 
 
The unifying concept underpinning this body of work, relates to the application of recent 
advances in flexible endoscopic technology for the benefit of minimally invasive patient 
care. This work tested the principle of ‘advancing minimally invasive aspects of flexible 
gastrointestinal endoscopy’ by evaluating the role of examples of such technologies in 
the three key divisions of the luminal digestive system, namely the upper GI tract, SB 
and the colon, within a UK clinical setting. Measures of patient comfort, diagnostic 
ability and new therapeutic indications were evaluated; the overall hypothesis being that 
these technological advancements can provide an alternative minimally invasive option 
of care which is safe, at least as effective and better tolerated by patients. 
 
10.1.2 Upper GI endoscopy 
The study described in Chapter 2, is the first prospective, randomised, comparison to 
evaluate the role of unsedated transnasal OGD (T-OGD) as an alternative to per-oral 
conventional OGD (C-OGD) in the UK. This comparison of latest available UT 
endoscopes with the most commonly available conventional gastroscope is also one of 
the most comprehensive. Aside from a general comparison of T-OGD with C-OGD in 
terms of patient tolerance (from multiple perspectives i.e. patient, nurse and 
endoscopist), T-OGD feasibility (procedure preparation, duration and recovery times), 
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safety and diagnostic performance (endoscopic view and biopsy quality); the study also 
compared the performance of 2 different sized UT endoscopes used via both the 
transnasal and oral route. 
 
The findings for the general appraisal of C-OGD1 (OGD using 9.0mm endoscopes) as 
compared with T-OGD are similar to those of studies performed in other countries and 
show that T-OGD is significantly better tolerated than C-OGD1 performed with or  
without low dose sedation [8;9;11-13;133;134].  The comparative evaluation of the use 
of UT endoscopes for OGD performed via the transnasal vs. the oral route suggested that 
improved patient experience during OGD is more dependent upon the route used for the 
procedure than the endoscope calibre itself, echoing reports from other groups 
[2;12;13;16;135].  
My comparisons of endoscopic view quality, diagnostic yield (including biopsy quality) 
and technical feasibility showed that the performance of UT endoscopes is comparable 
to that of the wider calibre conventional endoscope used in the study. The failure rate for 
passage of the UT endoscope through the transnasal route was low (6%) and within the 
same range reported elsewhere (3-8%) [2;10;13;144]. As regards to preparation and 
procedure duration, I found that it took longer to prepare for and to perform T-OGD; 
however, this was offset by a significantly shorter recovery time for T-OGD. The 
enhanced recovery associated with T-OGD has been shown to potentially facilitate 
savings in personnel and facility costs in the order of 20-36% [145;146].   
My comparison of patient experience and overall performance with the 2 UT endoscopes 
showed that the slimmer, 4.9mm endoscope did not offer any significant advantages over 
the 5.9mm UT endoscope; in fact views of the duodenum were deemed to be inferior and 
handling of the thinner endoscope more difficult.  
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The first prospective study to compare T-OGD using the latest available UT 5.9mm and 
4.9mm endoscopes with C-OGD in the UK, has confirmed that unsedated transnasal 
endoscopy is associated with significantly higher levels of patient tolerance and 
satisfaction as compared with C-OGD. The study also confirmed that even within a UK 
clinical setting, T-OGD is a highly feasible and safe alternative to C-OGD and affords 
similar diagnostic quality. The use of UT endoscopes via the oral but more so the 
transnasal route is confirmed to be associated with improved patient tolerance as 
compared with C-OGD.  
 
Although this study was performed in a tertiary referral institute of academic endoscopy, 
its findings are universally applicable to other endoscopy centres within the country. In 
my experience and that of others [276], T-OGD is not a difficult procedure to learn and 
after a short session of mentoring, one only requires a few cases to gain proficiency. The 
key to success relies on adequate patient preparation with topical anaesthesia and 
‘generous’ lubrication of the endoscope shaft, in order to ensure ease of insertion and 
patient comfort. The procedure’s safety and tolerability lends itself well to endoscopy 
nurse-led services. In our institution, for example, the senior nurse endoscopist who took 
part in our study took initiative to train other nurses in the technique in order to be able 
to provide a sedation free, ‘pure’ T-OGD list in the near future. It is also likely, that the 
advantages associated with T-OGD may be amplified further in the setting of a district 
general or community hospital or specialised GP practice where investigation of upper 
GI symptoms could be performed more cost effectively while avoiding the need for 
additional staff and sedation associated risks and expense. The findings of the study may 
help to generate more awareness of the success and tolerability of T-OGD and its general 
applicability to UK clinical practice. Furthermore, new indications which take advantage 
of the favourable characteristics of UT endoscopes such as single-step naso-jejunal tube 
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placement and high resolution direct cholangioscopy [276-280] demonstrate that the 
place of these advanced instruments in the endoscopy unit is not limited to T-OGD. 
 
10.1.3 Small bowel endoscopy (Enteroscopy) 
 
The advances in endoscopic technology seen over the last few years have revolutionised 
the practice of flexible endoscopy of the SB. As a result of this breakthrough, brought 
about by the introduction of device assisted enteroscopy, DBE in particular, endoscopists 
are no longer confined by the intrinsic limitations of push enteroscopy (PE) or the 
invasiveness of intra-operative enteroscopy (IOE) and instead, are able to effectively 
‘delve into the depths of the SB’ without the need for major operative surgery.  
As a reflection of this impressive leap forward, much of this thesis has involved studies 
examining minimally invasive aspects of flexible endoscopy as applied to the SB. These 
studies included an evaluation of the current overall performance, limitations and safety 
of DBE practised in UK hospitals with an interest in deep enteroscopy, the application of 
DBE to the provision of minimally invasive endotherapy and a comparison of DBE with 
the more recently developed SB technology, known as spiral enteroscopy (SE).  
 
My evaluation of the performance, limitations and safety of DBE practice in the UK is 
described in Chapter 3. The overall diagnostic yield of positive findings of the first 1000 
DBE cases performed in the UK was 57.8%; a result that is comparable to the overall 
pooled detection rate of 68.1%, as reported [148] in a recent international systematic 
review including 45 studies with a total of 5615 patients. Similar to the findings of a 
German database [39], the diagnostic yield of the UK cases was (at least in part), 
dependent on indication and suggests that careful patient selection before consideration 
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for DBE may impact procedure outcome. Perhaps not surprisingly, the diagnostic yield 
was higher for patients, in whom pan-enteroscopy was achieved, supporting the view 
that although challenging, particularly in patients with a history of laparotomy, an 
attempt at achieving pan-enteroscopy in selected patients can be worthwhile [155].   
DBE procedures performed in patients with a history of abdominal or pelvic surgery 
were associated with a significantly lower median SB insertion depth as compared with 
procedures performed in surgically naïve patients. SB tethering and unfavourable 
looping occurred significantly more often in patients with a history of surgery and were 
considered to be the major limitations to DBE insertion. The UK experience and that of 
others [27;152;156;157] highlights how post-surgical changes to SB anatomy may 
challenge successful intubation during DBE procedures by leading to a reduction in 
insertion depth. Adhesive disease is also likely to be a contributing factor to the UK pan-
enteroscopy outcome of 17.7%, while similar to the pan-enteroscopy rate of 21%, 
reported by the (prospective) German database [39], is at the lower end of the range of 
pan-enteroscopy rates (8-66%) described by other European series [30;155;158].  
I found that the median depth of SB insertion during DBE appears to be affected by the 
route of approach and type of gas used for insufflation. The anterograde route was found 
to be associated with deeper SB insertion as compared with the retrograde route and 
supports the notion that the latter approach is more technically challenging [152;153]. 
The results also supported the findings of Domagk et al. [154] who showed that the use 
of CO2 as an insufflating agent was also associated with deeper SB insertion.  
In the UK, the overall immediate complication rate of 1% is similar to that (0.72-1.2%) 
reported by others [27;30;38;39;148]. Also similar to the findings of other reports 
[27;30;38;39;148], most immediate adverse events (9/10) were related to the use of 
endotherapy (such as polypectomy and dilatation of SB strictures). In the UK 
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experience, post-DBE pancreatitis was also rare entity and only occurred during 1 
anterograde case (0.1% of all DBE procedures, 0.l5% of anterograde DBEs); a result 
which compares favourably to those reported by others (0.2%-0.49%) [27;30;38;39;148]. 
Although none of the UK complications was associated with any mortality, it must be 
stressed that our series lacked formal 30 day complication data and it is therefore 
possible that serious longer-term complications may have been missed. 
Despite the study’s limitations (related to retrospective analysis, heterogeneity of 
experience among DBE users and lack of 30 day complication data), this first report of 
the performance, limitations and safety of DBE performed in the UK provides 
reassurance of the safety and effectiveness of DBE, particularly in a UK setting. Careful 
consideration to the limitations of DBE as highlighted in the report may help 
endoscopists to improve the success of future procedures. The use of the two published 
[167;168] original, alternative techniques for DBE insertion, described in chapter 4 may 
also help endoscopists to overcome some of the technical limitations reported by the UK 
DBE experience. 
 
The application of specific types of minimally invasive DBE facilitated endotherapy 
with the deep SB is described in chapters 5, 6 and 7, respectively. 
 
Chapter 5 describes one of the first published series [188] to demonstrate the 
effectiveness of DBE enabled endoscopic balloon dilatation of SB strictures, related to 
Crohn’s disease (CD). The results of this cohort study (which were drawn upon by an 
international OMED-ECCO committee for the formulation of consensus statements on 
the use of SB endoscopy in patients with inflammatory bowel disease (IBD) [171]), 
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showed that DBE facilitated SB stricture dilatation in CD is feasible and effective. In 
this study of 11 patients, stricture dilatation was feasible in 9 patients (in the other 2 
patients, the strictures could not be reached, due to limited insertion depth within the 
post-surgical abdomen). In 8 of these 9 patients, stricture dilatation was uncomplicated 
and at a mean follow-up period of 20.5 months, although 2 patients required repeat 
dilatation, all 8 patients remained surgery-free, with significant improvement of their 
VAS scores for obstructive symptoms.  In this study, 1 patient (with actively inflamed 
CD strictures) unfortunately developed a delayed perforation requiring a temporary 
jejunostomy. This case highlights the fact that although endoscopic balloon dilatation of 
strictures is considered a relatively safe procedure, the risk of perforation in certain cases 
may be as high as 11% [186;187]. SB strictures that are long (>5cm), severely inflamed 
and ulcerated should therefore be considered high-risk and a potential contraindication to 
DBE assisted balloon dilatation [42].  
The study demonstrated that the technique of DBE facilitated SB stricture dilatation 
offers a minimally invasive, effective alternative to surgical resection or stricturoplasty 
for selected patients with fibrostenotic CD of the SB.  Since the publication of this study 
[188], a further study from Japan [189] has confirmed these findings and showed that 
DBE facilitated endoscopic balloon dilatation was successful in 18 of 25 cases. Two 
patients in the Japanese cohort suffered complications in the form of bleeding and 
pancreatitis but the cumulative surgery-free rates for all subjects were 83% and 72% at 6 
and 12 months respectively [189].   
The results add to the growing evidence in support of this minimally invasive approach 
to the management of selected patients with CD SB strictures and its incorporation into 
daily clinical practice as proposed by the original, published algorithm (Figure 39) 
[281;282] . 
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In chapter 6, the largest study to date on DBE facilitated polypectomy of SB polyps in 
patients with PJS is described. In this cohort of 36 patients (24 adults and 12 children), 
DBE facilitated polypectomy was shown to be an effective alternative to laparotomy and 
IOE for selected adult and paediatric patients with PJS and significant SB polyposis. 
DBE (with or without laparoscopic assistance) facilitated significant polyp clearance in 
74% of patients and these remained symptom and intervention free at a median follow-
up of 2 years.  This study also confirmed that a past history of surgery and resultant 
formation of adhesive disease limits the depth of SB insertion achievable at DBE and led 
to incomplete procedures in several cases. Interestingly, SB tethering with tight 
angulations and irreducible looping, resulting in inadequate depth of insertion were 
encountered solely in adults but none of the children, most likely to be reflective of 
underlying post-surgical SB adhesive disease, since 92% of adults had a history of 
previous, often multiple laparotomies, as compared with just 25% of children. The 
outcome here suggests that removal of significant SB polyps for selected patients with 
PJS by DBE is likely to be most successful when offered to patients earlier-on in life, 
before exposure to multiple major abdominal surgeries. The study also evaluated the use 
of laparoscopic assistance [216] for high risk, sessile polyps. Although more invasive 
than DBE alone, lap-DBE is still less invasive than laparotomy with IOE and was 
successful in 3 of 4 patients undergoing this procedure.  
Considering these limitations (26% of patients in the cohort ultimately required surgery) 
as well as the natural history of PJS, it is clear, that laparotomy with IOE will continue to 
have a major role in the therapeutic management of PJS SB polyposis. The study also 
underlines the importance of ensuring that these procedures are performed with expert 
surgical back-up to hand. One of the patients in this cohort suffered an acute post-
polypectomy perforation during an emergency DBE for intussusception and a successful 
207 
  
outcome was ensured by the immediate conversion of the procedure to a laparotomy and 
IOE through the defect by the attending surgeon and endoscopist.  
The ideal management of patients affected by this condition will continue to demand a 
dedicated, multi-disciplinary approach that is tailor-made according to the needs of each 
patient. Nonetheless, this largest combined series of adult and paediatric patients with 
PJS to be reported to date, demonstrates that DBE facilitated polypectomy provides an 
effective therapeutic alternative to laparotomy with IOE [207-210;212]. The introduction 
of a DBE-based approach to therapy earlier-on in life may improve polyp clearance 
success rates if small bowel surgery and therefore adhesional disease can be avoided. If 
successfully achieved, the outcomes of this minimally invasive approach, like more 
traditional methods, have the potential to alter the course of the disease process in 
patients with PJS SB polyposis. 
 
Chapter 7 describes the first prospective published series to focus on the feasibility and 
technique of DBE assisted DPEJ [238]. This series demonstrated the success and safety 
of an adaptation of the original PE method described by Shike et al. [232], using DBE to 
facilitate ‘a stable platform’ for DPEJ insertion within a suitably accessible, superficial 
loop of jejunum. In this cohort, the intrinsic characteristics of controlled endoscopic 
insertion with minimal of SB looping and stretching [20;45;54;152] facilitated safe and 
successful DPEJ placement in 9 of the 10 patients in whom it was attempted. This result 
compares favourably to the outcomes relating to the PE based technique, where failure 
rates may be as high as 32% [231]. 
 
This small cohort was the first published study [238] to demonstrate the feasibility and 
safety of DBE assisted DPEJ placement as a safe and successful alternative technique to 
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PE facilitated insertion. Although no adverse events occurred in this series, it is likely 
that the overall complication rate (of up to 10%) associated with DPEJ placement by PE 
[231], may still apply to the DBE facilitated technique and this should be borne in mind 
when considering this type of enteral access in routine clinical practice.  
 
The prospective comparative study of spiral enteroscopy (SE) and DBE described in 
chapter 8 is the first back-to-back study to be performed within the same cohort of 
patients, using the same method of SB insertion depth estimation for both SE and DBE. 
Since initial experience suggested that this technology may facilitate relatively faster 
deep enteroscopy [57-59;62;264-266], the introduction of SE was met with much 
interest. However, 2 dedicated prospective studies [60;61] which compared SE with 
DBE, used different methodologies to assess SB insertion depth achieved during SE and 
DBE procedures and it therefore remained unclear as to whether these 2 procedures 
facilitated the achievement of similar SB insertion depths. In order to try to provide a 
definitive conclusion, a prospective, back-to-back comparative study of SE and DBE 
performance, using the same method of SB insertion depth estimation was performed.  
In this study, SB insertion depth was estimated during DBE procedures, only using the 
method described by May et al. [51]. The results showed that DBE facilitated deeper SB 
intubation than SE most often and in 14/15 patients enrolled, DBE not only enabled 
visualisation of the sub-mucosal tattoo placed at SE but also facilitated significantly 
deeper enteroscopy, as compared with SE. Similar to the results of the Wiesbaden study 
[61], the median time taken to reach maximal SB insertion depth was significantly 
shorter for SE as compared with DBE. However, in the 14/15 patients where the 
comparison was possible, our study showed that the median times taken to reach the 
same the same depth were similar for both procedures, suggesting that both had a similar 
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a rate of advancement into the SB. Although I accept that this study has limitations 
relating to potential intrinsic bias (non-randomised order of procedures and early 
conclusion), it is the first study to compare the performance of SE with DBE using the 
same method for estimating SB insertion depth, showed that in its current (manual) 
form, SE appears to be inferior to DBE in terms of its ability to achieve deep SB 
insertion and similar to DBE in terms of SB insertion speed. While larger studies are 
required to confirm these results, the findings suggest that DBE remains the ‘gold 
standard’ deep enteroscopy technology and that the performance of manual SE does not 
appear to be equivalent.  
The main outcome measure of this study related to a comparison of SB insertion depth. 
Although this is often used as a surrogate marker for clinical performance of these 
respective technologies, one must bear in mind that we remain uncertain as to whether or 
not this translates into improved clinical outcomes. Possibly, a more clinically useful 
comparison may be obtained by using diagnostic yield or detection/treatment of SB 
pathology as the main outcome measure. Since it is likely that such a comparative study 
would need to enrol much larger numbers of patients than those included in our study 
and the studies by Frieling and May [60;61], a multi-centre, possibly international set-up 
is likely to be required. 
 
The remarkable technological developments witnessed over the last decade have 
revolutionised the investigation and management of SB disease. In parallel to the 
introduction of the breakthrough endoscopic technologies of SBCE and deep 
enteroscopy, there has also been significant progress in dedicated SB cross-sectional 
imaging technologies in the form of CT and MR enterography/enteroclysis [283-292].   
These radiological technologies complement their endoscopic ‘counterparts’ in that they 
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are also able to provide detail about mural and extramural pathology/anatomy while also 
providing further information regarding the vascularity of lesions and the degree of 
active inflammation. State-of-the-art dedicated SB cross-sectional imaging also has a 
role to play in the pre-assessment of patients being considered for deep enteroscopy, 
particularly in the presence of suspected SB strictures which have precluded (or 
complicated) the use of SBCE.  The SB endoscopic technologies on the other hand, are 
able to provide a detailed visual assessment of SB mucosal pathology. SBCE and deep 
enteroscopy technologies are also non-competitive modalities which complement each 
other. SBCE, being the least invasive ‘arm’ of SB endoscopy is used as a first-line 
‘scout’ in patients with suspected SB disease. Deep enteroscopy is then employed in 
patients who require further evaluation or treatment of pathology identified by other 
means, since it is generally considered to represent the ‘therapeutic arm’ of SB 
endoscopy.  
Although all these relatively new technologies require dedicated training to gain 
proficiency, deep enteroscopy is particularly labour-intensive and requires prolonged, 
focused commitment. While some reports on DBE training have suggested that 
performance may improve after about 20 to 35 procedures [152;159], as reported by 
Gross et al.[160], expertise in the procedure requires significantly more experience to be 
achieved (>100 – 150 procedures); this is particularly relevant to the more challenging 
retrograde (rectal route) approach. These data on training strongly suggests that expertise 
in DBE (and related deep enteroscopy technologies such as single-balloon and spiral 
enteroscopy) would best be achieved through dedicated, lengthy advanced endoscopy 
fellowships in specialist centres. Measures of competency in deep enteroscopy should in 
the future be assessed by validated competency assessment tools, similar to those used 
for colonoscopy and polypectomy [161-165]. Key performance indicators could include 
measures of lesion recognition, diagnostic yield, depth of SB insertion, success of deep 
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SB intubation via the retrograde route, success of deep SB intubation in technically 
challenging cases (such as procedures performed in patients with a history of 
abdominal/pelvic surgery), success of therapy in cases with a therapeutic indication and 
peri-procedure and 30 day complication rates. Given the labour intensive and 
challenging nature of these procedures, it is likely that in order to achieve long-term, 
high quality safe and successful outcomes deep enteroscopy services will only be 
provided by a few tertiary referral centres across the country. Apart from enhancing 
outcomes for patients, this model of care in dedicated SB endoscopy centres would also 
enable the efficient use of scarce and expensive resources (such as anaesthetic support 
and case-specific lists) within our healthcare system.  
 
10.1.4 Colonoscopy 
Chapter 9 describes a prospective, randomised comparative study of DBC vs. CC for TD 
cases. This is only the second study to perform such a comparison and the first to use an 
objective, evidence based [63;65-68;70-77;80-100], cumulative scoring system (Table 
20) to define TD colonoscopy. The construct validity of the scoring system was assessed 
by means of a pilot study which demonstrated significant positive correlation between 
the magnitude of the proposed TD score and the time taken to achieve caecal intubation 
(a frequently used surrogate marker of technical difficulty [67;68;70-77;79]). The 
comparative study of DBC vs. CC for TD cases showed that the unassisted caecal 
intubation rate (i.e. where no ancillary equipment was required) was significantly higher 
for DBC. These findings are similar to those of Suzuki et al. [113] who also showed a 
significantly higher caecal intubation rate for DBC, even though the Japanese 
investigators used ancillary assistance with  magnetic endoscopic imaging (MEI) + 
transparent cap for all their CC cases from the start of each procedure. Unlike the 
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findings of the Japanese study, the results of our study did not show a significant 
difference in the time taken to complete either of the 2 types of colonoscopy. However, 
our findings showed that patient discomfort and pain VAS scores were significantly 
lower for DBC as compared with CC procedures. Sedation requirements were also 
significantly lower for DBC and this was reflected by a shorter recover period after DBC 
procedures. My findings support the results of Suzuki et al. [113] who reported that DBC 
was associated with lower pain VAS scores and sedation requirements. Analysis of 
patient satisfaction showed significantly higher levels of satisfaction in the DBC group 
and while all the patients in DBC group said that they were ready to undergo the same 
type of procedure again, 41% of patients in the CC group said that they would consider 
an alternative option in the future. Finally, evaluation of the technical performance VAS 
scores showed that endoscopists found DBC easier to perform than CC procedures.  
‘Technical difficulty’ was defined by the use of an evidenced based, cumulative scoring 
system, incorporating patient characteristics which have been shown to be associated 
with a TD procedure. This scoring system (which was provisionally validated by a pilot 
study), may lend itself to routine clinical practice, potentially allowing endoscopists to 
pre-plan their lists according to the TD score of patients, which is calculated prior to 
colonoscopy. This randomised comparative study of DBC vs. CC for TD colonoscopy 
suggests that DBC is a useful instrument for achieving successful caecal intubation and 
is associated with an improved patient experience. The findings favour the incorporation 
of DBC into the armamentarium of the endoscopy unit. 
DBC complements other alternative technologies such as computed tomographic 
colonography (CTC) [293-304] and colon capsule endoscopy (CCE) (Pillcam Colon2, 
Given Imaging, Yoqneam, Israel) [305-309] in the investigation of suspected colonic 
pathology in cases of TD colonoscopy. CTC, which is the more established and readily 
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available of these 2 alternative technologies, can be performed using minimal bowel 
preparation (incorporating faecal tagging with simple radio-opaque contrast media (such 
as barium) with subsequent electronic ‘subtraction’ of the luminal contents, also known 
as ‘electronic cleansing’) [295;296;300-304], also allows for the detection of extra-
luminal pathology and has diagnostic sensitivities and specificities which are similar to 
colonoscopy [295-297;299-303]. Its main disadvantage comes from radiation-exposure 
related risks [293]. Second generation CCE is an emerging technology which employs 
the use of a ‘dual-headed’ wireless capsule endoscope (Figure 62) with a capacity to 
vary its image capture frame-rate (from 4 to 35 frames per second), depending on the 
speed of colonic transit. This technology’s main advantages relate to its minimally 
invasive and radiation-free nature. Although recent data have reported a diagnostic 
sensitivity and specificity of 89% [310;311], which approaches that of colonoscopy, 
these outcomes are dependent on a rigorous bowel preparation regimen which at present 
may reduce this modality’s appeal and clinical applicability [310;311]. 
 
Figure 62:  The Pillcam Colon2 second generation wireless colon capsule endoscope (Image 
courtesy of Given Imaging, Yoqneam, Israel) 
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It is therefore likely that in the day-to-day clinical setting of TD or failed conventional 
colonoscopy, patients will be referred for a CTC or possibly a CCE in the first instance 
and if these initial investigations were to reveal colonic pathology, warranting further 
colonoscopic evaluation or intervention, DBC could be considered next since this may 
facilitate success. 
 
10.2 Conclusion and future directions 
 
In conclusion, this thesis has examined the role and usefulness of a selection of advanced 
flexible GI endoscopic technologies for the enhancement of minimally invasive patient 
care. The first evaluation of transnasal upper GI endoscopy performed in the UK, 
confirmed that transnasal endoscopy using ultrathin endoscopes, is a feasible, effective 
and acceptable alternative to conventional oral upper GI endoscopy and may help to 
broaden its clinical appeal in this country. 
The series of studies which followed were dedicated to device assisted enteroscopy 
(DBE in particular); these studies showed that DBE is capable of providing a safe and 
effective, minimally invasive alternative to surgery in selected patients with particular 
clinical conditions. A comparison of spiral enteroscopy as an alternative to DBE, showed 
that spiral enteroscopy (in its current, manual form), appears to be inferior to DBE in its 
ability to facilitate deep enteroscopy. Further work is required in order to establish 
whether or not this translates to improved outcomes in routine clinical practice. It is also 
important to note that deep enteroscopy requires intensive dedicated training which may 
best be obtained through advanced fellowships at specialised tertiary centres. Given the 
set-up and training required, it is also likely that deep enteroscopy services are likely to 
continue to be delivered at dedicated centres.  
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The work evaluating technically difficult colonoscopy has i) enabled the development 
and preliminary validation of a score for technical difficulty which after further work, 
has the potential to be applied to routine clinical practice in the future and ii) established 
the usefulness of DBC as a more effective tool (as compared to conventional 
colonoscopy without ancillary assistance) in technically difficult cases where caecal 
intubation is required. In day-to-day clinical practice, DBC may complement alternative 
technologies such as CTC and CCE for the investigation and management of cases of 
TD colonoscopy. 
 
In the future, further technical developments may continue to enhance the performance 
of ultrathin upper GI endoscopes by the integration of higher definition CCD and 
brighter, more efficient illumination using advanced light emitting diode (LED) 
technology. The incorporation of a wider calibre instrument channel may also expand 
the therapeutic applications of these endoscopes. Such improvements may also continue 
to broaden the application of ultrathin instruments to other fields of GI endoscopy (such 
as one-step naso-jejunal tube placement, direct cholangioscopy and as auxiliary 
instruments for endoscopic resection of large polyps).  
Another technology which may have an impact on deep enteroscopy practice is the 
concept of ‘motor-powered’ spiral enteroscopy [312]. This technology (which still 
awaits FDA and CE approval), involves the use of a motor-powered, single-operator; 
foot-pedal controlled spiral incorporated into a dedicated 160cm enteroscope (Figure 
63). A pilot study performed by Akerman et al. in 27 patients [312] using the  latest 
version of the prototype, showed that the motor-powered spiral enteroscopy was able to 
facilitate visualisation of the entire GI tract (using a combination of anterograde and 
retrograde approaches) within approximately 60 minutes. Although this appears to be 
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promising, it is likely that some of the limitations relating to manual spiral enteroscopy 
(such as tissue trauma and concern about its use in the post-surgical abdomen) would 
still apply to the motor-powered version and that specific measures to mitigate these 
limitations (possibly including the use of a retractable spiral) may need to be developed.  
 
Figure 63:  The ‘Endeavour®’ motorised-spiral enteroscope prototype (Spirus Medical, LLC, MA, 
USA) incorporating a removable, motor-controlled plastic spiral. (Image courtesy of 
Spirus Medical, LLC, MA, USA) 
 
 
 
 
 
 
 
 
 
Other ground-breaking advances in the field of flexible GI endoscopy also include the 
award winning ‘i-Snake’, developed by a multidisciplinary team from the Departments 
of Computing and Surgery and the Institute of Biomedical Engineering at this university 
(Imperial College London) [313;314]. The ‘i-Snake’ aims to become the ‘intelligent 
endoscopic platform of the future’, with integration of state of the art imaging 
technology, specially designed articulated ‘joints’ and sensor-assisted control (Figure 
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64) [313;314]. This cutting-edge platform is intended to augment the precision and 
success of minimally invasive flexible endoscopy and endo-surgery and associated 
benefits to patient care. 
 
Figure 64: Computer generated model of the ‘i-Snake’ illustrating the head of the instrument and 
specially designed robotic ‘joints’ and sensors (Image courtesy of Imperial College 
London) 
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7. UEGW Travel Grant  
UEGW, Vienna, Austria  
(€1,000; Oct 2008)  
Awarded for the quality of an abstract accepted for presentation 
 
8. British Society of Gastroenterology/Keymed-Olympus Travel Grant 
DDW and Advanced Endoscopy Update, San Diego and South Carolina, USA  
($1,500; May 2008)  
Awarded one of the only 10 UK places to attend DDW and the Advanced 
Endoscopy Update at Professor P. Cotton’s Unit at the Medical University of 
South Carolina (MUSC) 
 
 
A1.7 Organisation of courses and symposia 
 
Throughout the course of my studies, I have also taken the opportunity to co-organise 
with Dr Fraser several symposia and courses relating to the advanced endoscopy 
technologies described in this thesis. These included the ‘1st and 2nd UK double-balloon 
enteroscopy symposia’ and the ‘1st European Deep Enteroscopy Masterclass’ which also 
included hands-on training on dedicated endoscopy animal training models. 
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Appendix 2 
St Mark's Conventional Endoscopy versus trans-
Nasal endoscopy sTudy (SCENT): data collection 
sheets  
A2.1 Patient’s own assessment: visual analogue scale (VAS)  
 
Please place an “X” at the appropriate point on each line that best represents how you felt during the test you have just 
undergone: 
 
           
          No discomfort                Severe discomfort 
   
 
               No pain                          Severe pain 
 
   
                 No gagging sensation                                                 Severe gagging sensation 
 
     
                             No nausea                          Severe nausea   
  
 
                            No anxiety               Severe anxiety   
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A2.2 Patient’s own assessment: Likert satisfaction score 
 
Overall, how satisfied are you with the test you have undergone?  
 (Please tick the appropriate box as shown:  ) 
 
 
       very satisfied         satisfied          neutral          dissatisfied     very dissatisfied 
 
                 □                      □                   □                    □                    □                              
 
 
Should you require another gastroscopy in the future, would you have the test done the same way next time?  
 
Yes □       No □ 
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A2.2 Nurse assessment: visual analogue scales (VAS) for perceived 
patient discomfort and anxiety; record of vital parameters and dose of 
sedative used      
 
                             No discomfort               Severe discomfort  
 
                             
             No anxiety               Severe anxiety   
 
 
 
Lowest oxygen saturation during the procedure: ____ 
 
 
 
Lowest systolic blood pressure during the procedure: ____ 
 
 
Highest systolic blood pressure during the procedure: ____ 
 
 
Lowest pulse rate during the procedure: ____ 
 
 
Highest pulse rate during the procedure: ____ 
 
 
Timing of the actual procedure (mins): ____ 
 
 
Dose of midazolam used: ____ 
 
 
Recovery time (mins): ____ 
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 A2.3 Endoscopist assessment: visual analogue scales (VAS) for 
perceived patient discomfort, anxiety and technical aspects  
 
                         No discomfort              Severe discomfort  
 
 
                             No anxiety               Severe anxiety   
 
Technical Aspects  
Ease of endoscope insertion 
 
                      Very difficult                        Very easy 
   
 
Endoscope handling, steerability 
 
                              Very poor                   Very good  
 
 
Ease of D2 intubation 
                            Very difficult              Very easy 
 
 
Ease of taking random biopsies 
                        Very difficult             Very easy 
 
 
Ease of taking targeted biopsies 
                        Very difficult            Very easy 
 
Overall feasibility of procedure 
                           Not feasible          Very feasible 
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A2.4 Endoscopist assessment: visual analogue scales (VAS) for 
endoscopic view quality 
 
Views of the oesophagus 
                              Very poor              Very good 
 
 
Views of the stomach (forward view) 
                             Very poor             Very good 
 
 
Views of the stomach (retroflexed view) 
                               Very poor                Very good 
 
 
Views of the first part of the duodenum (D1) 
 
                             Very poor             Very good 
 
 
Views of the second part of the duodenum (D2) 
                               Very poor                Very good 
 
 
Overall impression of diagnostic ability of the endoscope 
                               Very poor          Very good 
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A2.5 Views obtained through ultrathin and conventional upper GI 
endoscopes 
Figure A2.5.1        Views of the upper GI tract as obtained through an ultrathin endoscope (EG-530N, 
Fujifilm, Saitama, Japan); gastro-oesophageal junction (A); fundus and cardia (B); 
pyloric antrum (C) and second part of duodenum (D). 
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Figure A2.5.2 Views of the upper GI tract as obtained by a conventional endoscope (GIF-XQ260, 
Olympus, Tokyo, Japan); gastro-oesophageal junction (A); fundus and cardia (B); 
pyloric antrum (C) and second part of duodenum (D). 
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Appendix 3 
SPiral Enteroscopy Comparative Study (SPECS): 
data collection sheets  
 
A3.1 Patient demographics, indication for deep enteroscopy and past 
surgical history                  
 
Gender:          M □           F□ 
  
Age: ____ 
  
Indication for deep enteroscopy procedure: 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
  
Past history of abdominal or pelvic surgery: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
Additional comments: 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
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A3.2 Spiral enteroscopy (SE) data                 
 
 
Time taken to reach most distal point of insertion: ________ (min) 
 
Time taken to complete the whole SE procedure: ________(min) 
 
Estimated depth of insertion at SE: _________________ (cm) 
 
Findings at SE: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
VAS: ease of SE procedure (estimated by endoscopist): 
 
 Very easy                          Very difficult 
   
 
 
 
 
Complications (if any): 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
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A3.3 Double-balloon enteroscopy (DBE) data                 
 
 
Time taken to reach most distal point of insertion: ________ (min) 
 
Time taken to complete the whole DBE procedure: ________(min) 
 
Estimated depth of insertion at DBE: _________________ (cm) 
 
Findings at DBE: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
VAS: ease of DBE procedure (estimated by endoscopist): 
 
 Very easy                          Very difficult 
   
 
 
 
 
Complications (if any): 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________ 
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Appendix 4 
Double-balloon colonoscopy vs. conventional 
colonoscopy: data collection sheets  
 
A4.1 Patient’s own assessment: visual analogue scale (VAS) and Likert 
satisfaction score 
 
 
Please place an “X” at the appropriate point on each line which best represents how you felt during the test you have 
just undergone: 
 
          
 
 
          No discomfort                 Severe discomfort 
   
 
 
 
 
 
 
 
 
 
              No pain                           Severe pain 
 
 
   
 
 
   
 
 
Overall, how satisfied are you with the test you have undergone?  
 (Please tick the appropriate box as shown:  ) 
 
 
 
 
       very satisfied         satisfied          neutral          dissatisfied     very dissatisfied 
 
                 □                      □                   □                    □                    □                    
 
 
           
Should you require another colonoscopy in the future, would you have the test done the same way next time?  
Yes □       No □ 
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A4.2 Nurse assessment: visual analogue scales (VAS) for perceived 
patient discomfort and pain; record of vital parameters and dose of 
sedative used 
 
 
 
Perceived overall patient discomfort and pain during procedure 
 
 
 
                  No discomfort                    Severe discomfort
    
 
 
 
 
 
 
             No pain                       Severe pain 
 
 
   
 
 
 
 
Lowest oxygen saturation during the procedure: ____ 
 
Lowest systolic blood pressure during the procedure: ____ 
 
 
Highest systolic blood pressure during the procedure: ____ 
 
 
Lowest pulse rate during the procedure: ____ 
 
 
Highest pulse rate during the procedure: ____ 
 
 
Timing of the actual procedure (mins): ____ 
 
 
Dose of midazolam used: ____ 
 
 
Dose of pethidine used: ____ 
 
 
Dose of propofol used: ____ 
 
 
Dose of Buscopan® used: ____ 
 
 
Dose of glucagon used: ____ 
 
 
Recovery time (mins): ____ 
 
Time to caecal intubation (mins): ____   
 
Time taken to complete the colonoscopy (mins):  ____ 
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A4.3 Waist, hip-girth, height and weight measurements and calculated 
BMI 
             
                       
 
Using a tape measure: 
1) Please measure the patient’s waist at the level of the umbilicus as shown by 
black rectangular mark on the diagram of the abdomen below  
and  
2) The patient’s hip girth at the level of the iliac crests as shown by the white 
rectangular mark on the diagram of the abdomen below 
 
 
 
 
Waist measurement (Black); Hip Measurement (White) 
 
 
Waist measurement (cm):________      
 
Hip measurement (cm):__________ 
 
Weight (kg): _________ 
 
Height (m):__________ 
 
BMI (weight (kg)/ height
2 
(m
2
): __________ 
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A4.4 Endoscopist assessment: visual analogue scales (VAS) for 
perceived patient discomfort and pain; technical ease of colonoscopy  
 
 
Perceived overall patient discomfort and pain during procedure 
 
 
 
                  No discomfort                    Severe discomfort
    
 
 
 
 
 
 
             No pain                       Severe pain 
 
 
   
 
 
 
 
Technical ease of colonoscopy procedure 
 
 
 
             Very easy                               Very challenging 
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A4.5 Patient recovery and discharge using the Modified Aldrete 
Recovery Scoring System 
 
            
Please use the following scoring system to record the patient’s recovery score at 5 minutes post-procedure 
and then at 10 minute intervals until a score ≥9 is reached.             
                      
 
 
 
Modified Aldrete Recovery Scoring System
* 
Respiration Score 
Able to breathe deeply and cough freely 2 
Dyspnoea, shallow or limited breathing 1 
Apnoea 0 
Oxygen saturation  
Saturation > 92% 2 
Needs supplemental oxygen to maintain saturation >90% 1 
Saturation <90% with oxygen 0 
Circulation  
Systolic blood pressure within 20mm Hg of pre-operative level 2 
Systolic blood pressure within 20-50mm Hg of pre-operative level  1 
Systolic blood pressure +/- 50mm Hg of pre-operative level 0 
Consciousness  
Fully awake 2 
Arousable on calling 1 
Unresponsive 0 
Activity: able to move voluntarily or on command  
Four extremities 2 
Two extremities 1 
No extremities 0 
*
Recovery is confirmed when the total score ≥9 
 
 
 
Full recovery has occurred (and the patient may be discharged) when the  
Aldrete score ≥9  
 
Time post procedure 
(minutes) 
5 10 20 30 40 50 60 
Total Aldrete score 
(Max score=10) 
       
265 
  
 
 
